0000950170-23-002467 | 10-K | XBRL Viewer

Other Accrued Liabilities

Note 19. Other Accrued Liabilities

The following table sets forth the components of the Company’s other accrued liabilities at December 31, 2022 and 2021.


	December 31,
	2022		2021
Accrued litigation (1)	$	41	$	36
Asset retirement obligations (1)		10		14
Income taxes		19		43
Customer rebates		90		83
Accrued interest		17		17
Operating lease liabilities (2)		49		59
Miscellaneous (3)		74		73
Total other accrued liabilities	$	300	$	325

(1)

Represents the current portions of accrued litigation and asset retirement obligations (see “Note 22 – Commitments and Contingent Liabilities”).

(2)

Represents the current portion of operating lease liabilities (see “Note 14 – Leases”).

(3)

Miscellaneous primarily includes accruals related to utility expenses, property taxes, a workers compensation indemnification liability and other miscellaneous expenses.

Property, Plant, and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Finance leased assets, gross	$ 91	$ 95
Interest capitalized	7	5	$ 4
Depreciation expense	$ 286	$ 309	$ 313

Debt

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Debt

20. Debt

The following table sets forth the components of the Company’s debt at December 31, 2022 and 2021.


	December 31,
	2022			2021
Senior secured term loans:
Tranche B-2 U.S. dollar term loan due April 2025	$	766		$	776
Tranche B-2 euro term loan due April 2025 (€333 at December 31, 2022 and €337 at December 31, 2021)		355			381
Senior unsecured notes:
4.000% due May 2026 (€441 at December 31, 2022 and €450 at December 31, 2021)		470			510
5.375% due May 2027		495			500
5.750% due November 2028		783			800
4.625% due November 2029		620			650
Finance lease liabilities		61			72
Financing obligation (1)		91			93
Total debt principal		3,641			3,782
Less: Unamortized issue discounts		(4	)		(5	)
Less: Unamortized debt issuance costs		(22	)		(28	)
Less: Short-term and current maturities of long-term debt		(25	)		(25	)
Long-term debt, net	$	3,590		$	3,724

(1)

At December 31, 2022 and 2021, financing obligation relates to the financed portion of the Chemours Discovery Hub. Refer to “Note 14 – Leases” for further details.

Senior Secured Credit Facilities

The Company’s credit agreement, as amended and restated on April 3, 2018, (“Credit Agreement”) provides for a seven-year, senior secured term loan facility and a five-year, $800 senior secured revolving credit facility (“Revolving Credit Facility”) (collectively, the “Senior Secured Credit Facilities”). On October 7, 2021, the Company entered into an amendment to the Credit Agreement (“Credit Agreement Amendment”) to, among other things, increase the aggregate commitment amount under the Revolving Credit Facility to $900 and extend the stated maturity date to October 7, 2026 (from April 3, 2023). The Credit Agreement is subject to a springing maturity in the event that the senior secured term loans due April 2025 and the senior unsecured notes due in May 2026 are not redeemed, repaid, modified, and/or refinanced within the 91-day period prior to their maturity date.

The senior secured term loan facility under the Senior Secured Credit Facilities provides for a class of term loans, denominated in U.S. dollars, in an aggregate principal amount of $900 (“Dollar Term Loan”) and a class of term loans, denominated in euros, in an aggregate principal amount of €350 (“Euro Term Loan”) (collectively, the “Term Loans”). The Dollar Term Loan bears a variable interest rate equal to, at the election of the Company, adjusted LIBOR plus 1.75% or adjusted base rate plus 0.75%, subject to an adjusted LIBOR or an adjusted base rate floor of 0.00% or 1.00%, respectively. The Euro Term Loan bears a variable interest rate equal to adjusted Euro Interbank Offered Rate ("EURIBOR") plus 2.00%, subject to an adjusted EURIBOR floor of 0.50%. The Term Loans will mature on April 3, 2025, and are subject to acceleration in certain circumstances.

At December 31, 2022, the effective interest rates on the Dollar Term Loan and the Euro Term Loan were 6.1% and 3.9%, respectively.

For the years ended December 31, 2022, 2021 and 2020, the Company made term loan repayments of $13 on its Term Loans. During 2021, the Company repurchased through open market transactions, an aggregate principal amount of $37 and made an optional prepayment of $54 on its senior secured term loans.

The proceeds of any loans made under the Revolving Credit Facility can be used for working capital needs and other general corporate purposes, including permitted acquisitions, as defined in the Credit Agreement. The Revolving Credit Facility bears a variable interest rate range based on the Company’s total net leverage ratio, as defined in the Credit Agreement, between (i) a 0.25% and a 1.00% spread for adjusted base rate loans, and (ii) a 1.25% and a 2.00% spread for LIBOR and EURIBOR loans. In addition, the Company is required to pay a commitment fee on the average daily unused amount of the Revolving Credit Facility within an interest rate range based on its total net leverage ratio, between 0.10% and 0.25%. At December 31, 2022, commitment fees on the Revolving Credit Facility were assessed at a rate of 0.10% per annum.

In 2020, as a precautionary measure in light of macroeconomic uncertainties driven by COVID-19, the Company drew $300 from its Revolving Credit Facility; the borrowings were repaid in the same year. No borrowings were outstanding under the Revolving Credit Facility at December 31, 2022 and 2021. Chemours also had $108 and $107 in letters of credit issued and outstanding under the Revolving Credit Facility at December 31, 2022 and 2021, respectively.

Under the Credit Agreement, solely with respect to the Revolving Credit Facility, the Company is required to maintain a senior secured net leverage ratio not to exceed 2.00 to 1.00 in each quarter, through the date of maturity. In addition, the Credit Agreement contains customary affirmative and negative covenants that, among other things, limit or restrict the Company’s and its subsidiaries’ ability, subject to certain exceptions, to incur additional indebtedness or liens, pay dividends, and engage in certain transactions, including mergers, acquisitions, asset sales, or investments, outside of specified carve-outs. The Credit Agreement also contains customary representations and warranties and events of default. The Company was in compliance with its debt covenants at December 31, 2022 and 2021.

The Company’s obligations under the Senior Secured Credit Facilities are guaranteed on a senior secured basis by all of its material domestic subsidiaries, which are also guarantors of the Company’s outstanding notes, subject to certain exceptions. The obligations under the Senior Secured Credit Facilities are also, subject to certain exceptions, secured by a first priority lien on substantially all of the Company’s assets and substantially all of the assets of its wholly-owned, material domestic subsidiaries, including 100% of the stock of certain of its domestic subsidiaries and 65% of the stock of certain of its foreign subsidiaries.

Senior Unsecured Notes

Senior Unsecured Notes Due May 2027

On May 23, 2017, the Company issued a $500 aggregate principal amount of 5.375% senior unsecured notes due May 2027 (the “2027 Notes”). The 2027 Notes require payment of principal at maturity and interest semi-annually in cash and in arrears on May 15 and November 15 of each year. The Company received proceeds of $489, net of an original issue discount of $5 and underwriting fees and other related expenses of $6, which are deferred and amortized to interest expense using the effective interest method over the term of the 2027 Notes. A portion of the net proceeds from the 2027 Notes was used to pay the $335 of the First MDL Settlement, as discussed in “Note 22 – Commitments and Contingent Liabilities”. The remaining proceeds from the 2027 Notes were available for general corporate purposes.

The 2027 Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured unsubordinated basis by each of the Company’s existing and future direct and indirect domestic restricted subsidiaries that (i) incurs or guarantees indebtedness under the Senior Secured Credit Facilities, or (ii) guarantees certain other indebtedness of the Company or any guarantor in an aggregate principal amount in excess of $100. The guarantees of the 2027 Notes will rank equally with all other senior indebtedness of the guarantors. The 2027 Notes rank equally in right of payment to all of the Company’s existing and future unsecured unsubordinated debt and are senior in right of payment to all of its existing and future debt that is by its terms expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes are subordinated to indebtedness under the Senior Secured Credit Facilities, as well as any future secured debt to the extent of the value of the assets securing such debt, and structurally subordinated to the liabilities of any non-guarantor subsidiaries.

Pursuant to the terms of the indenture governing the 2027 Notes, the Company is obligated to offer to purchase the 2027 Notes at a price of 101% of the principal amount, together with accrued and unpaid interest, if any, up to, but not including, the date of purchase, upon the occurrence of certain change of control events. The Company may redeem the 2027 Notes, in whole or in part, at an amount equal to 100% of the aggregate principal amount plus a specified “make-whole” premium and accrued and unpaid interest, if any, to the date of purchase prior to February 15, 2027. The Company may also redeem some or all of the 2027 Notes by means other than a redemption, including tender offer and open market repurchases.

Senior Unsecured Notes Due May 2026

On June 6, 2018, the Company issued an aggregate principal amount of €450 4.000% senior unsecured notes due May 2026, denominated in euros (the “2026 Euro Notes”). The 2026 Euro Notes require payment of principal at maturity and payments of interest semi-annually in cash and in arrears on May 15 and November 15 of each year. The Company received net proceeds of €445, which, together with cash on hand, were used to purchase or redeem, as the case may be, the previously outstanding euro notes due May 2023 and a $250 aggregate principal amount of the 6.625% senior unsecured notes due May 2023, denominated in U.S. dollars (the “2023 Dollar Notes”) pursuant to a tender offer and the redemption, as well as pay for any fees and expenses in connection therewith.

The 2026 Euro Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured unsubordinated basis by each of the Company’s existing and future direct and indirect domestic restricted subsidiaries that (i) incurs or guarantees indebtedness under the Senior Secured Credit Facilities, or (ii) guarantees certain other indebtedness of the Company or any guarantor in an aggregate principal amount in excess of $100. The guarantees of the 2026 Euro Notes will rank equally with all other senior indebtedness of the guarantors. The 2026 Euro Notes also rank equally in right of payment to all of the Company’s existing and future unsecured unsubordinated debt and are senior in right of payment to all of its existing and future debt that is, by its terms, expressly subordinated in right of payment to the 2026 Euro Notes. The 2026 Euro Notes are subordinated to indebtedness under the Senior Secured Credit Facilities, as well as any future secured debt to the extent of the value of the assets securing such debt, and are structurally subordinated to the liabilities of any non-guarantor subsidiaries.

Pursuant to the terms of the indenture governing the 2026 Euro Notes, the Company is obligated to offer to purchase the 2026 Euro Notes at a price of 101% of the principal amount, together with accrued and unpaid interest, if any, up to, but not including, the date of purchase, upon the occurrence of certain change of control events. Prior to May 15, 2021, the Company may redeem the 2026 Euro Notes (i) in whole or in part, at an amount equal to 100% of the aggregate principal amount plus a specified “make-whole” premium, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date and (ii) on one or more occasions, up to 35% of the aggregate principal amount of the notes, with the net cash proceeds of one or more equity offerings at a price equal to 104% of the principal amounts of such notes, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date. On or after May 15, 2021, the Company may redeem the 2026 Euro Notes at specified redemption prices. The Company may also redeem some of all of the 2026 Euro Notes by means other than a redemption, including tender offer and open market repurchases.

Senior Unsecured Notes Due November 2028

On November 27, 2020, the Company issued an $800 aggregate principal amount of 5.750% senior unsecured notes due November 2028 (the “2028 Notes”) in an offering that was exempt from the registration requirements of the Securities Act. The 2028 Notes require payment of principal at maturity and interest semi-annually in cash and in arrears on May 15 and November 15 of each year. The Company received proceeds of $790, net of underwriting fees and other related expenses of $10, which are deferred and amortized to interest expense using the effective interest method over the term of the 2028 Notes. The net proceeds from the 2028 Notes were used, together with cash on hand, to purchase or redeem, as applicable, the remaining $908 aggregate principal amount of the 2023 Dollar Notes. In connection with the purchase and redemption of the remaining 2023 Dollar Notes, the Company incurred a loss on extinguishment of $22 for the year ended December 31, 2020.

The 2028 Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured unsubordinated basis by each of the Company’s existing and future direct and indirect domestic restricted subsidiaries that (i) incurs or guarantees indebtedness under the Senior Secured Credit Facilities, or (ii) guarantees certain other indebtedness of the Company or any guarantor in an aggregate principal amount in excess of $100. The guarantees of the 2028 Notes will rank equally with all other senior indebtedness of the guarantors. The 2028 Notes rank equally in right of payment to all of the Company’s existing and future unsecured unsubordinated debt and are senior in right of payment to all of its existing and future debt that is by its terms expressly subordinated in right of payment to the 2028 Notes. The 2028 Notes are subordinated to indebtedness under the Senior Secured Credit Facilities, as well as any future secured debt to the extent of the value of the assets securing such debt, and structurally subordinated to the liabilities of any non-guarantor subsidiaries.

Pursuant to the terms of the indenture governing the 2028 Notes, the Company is obligated to offer to purchase the 2028 Notes at a price of 101% of the principal amount, together with accrued and unpaid interest, if any, up to, but not including, the date of purchase, upon the occurrence of certain change of control events. Prior to November 15, 2023, the Company may redeem the 2028 Notes (i) in whole or in part, at an amount equal to 100% of the aggregate principal amount plus a specified “make-whole” premium and accrued and unpaid interest, if any, to the date of purchase, and (ii) on one or more occasions, up to 35% of the aggregate principal amount of the notes, with the net cash proceeds of one or more equity offerings at a price equal to 105.750% of the principal amounts of such notes, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date. On or after November 15, 2023, the Company may redeem the 2028 Notes at specified redemption prices. The Company may also redeem some or all of the 2028 Notes by means other than a redemption, including tender offer and open market repurchases.

Senior Unsecured Notes Due November 2029

On August 18, 2021, the Company issued a $650 aggregate principal amount of 4.625% senior unsecured notes due November 2029 (the “2029 Notes”) in an offering that was exempt from the registration requirements of the Securities Act. The 2029 Notes require payment of principal at maturity and interest semi-annually in cash and in arrears on May 15 and November 15 of each year. The Company received proceeds of $642, net of underwriting fees and other related expenses of $8, which are deferred and amortized to interest expense using the effective interest method over the term of the 2029 Notes. The net proceeds from the 2029 Notes were used, together with cash on hand, to purchase or redeem, as applicable, the $750 aggregate principal of the 7.000% senior unsecured notes due May 2025 (the "2025 Notes"). In connection with the purchase and redemption of the 2025 Notes, the Company incurred a loss on extinguishment of $20 for the year ended December 31, 2021.

The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured unsubordinated basis by each of the Company’s existing and future direct and indirect domestic restricted subsidiaries that (i) incurs or guarantees indebtedness under the Senior Secured Credit Facilities, or (ii) guarantees certain other indebtedness of the Company or any guarantor in an aggregate principal amount in excess of $100. The guarantees of the 2029 Notes will rank equally with all other senior indebtedness of the guarantors. The 2029 Notes rank equally in right of payment to all of the Company’s existing and future unsecured unsubordinated debt and are senior in right of payment to all of its existing and future debt that is by its terms expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes are subordinated to indebtedness under the Senior Secured Credit Facilities, as well as any future secured debt to the extent of the value of the assets securing such debt, and structurally subordinated to the liabilities of any non-guarantor subsidiaries.

Pursuant to the terms of the indenture governing the 2029 Notes, the Company is obligated to offer to purchase the 2029 Notes at a price of 101% of the principal amount, together with accrued and unpaid interest, if any, up to, but not including, the date of purchase, upon the occurrence of certain change of control events. Prior to November 15, 2024, the Company may redeem the 2029 Notes (i) in whole or in part, at an amount equal to 100% of the aggregate principal amount plus a specified “make-whole” premium and accrued and unpaid interest, if any, up to, but excluding the redemption date, and (ii) on one or more occasions, up to 35% of the aggregate principal amount of the notes, with the net cash proceeds of one or more equity offerings at a price equal to 104.625% of the principal amounts of such notes, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date. On or after November 15, 2024, the Company may redeem the 2029 Notes at specified redemption prices. The Company may also redeem some or all of the 2029 Notes by means other than a redemption, including tender offer and open market repurchases.

2025 Notes Tender Offer and Redemption

On August 4, 2021, the Company commenced an all-cash tender offer to purchase any and all of the outstanding 2025 Notes for a purchase price of $1,025.00 per $1,000.00 of principal amount through an early tender deadline of August 17, 2021, and $995.00 per $1,000.00 of principal amount thereafter, through August 31, 2021, the tender expiration date, plus any accrued and unpaid interest thereon (the “2025 Notes Tender Offer”). In connection with the 2025 Notes Tender Offer, the Company received consents from the holders of a majority of the aggregate principal amount of the 2025 Notes to amend certain provisions of the indenture governing the 2025 Notes, thereby allowing the Company to call and redeem the remaining 2025 Notes outstanding upon two business days’ notice to the noteholders (the “2025 Notes Redemption”) (collectively, the “2025 Notes Tender Offer and Redemption”). The Company completed the 2025 Notes Tender Offer and Redemption on August 20, 2021 for an aggregate purchase price of $782, inclusive of an early participation premium of $18 and accrued interest of $14. The 2025 Notes Tender Offer and Redemption was funded with the proceeds from the offering of the 2029 Notes and cash on hand.

2023 Dollar Notes Tender Offer and Redemption

On November 12, 2020, the Company commenced an all-cash tender offer to purchase any and all of the outstanding 2023 Dollar Notes for a purchase price of $1,017.94 per $1,000.00 of principal amount through an early tender deadline of November 25, 2020, and $987.94 per $1,000.00 of principal amount thereafter, through December 10, 2020, the tender expiration date, plus any accrued and unpaid interest thereon (the “2023 Dollar Notes Tender Offer”). In connection with the 2023 Dollar Notes Tender Offer, the Company received consents from the holders of a majority of the aggregate principal amount of the 2023 Dollar Notes to amend certain provisions of the indenture governing the 2023 Dollar Notes, thereby allowing the Company to call and redeem the remaining 2023 Dollar Notes outstanding upon two business days’ notice to the noteholders (the “2023 Dollar Notes Redemption”) (collectively, the “2023 Dollar Notes Tender Offer and Redemption”).

The Company completed the 2023 Dollar Notes Tender Offer and Redemption on December 1, 2020 for an aggregate purchase price of $926, inclusive of an early participation premium of $16 and accrued interest of $2. The 2023 Dollar Notes Tender Offer and Redemption was funded with the proceeds from the offering of the 2028 Notes and cash on hand.

Note Repurchases

During the year ended December 31, 2022, the Company repurchased through open market transactions, an aggregate principal of $62 of its senior unsecured notes for cash payment of $54. The Company recorded a gain of $7 in "Gain (loss) on extinguishment of debt" in the consolidated statements of operations, net of $1 in charges related to the write-off of deferred financing costs associated with the extinguished debt.

Accounts Receivable Securitization Facility

On July 12, 2019, the Company, through a wholly-owned special purpose entity (“SPE”), executed an agreement with a bank for an accounts receivable securitization facility (“Securitization Facility”) for the purpose of enhancing the Company’s liquidity (the “Original Purchase Agreement”). Under the Securitization Facility, certain of the Company’s subsidiaries sell their accounts receivable to the SPE, which is a non-guarantor subsidiary. In turn, the SPE may transfer undivided ownership interests in such receivables to the bank in exchange for cash. The Securitization Facility permitted the SPE to borrow up to a total of $125, with an option to increase to $200. The bank has a first priority security interest in all receivables held by the SPE, and the SPE has not granted a security interest to anyone else.

As the SPE previously maintained effective control over the accounts receivable under the Original Purchase Agreement, the transfers of the ownership interests to the bank did not meet the criteria to account for the transfers as true sales. As a result, the Company accounted for the transfers as collateralized borrowings. Cash received from the bank was a short-term obligation of the Company, which was fully-collateralized by all receivables held by the SPE. The Securitization Facility was subject to interest charges against both the amount of outstanding borrowings and the amount of available but undrawn commitments. The Securitization Facility bore a variable interest rate on outstanding borrowings and a fixed commitment fee on the average daily undrawn amount. Borrowings under the Securitization Facility were classified in the consolidated balance sheets as a component of current liabilities due to the short-term nature of the obligation.

On March 9, 2020, the Company, through its wholly-owned SPE, entered into an amended and restated receivables purchase agreement (the “Amended Purchase Agreement”) under the Securitization Facility. The Amended Purchase Agreement amends and restates, in its entirety, the Original Purchase Agreement. The Amended Purchase Agreement, among other things, extends the term of the Original Purchase Agreement such that the SPE may sell certain receivables and request investments and letters of credit until the earlier of March 5, 2021 or a termination event, and contains customary representations and warranties, as well as affirmative and negative covenants.

Pursuant to the Amended Purchase Agreement, the Company no longer maintains effective control over the transferred receivables, and therefore accounts for these transfers as sales of receivables. As a result, on March 9, 2020, the Company repurchased the then-outstanding receivables under the Securitization Facility through repayment of the secured borrowings under the Original Purchase Agreement, resulting in net repayments of $110 and subsequent sale of $125 of its receivables to the bank during the first quarter of 2020. These sales were transacted at 100% of the face value of the relevant receivables, resulting in derecognition of the receivables from the Company’s consolidated balance sheets.

On March 5, 2021, the Company, through the SPE, entered into an amendment (the “First Amendment”) to its Amended Purchase Agreement (together with the First Amendment, the “Purchase Agreement”) to, among other things, extend the term of the Purchase Agreement, such that the SPE may sell certain receivables and request investments and letters of credit until the earlier of March 6, 2023 or another event that constitutes a “Termination Date” under the Purchase Agreement. The First Amendment also increases the facility limit under the arrangement from $125 to $150.

On November 24, 2021, the Company, through the SPE, entered into an amendment (the “Second Amendment”) to its Purchase Agreement to, among other things, extend the term of the Purchase Agreement, such that the SPE may sell certain receivables and request investments and letters of credit until the earlier of March 6, 2024 or another event that constitutes a “Termination Date” under the Purchase Agreement. As of December 31, 2022, the Securitization Facility is fully utilized.

Cash received from collections of sold receivables is used to fund additional purchases of receivables at 100% of face value on a revolving basis, not to exceed the facility limit, which is the aggregate purchase limit. For the years ended December 31, 2022 and 2021, the Company received $1,481 and $1,364, respectively, of cash collections on receivables sold under the Amended Purchase Agreement, following which it sold and derecognized $1,481 and $1,389, respectively, of incremental accounts receivable. The Company maintains continuing involvement as it acts as the servicer for the sold receivables and guarantees payment to the bank. As collateral against the sold receivables, the SPE maintains a certain level of unsold receivables, which amounted to $46 and $76 at December 31, 2022 and 2021, respectively. During the years ended December 31, 2022 and 2021, the Company incurred $3 of fees associated with the Securitization Facility. Costs associated with the sales of receivables are reflected in the Company’s consolidated statements of operations for the periods in which the sales occur.

Other

In 2020, the Company entered into a financing arrangement, by which an external financing company funded certain of the Company’s annual insurance premiums for $16, and subsequently repaid in full for the year ended December 31, 2020. In 2019, the Company entered into a similar financing arrangement for $11, of which $5 was repaid during the year ended December 31, 2019 and the remainder in 2020.

Maturities

The Company has required quarterly principal payments related to the Senior Secured Credit Facilities equivalent to 1.00% per annum through December 2024, with the balance due at maturity. Also, on an annual basis, the Company is required to make additional principal payments depending on leverage levels, as defined in the Credit Agreement, equivalent to up to 50% of excess cash flows based on certain leverage targets with step-downs to 25% and 0% as actual leverage decreases to below a 3.50 to 1.00 leverage target. The Company is not expected to make additional principal payments in 2023.

The following table sets forth the Company’s debt principal maturities for the next five years and thereafter.


2023	$	13
2024		13
2025		1,095
2026		470
2027		495
Thereafter		1,403
Total principal maturities on debt	$	3,489

Debt Fair Value

The following table sets forth the estimated fair values of the Company’s senior debt issues, which are based on quotes received from third-party brokers, and are classified as Level 2 financial instruments in the fair value hierarchy.


	December 31, 2022					December 31, 2021
	Carrying Value			Fair Value		Carrying Value			Fair Value
Senior secured term loans:
Tranche B-2 U.S. dollar term loan due April 2025	$	766		$	755	$	776		$	769
Tranche B-2 euro term loan due April 2025 (€333 at December 31, 2022 and €337 at December 31, 2021)		355			345		381			378
Senior unsecured notes:
4.000% due May 2026 (€441 at December 31, 2022 and €450 at December 31, 2021)		470			422		510			518
5.375% due May 2027		495			459		500			538
5.750% due November 2028		783			702		800			846
4.625% due November 2029		620			509		650			645
Total senior debt principal		3,489		$	3,192		3,617		$	3,694
Less: Unamortized issue discounts		(4	)				(5	)
Less: Unamortized debt issuance costs		(22	)				(28	)
Total senior debt, net	$	3,463				$	3,584

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Research and Development Expense

Debt - Estimated Fair Values of Senior Debt Issues (Details) € in Millions, $ in Millions	Dec. 31, 2022 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 USD ($)	Aug. 18, 2021 USD ($)
Debt Instrument [Line Items]
Less: Unamortized issue discounts		$ (4)		$ (5)
Less: Unamortized debt issuance costs		(22)		(28)
Senior Secured Tranche B-2 U.S Dollar Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		766		776
Senior Secured Tranche B-2 Euro Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value	€ 333	355	€ 337	381
4.000% Senior Unsecured Notes Due May 2026 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value	€ 441	470	€ 450	510
5.750% Senior Unsecured Notes Due November 2028 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		783		800
5.375% Senior Unsecured Notes Due May 2027 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		495		500
4.625% Senior Unsecured Notes Due November 2029 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		620		650	$ 650
Level 2 [Member]
Debt Instrument [Line Items]
Total senior debt, Fair Value		3,192		3,694
Total senior debt, Carrying Value		3,489		3,617
Less: Unamortized issue discounts		(4)		(5)
Less: Unamortized debt issuance costs		(22)		(28)
Total senior debt, net		3,463		3,584
Level 2 [Member] \| Senior Secured Tranche B-2 U.S Dollar Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		766		776
Long-term debt, Fair Value		755		769
Level 2 [Member] \| Senior Secured Tranche B-2 Euro Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		355		381
Long-term debt, Fair Value		345		378
Level 2 [Member] \| 4.000% Senior Unsecured Notes Due May 2026 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		470		510
Long-term debt, Fair Value		422		518
Level 2 [Member] \| 5.750% Senior Unsecured Notes Due November 2028 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		783		800
Long-term debt, Fair Value		702		846
Level 2 [Member] \| 5.375% Senior Unsecured Notes Due May 2027 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		495		500
Long-term debt, Fair Value		459		538
Level 2 [Member] \| 4.625% Senior Unsecured Notes Due November 2029 [Member]
Debt Instrument [Line Items]
Long-term debt, Carrying Value		620		650
Long-term debt, Fair Value		$ 509		$ 645

Geographic and Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 6,794	$ 6,345	$ 4,969
Adjusted EBITDA	1,573	1,533	1,063
Depreciation and amortization	291	317	320
Equity in earnings of affiliates	55	43	23
Total assets	7,640	7,550	7,082
Investments in affiliates	175	169	167	$ 162
Purchases of property, plant, and equipment	307	277	267
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales	6,794	6,345	4,969
Adjusted EBITDA	1,573	1,533	1,063
Depreciation and amortization	270	287	290
Equity in earnings of affiliates	55	43	23
Total assets	5,488	5,212	5,222
Investments in affiliates	175	169	167
Purchases of property, plant, and equipment	300	272	251
Operating Segments [Member] \| Titanium Technologies [Member]
Segment Reporting Information [Line Items]
Net sales	3,380	3,355	2,402
Adjusted EBITDA	601	799	498
Depreciation and amortization	125	126	128
Total assets	2,384	2,318	2,130
Purchases of property, plant, and equipment	149	104	89
Operating Segments [Member] \| Thermal & Specialized Solutions [Member]
Segment Reporting Information [Line Items]
Net sales	1,680	1,257	1,105
Adjusted EBITDA	603	401	344
Depreciation and amortization	55	59	53
Equity in earnings of affiliates	24	15	6
Total assets	1,238	1,124	1,041
Investments in affiliates	82	72	66
Purchases of property, plant, and equipment	30	26	28
Operating Segments [Member] \| Advanced Performance Materials [Member]
Segment Reporting Information [Line Items]
Net sales	1,618	1,397	1,104
Adjusted EBITDA	367	284	146
Depreciation and amortization	82	86	88
Equity in earnings of affiliates	31	28	17
Total assets	1,742	1,621	1,520
Investments in affiliates	93	97	101
Purchases of property, plant, and equipment	115	103	109
Operating Segments [Member] \| Other Segment [Member]
Segment Reporting Information [Line Items]
Net sales	116	336	358
Adjusted EBITDA	2	49	75
Depreciation and amortization	8	16	21
Total assets	124	149	531
Purchases of property, plant, and equipment	$ 6	$ 39	$ 25

Background and Description of the Business - Narrative (Details)	12 Months Ended
	Dec. 31, 2022 Segment Facility
Segment Reporting Information [Line Items]
Number of reportable segments \| Segment	3
Number of facilities	29
Operating Segments [Member]
Segment Reporting Information [Line Items]
Number of facilities	3
Titanium Technologies [Member]
Segment Reporting Information [Line Items]
Number of facilities	8
Thermal & Specialized Solutions [Member]
Segment Reporting Information [Line Items]
Number of facilities	8
Advanced Performance Materials [Member]
Segment Reporting Information [Line Items]
Number of facilities	10

Leases - Schedule of Company's Lease Liabilities' Maturities For Next Five Years and Thereafter (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Operating Leases
2023	$ 61
2024	52
2025	42
2026	36
2027	23
Thereafter	91
Total lease payments	305
Less: Imputed interest	58
Present value of lease liabilities	247
Finance Leases
2023	14
2024	13
2025	13
2026	11
2027	8
Thereafter	13
Total lease payments	72
Less: Imputed interest	11
Present value of lease liabilities	61	$ 72
Operating and Finance Leases, Total
2023	75
2024	65
2025	55
2026	47
2027	31
Thereafter	104
Total lease payments	377
Less: Imputed interest	69
Present value of lease liabilities	$ 308

Geographic and Segment Information - Reconciliation of Segment Adjusted EBITDA from Segments to Consolidated Income (Loss) Before Income Taxes (Details) (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Gain on restructuring and related cost		$ 9
Environmental remediation expense	$ 269	269	$ 71
PFOA Multi District Litigation in Ohio [Member]
Segment Reporting Information [Line Items]
Legal charges			$ 29
PFOA Litigation Settlements [Member]
Segment Reporting Information [Line Items]
Legal charges	20	25
On-site and Off-site Remediation Costs at Fayetteville [Member]
Segment Reporting Information [Line Items]
Environmental remediation expense	$ 196	$ 169

Other Income (Expense), Net - Components of Other Income (Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Income and Expenses [Abstract]
Leasing, contract services and miscellaneous income	$ 53	$ 14	$ 20
Royalty income	6	22	18
Gain on sales of assets and businesses, net	21	115	8
Exchange (losses) gains, net	(15)	3	(26)
Non-operating pension and other post-retirement employee benefit income	5	9	1
Total other income, net	$ 70	$ 163	$ 21

Research and Development Expense

12 Months Ended

Dec. 31, 2022

Research and Development [Abstract]

Note 6. Research and Development Expense

The following table sets forth the Company’s R&D expense by segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Titanium Technologies	$	34	$	36	$	31
Thermal & Specialized Solutions		25		20		18
Advanced Performance Materials		54		46		41
Other Segment		1		2		2
Corporate and Other		4		3		1
Total research and development expense	$	118	$	107	$	93

Summary of Significant Accounting Policies - Narrative (Details)	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2023
ASU 2021-08 \| Subsequent Event [Member]
Summary Of Significant Accounting Policies [Line Items]
Change In Accounting Principle Accounting Standards Update Adopted		true
Change In Accounting Principle Accounting Standards Update Adoption Date		Jan. 01, 2023
Change In Accounting Principle Accounting Standards Update Immaterial Effect		true
ASU 2021-10
Summary Of Significant Accounting Policies [Line Items]
Change In Accounting Principle Accounting Standards Update Adopted	true
Change In Accounting Principle Accounting Standards Update Adoption Date	Dec. 31, 2022
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets, useful life	20 years
Asset retirement costs estimated remaining useful life	25 years
Maximum [Member] \| Equipment and Buildings [Member]
Summary Of Significant Accounting Policies [Line Items]
Useful Life	25 years
Maximum [Member] \| Software Development [Member]
Summary Of Significant Accounting Policies [Line Items]
Useful Life	7 years
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Asset retirement costs estimated remaining useful life	2 years
Minimum [Member] \| Equipment and Buildings [Member]
Summary Of Significant Accounting Policies [Line Items]
Useful Life	15 years
Minimum [Member] \| Software Development [Member]
Summary Of Significant Accounting Policies [Line Items]
Useful Life	5 years
Consolidated Subsidiaries [Member] \| Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Voting stock ownership percentage	50.00%
Consolidated Subsidiaries [Member] \| Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Voting stock ownership percentage	20.00%
Consolidated Subsidiaries [Member] \| Outside Shareholders [Member] \| Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Consolidated subsidiaries ownership percentage	100.00%

Investments in Affiliates (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Investments in Affiliates

The following table sets forth the jurisdiction, carrying value, and ownership percentages of the Company’s investments in affiliates at December 31, 2022 and 2021.


		December 31, 2022			December 31, 2021
Investee	Jurisdiction	Carrying Value		Ownership	Carrying Value		Ownership
Chemours-Mitsui Fluorochemicals Company, Ltd.	Japan	$	87	50.0%	$	98	50.0%
The Chemours Chenguang Fluoromaterials Company Limited	China		36	50.0%		33	50.0%
Changshu 3F Zhonghao New Chemical Materials Co., Ltd.	China		52	10.0%		38	10.0%
		$	175		$	169

Schedule of Changes in Investments in Affiliates

The following table sets forth the changes in the Company’s investments in affiliates for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Balance at January 1,	$	169		$	167		$	162
Equity in earnings of affiliates		55			43			23
Dividends		(33	)		(30	)		(25	)
Currency translation and other		(16	)		(11	)		7
Balance at December 31,	$	175		$	169		$	167

Accounts Payable - Schedule of Accounts Payable (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Trade payables	$ 1,228	$ 1,141
VAT and other payables	23	21
Total accounts payable	$ 1,251	$ 1,162

Leases - Narrative (Details)	12 Months Ended
Leases - Narrative (Details)	Dec. 31, 2022
Lessee Lease Description [Line Items]
Lease agreements initial terms	12 months
Maximum [Member]
Lessee Lease Description [Line Items]
Operating lease term of contract	24 years

Supplemental Cash Flow information - Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Supplemental Cash Flow Elements [Abstract]

Cash and cash equivalents

$ 1,102

$ 1,451

Restricted cash and restricted cash equivalents

^[1]

202

100

Cash, cash equivalents, restricted cash and restricted cash equivalents

$ 1,304

$ 1,551

$ 1,105

$ 943

[1]	Restricted cash and restricted cash equivalents balance includes cash and cash equivalents deposited in an escrow account as per the terms of the MOU (see “Note 22 – Commitments and Contingent Liabilities”).

Commitments and Contingent Liabilities - Environmental - Narrative (Details)
$ in Thousands

1 Months Ended

6 Months Ended

12 Months Ended

Oct. 31, 2021

USD ($)

CivilPenalty

Mar. 31, 2019

USD ($)

Lawsuit

Jun. 30, 2022

USD ($)

Dec. 31, 2022

USD ($)

Lawsuit

Owner

Dec. 31, 2021

USD ($)

Dec. 31, 2020

USD ($)

Oct. 31, 2020

Lawsuit

Sep. 30, 2020

Lawsuit

Environmental remediation expense

$ 269,000

$ 71,000

Environmental Remediation Expense, Statement of Income or Comprehensive Income [Extensible Enumeration]

Restructuring Charges Asset Related And Other Charges

Selling, general, and administrative expense

$ 710,000

$ 592,000

$ 527,000

Number of civil penalty assessments for violation to reduce facility-wide annual emissions of GenX compounds | CivilPenalty

668,000

$ 562,000

Amount of civil penalty assessed for violation to reduce facility-wide annual emissions of GenX compounds

$ 300

Environmental liabilities indemnification maximum amount

78,000

Indemnification expiration period

2026-12

Obligation related to indemnification

$ 0

Construction of Barrier Wall and Groundwater Treatment Facility [Member]

Off-Site Replacement Drinking Water Supplies and Toxicity Studies [Member]

$ 58,000

Selling, general, and administrative expense

$ 108,000

Off-site Replacement Drinking Water Supplies [Member]

Accrued for operation, maintenance, and monitoring period

20 years

Disbursements period

20 years

Assessment And Sampling Drinking Water Supplies [Member]

$ 163,000

59,000

On-site Surface Water and Groundwater Remediation [Member]

38,000

11,000

Estimated operation period

$ 64,000

20 years

Estimated cost of remediation

264,000

$ 289,000

Addendum specified penalties

150

Addendum specified additional penalties per week

$ 20

OM&M projected paid period

20 years

On-site Surface Water and Groundwater Remediation [Member] | Construction of Barrier Wall and Groundwater Treatment Facility [Member]

Upper range of cost estimates

49,000

$ 281,000

Cost estimates already accrued

$ 158,000

On-site Surface Water and Groundwater Remediation [Member] | Groundwater Extraction And Treatment System

Accrued for operation, maintenance, and monitoring period

20 years

Estimated operation starting year

2023

Fayetteville Works, Fayetteville, North Carolina [Member]

Environmental remediation expense

$ 229,000

228,000

$ 43,000

174,000

181,000

^[1]

$ 465,000

$ 359,000

PFAS Matters [Member]

Civil penalty and investigative costs

$ 13,000

Percentage of efficiency to control PFAS

99.999%

Number of lawsuits filed | Lawsuit

PFAS Matters [Member] | Fayetteville Works, Fayetteville, North Carolina [Member]

Percentage of efficiency to control PFAS

99.99%

Reduction of PFAS maximum period

2 years

Percentage of baseline

75.00%

Compensatory and Punitive Damages [Member]

Number of private well owners seeking for damages | Owner

1,800

Number of lawsuits filed | Lawsuit

PFOA [Member]

Number of lawsuits filed | Lawsuit

Minimum [Member]

Average time frame of disbursements of environmental site remediation

15 years

Maximum [Member]

Average time frame of disbursements of environmental site remediation

20 years

Loss contingency, potential additional loss

$ 730,000

[1]	For more information on this matter refer to “Fayetteville Works, Fayetteville, North Carolina” within this “Note 22 – Commitments and Contingent Liabilities”.

Long-term Employee Benefits (Tables)

12 Months Ended

Dec. 31, 2022

Retirement Benefits, Description [Abstract]

Schedules of Net Periodic Pension (Cost) Income

The following table sets forth the Company’s net periodic pension (cost) income and amounts recognized in other comprehensive income (loss) for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Service cost	$	(14	)	$	(15	)	$	(15	)
Interest cost		(7	)		(5	)		(6	)
Expected return on plan assets		18			20			17
Amortization of actuarial loss		(8	)		(7	)		(9	)
Amortization of prior service gain		2			2			3
Settlement loss		—			(1	)		(5	)
Curtailment gain		—			—			1
Total net periodic pension cost	$	(9	)	$	(6	)	$	(14	)

Net (loss) gain	$	(2	)	$	(22	)	$	4
Prior service benefit (cost)		2			—			(1	)
Amortization of actuarial loss		8			7			9
Amortization of prior service gain		(2	)		(2	)		(3	)
Settlement loss		—			1			5
Curtailment gain		—			—			4
Effect of foreign exchange rates		7			6			(9	)
Benefit (cost) recognized in other comprehensive income		13			(10	)		9
Total changes in plan assets and benefit obligations recognized in other comprehensive income	$	4		$	(16	)	$	(5	)

Schedule of Amounts Recognized in Other Comprehensive Income (Loss)

following table sets forth the pre-tax amounts recognized in accumulated other comprehensive loss at years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Net loss	$	132		$	148		$	143
Prior service credit		(9	)		(9	)		(12	)
Total amount recognized in accumulated other comprehensive loss	$	123		$	139		$	131

Summary of Benefit Obligations and Fair Value of Plan Assets and Funded Status of Plan

The following table sets forth summarized information on the Company’s pension plans at December 31, 2022 and 2021.


	December 31,
	2022			2021
Change in benefit obligation:
Benefit obligation at beginning of year	$	575		$	584
Service cost		14			15
Interest cost		7			5
Plan participants’ contributions		2			2
Actuarial (gain) loss		(145	)		19
Benefits paid		(5	)		(4	)
Plan amendments		(2	)		—
Settlements and transfers		(4	)		(11	)
Currency translation		(35	)		(35	)
Benefit obligation at end of year		407			575
Change in plan assets:
Fair value of plan assets at beginning of year		585			604
Actual return on plan assets		(129	)		17
Employer contributions		10			17
Plan participants’ contributions		2			2
Benefits paid		(5	)		(4	)
Settlements and transfers		(4	)		(11	)
Currency translation		(37	)		(40	)
Fair value of plan assets at end of year		422			585
Total funded status at end of year	$	15		$	10

Schedule of Amounts Recognized in the Consolidated Balance Sheet

The following table sets forth the net amounts recognized in the Company’s consolidated balance sheets at December 31, 2022 and 2021.


	December 31,
	2022			2021
Non-current assets	$	50		$	55
Current liabilities		(1	)		(1	)
Non-current liabilities		(34	)		(44	)
Total net amount recognized	$	15		$	10

Schedule of Projected Benefit Obligations in Excess of Fair Value of Plan Assets

The following tables set forth information related to the Company’s pension plans with projected and accumulated benefit obligations in excess of the fair value of plan assets at December 31, 2022 and 2021.


	December 31,
Pension plans with projected benefit obligation in excess of plan assets	2022		2021
Projected benefit obligation	$	121	$	142
Accumulated benefit obligation		104		119
Fair value of plan assets		86		97

Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets


	December 31,
Pension plans with accumulated benefit obligation in excess of plan assets	2022		2021
Projected benefit obligation	$	121	$	142
Accumulated benefit obligation		104		119
Fair value of plan assets		86		97

Schedule of Assumptions Used

The following tables set forth the assumptions that have been used to determine the Company’s benefit obligations and net benefit cost at December 31, 2022 and 2021.


	December 31,
Weighted-average assumptions used to determine benefit obligations	2022			2021
Discount rate		3.6	%		1.4	%
Rate of compensation increase (1)		3.5	%		3.4	%
Interest crediting rate (2)		2.5	%		1.0	%

(1)

The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant’s entire career at Chemours.

(2)

The interest crediting rate, which is applicable only for account balance type plans, represents the single effective annual account balance increase that an average participant would receive during the participant’s entire career at Chemours.


	December 31,
Weighted-average assumptions used to determine net benefit cost	2022			2021
Discount rate		1.4	%		1.0	%
Rate of compensation increase (1)		3.4	%		2.5	%
Expected return on plan assets		1.0	%		1.2	%

(1)

The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant’s entire career at Chemours.

Schedule of Allocation of Plan Assets

The following table sets forth the weighted-average allocation for the Company’s pension plan assets at December 31, 2022 and 2021.


	December 31,
	2022			2021
Cash and cash equivalents		11	%		8	%
U.S. and non-U.S. equity securities		36	%		37	%
Fixed income securities		53	%		55	%
Total weighted-average allocation		100	%		100	%

following tables set forth the fair values of the Company’s pension assets by level within the fair value hierarchy at December 31, 2022 and 2021.


	Fair Value Measurements at December 31, 2022
	Total		Level 1		Level 2
Asset category:
Debt - government issued	$	47	$	7	$	40
Debt - corporate issued		113		23		90
U.S. and non-U.S. equities		151		31		120
Derivatives - asset position		40		—		40
Cash and cash equivalents		48		48		—
Other		2		—		2
Total pension assets at fair value		401	$	109	$	292
Pooled mortgage funds (1)		21
Total pension assets	$	422

(1)

Pooled mortgage funds consist of funds that invest in residential mortgages. These funds generally allow for monthly redemption with 30 days' notice. Timing for redemption could be delayed based on the priority of the Company's request and the availability of funds. Interests in these funds are valued using the net asset value ("NAV") per share practical expedient and are not classified in the fair value hierarchy.


	Fair Value Measurements at December 31, 2021
	Total		Level 1		Level 2
Asset category:
Debt - government issued	$	74	$	10	$	64
Debt - corporate issued		147		29		118
U.S. and non-U.S. equities		217		44		173
Derivatives - asset position		70		—		70
Cash and cash equivalents		46		46		—
Other		3		—		3
Total pension assets at fair value		557	$	129	$	428
Pooled mortgage funds (1)		28
Total pension assets	$	585

(1)

Pooled mortgage funds consist of funds that invest in residential mortgages. These funds generally allow for monthly redemption with 30 days' notice. Timing for redemption could be delayed based on the priority of the Company's request and the availability of funds. Interests in these funds are valued using the NAV per share practical expedient and are not classified in the fair value hierarchy.

Schedule of Expected Benefit Payments

The following table sets forth the benefit payments that are expected to be paid by the plans over the next five years and the five years thereafter.


2023	$	11
2024		13
2025		14
2026		15
2027		18
2028 to 2032		111

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2022

Business Combinations [Abstract]

Acquisitions and Divestitures

4. Acquisitions and Divestitures

Divestitures

In December 2021, the Company entered into an agreement to sell land related to the Beaumont former operating site for cash consideration of approximately $17 (the “Beaumont Transaction”). The Company completed the land sale on May 24, 2022 and received net cash proceeds of $17. In January 2022, the Company entered into a stock agreement to sell certain of its wholly-owned subsidiaries and the remaining assets at its former Aniline business facilities in Pascagoula, Mississippi (the “Pascagoula Transaction”). The Company completed the sale on June 9, 2022 and received net cash proceeds of $16. Upon completion of the Beaumont Transaction and the Pascagoula Transaction, the Company recorded a net pre-tax gain of $5 and $18, respectively, in other income (expense), net in the consolidated statements of operations during the year ended December 31, 2022.

On July 26, 2021, the Company entered into a definitive agreement with Manchester Acquisition Sub LLC, a Delaware limited liability company and a subsidiary of Draslovka Holding a.s., to sell the Mining Solutions business of its Chemical Solutions segment for cash consideration of approximately $520 (the “Mining Solutions Transaction”). The Company completed the sale on December 1, 2021 and received net cash proceeds of $508, net of $13 cash divested. Upon completion of the sale, during the year ended December 31, 2021, the Company also recorded a net pre-tax gain on sale of $112 in other income (expense), net in the consolidated statements of operations, inclusive of $21 of transaction costs. The sale of the Mining Solutions business does not represent a strategic shift that will have a major effect on the Company’s operations and financial results. Accordingly, the disposal group is not classified as a discontinued operation.

Income Taxes - Schedule of Components of Provision for (Benefit from) Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current tax expense (benefit):
U.S. federal	$ 83	$ 60	$ 4
U.S. state and local	13	12	1
International	47	72	75
Total current tax expense	143	144	80
Deferred tax expense (benefit):
U.S. federal	8	(69)	(86)
U.S. state and local	(2)	(6)	(12)
International	14	(1)	(22)
Total deferred tax expense (benefit)	20	(76)	(120)
Total provision for (benefit from) income taxes	$ 163	$ 68	$ (40)

Inventories - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Inventory [Line Items]
Basic earnings per share of common stock	$ 3.72	$ 3.69	$ 1.33
Titanium Technologies [Member]
Inventory [Line Items]
Benefit to income (loss) from liquidation of LIFO inventory		$ 8
Basic earnings per share of common stock		$ 0.05
US [Member]
Inventory [Line Items]
LIFO inventory amount	$ 835	$ 650
Percentage of LIFO inventory	47.00%	47.00%

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Derivative Assets and Liabilities At Fair Value

The following table sets forth the fair value of the Company’s derivative assets and liabilities at December 31, 2022 and 2021.


		Fair Value Using Level 2 Inputs
	Balance Sheet Location	December 31, 2022		December 31, 2021
Asset derivatives:
Foreign currency forward contracts not designated as a hedging instrument	Accounts and notes receivable, net (Note 11)	$	—	$	1
Foreign currency forward contracts designated as a cash flow hedge	Accounts and notes receivable, net (Note 11)		2		5
Interest rate swaps designated as a cash flow hedge	Accounts and notes receivable, net (Note 11)		—		—
Total asset derivatives		$	2	$	6

Liability derivatives:
Foreign currency forward contracts not designated as a hedging instrument	Other accrued liabilities (Note 19)	$	1	$	1
Foreign currency forward contracts designated as a cash flow hedge	Other accrued liabilities (Note 19)		4		—
Total liability derivatives		$	5	$	1

Schedule of Pre-tax Charge Fair Value of Financial Instruments

The following table sets forth the pre-tax changes in fair value of the Company’s financial instruments for the years ended December 31, 2022, 2021 and 2020.


	Gain (Loss) Recognized In
										Accumulated Other
	Cost of			Interest			Other Income			Comprehensive
Year Ended December 31,	Goods Sold			Expense, Net			(Expense), Net			Loss
2022
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	2		$	—
Foreign currency forward contracts designated as a cash flow hedge		19			—			—			17
Interest rate swaps designated as a cash flow hedge		—			5			—			8
Euro-denominated debt designated as a net investment hedge		—			—			—			53

2021
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	(15	)	$	—
Foreign currency forward contracts designated as a cash flow hedge		(2	)		—			—			10
Interest rate swaps designated as a cash flow hedge		—			(2	)		—			2
Euro-denominated debt designated as a net investment hedge		—			—			—			73

2020
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	29		$	—
Foreign currency forward contracts designated as a cash flow hedge		3			—			—			(4	)
Interest rate swaps designated as a cash flow hedge		—			—			—			(4	)
Euro-denominated debt designated as a net investment hedge		—			—			—			(88	)

Supplemental Cash Flow Information (Tables)

12 Months Ended

Dec. 31, 2022

Supplemental Cash Flow Elements [Abstract]

Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

The following table provides a reconciliation of cash and cash equivalents, as reported on the Company’s consolidated balance sheets, to cash, cash equivalents, restricted cash and restricted cash equivalents, as reported on the Company’s consolidated statements of cash flows.


	December 31,
	2022		2021
Cash and cash equivalents	$	1,102	$	1,451
Restricted cash and restricted cash equivalents (1)		202		100
Cash, cash equivalents, restricted cash and restricted cash equivalents	$	1,304	$	1,551

(1)

Restricted cash and restricted cash equivalents balance includes cash and cash equivalents deposited in an escrow account as per the terms of the MOU (see “Note 22 – Commitments and Contingent Liabilities”).

Accounts and Notes Receivable, Net - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Balance at January 1,	$ 5	$ 7	$ 5
Additions charged to expenses	9	2	3
Deductions from reserves	(4)	(4)	(1)
Balance at December 31,	$ 10	$ 5	$ 7

Restructuring, Asset-Related, and Other Charges - Schedule of Restructuring Programs to Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Severance programs	$ 9	$ (2)	$ 17
Asset-related charges	5	0	22
Total restructuring and other charges	11	6	58
Total restructuring, asset-related, and other charges	16	6	80
Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2	13	5
2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	9	(1)	15
2019 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Severance programs			3
2020 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Severance programs		(1)	13
Operating Segments [Member]
Restructuring Cost and Reserve [Line Items]
Other charges	0	(6)	38
Operating Segments [Member] \| Other Segment [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges	0	0	8
Other charges	0	(7)	37
Operating Segments [Member] \| Other Segment [Member] \| Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2	13	4
Operating Segments [Member] \| Other Segment [Member] \| 2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	1
Operating Segments [Member] \| Titanium Technologies [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges	5	0	0
Other charges	0	0	1
Operating Segments [Member] \| Titanium Technologies [Member] \| 2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1	0	3
Operating Segments [Member] \| Thermal & Specialized Solutions [Member] \| 2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1	0	2
Operating Segments [Member] \| Advanced Performance Materials [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges	0	0	10
Other charges	0	1	0
Operating Segments [Member] \| Advanced Performance Materials [Member] \| 2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3	(1)	5
Corporate and Other [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges	0	0	4
Corporate and Other [Member] \| Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	1
Corporate and Other [Member] \| 2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 4	$ 0	$ 4

Restructuring, Asset-Related, and Other Charges

12 Months Ended

Dec. 31, 2022

Restructuring and Related Activities [Abstract]

Restructuring, Asset-Related, and Other Charges

Note 7. Restructuring, Asset-related, and Other Charges

The following table sets forth the components of the Company’s restructuring, asset-related, and other charges for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Restructuring and other charges:
Employee separation charges	$	9	$	(2	)	$	17
Decommissioning and other charges		2		8			41
Total restructuring and other charges		11		6			58
Asset-related charges		5		—			22
Total restructuring, asset-related, and other charges	$	16	$	6		$	80

The following table sets forth the impacts of the Company’s restructuring programs to segment earnings for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Restructuring and other charges:
Plant and product line closures:
Other Segment	$	2	$	13		$	4
Corporate and Other		—		—			1
Total plant and product line closures		2		13			5
2022, 2020, and 20191 restructuring programs:
Titanium Technologies		1		—			3
Thermal & Specialized Solutions		1		—			2
Advanced Performance Materials		3		(1	)		5
Other Segment		—		—			1
Corporate and Other		4		—			4
Total restructuring programs		9		(1	)		15
Other charges:
Titanium Technologies		—		—			1
Advanced Performance Materials		—		1			—
Other Segment		—		(7	)		37
Total other charges		—		(6	)		38
Total restructuring and other charges		11		6			58
Asset-related charges:
Titanium Technologies		5		—			—
Advanced Performance Materials		—		—			10
Other Segment		—		—			8
Corporate and Other		—		—			4
Total asset-related charges		5		—			22
Total restructuring, asset-related, and other charges	$	16	$	6		$	80

(1)

Year ended December 31, 2020 includes $3 of employee separation charges relating to the 2019 restructuring program. All remaining actions related to this program were completed in 2020.

Plant and Product Line Closures

Other Segment

In 2015, the Company announced its completion of the strategic review of its Reactive Metals Solutions business and the decision to stop production at its Niagara Falls, New York manufacturing plant. Following the closure of the facility, the Company incurred decommissioning and dismantling-related charges of $2 for the years ended December 31, 2021 and 2020. Through December 31, 2022, the Company has incurred, in the aggregate, $42 in restructuring charges related to these activities, excluding asset-related charges. The Company has substantially completed all actions and does not expect to incur additional charges related to these activities at its Niagara Falls site.

In 2020, the Company completed a business review of its Aniline business. It was determined that the Aniline business was not core to the Company’s future strategy, and production ceased at the Pascagoula, Mississippi manufacturing plant in the fourth quarter of 2020. As a result, during the year ended December 31, 2020, the Company recorded asset-related charges of $10, which are primarily comprised of $6 for property, plant, and equipment and other asset impairments, as well as $4 for environmental remediation liabilities to be paid over a period of approximately 16 years. The Company also recorded employee separation-related liabilities of $2. In conjunction with this decision, approximately 20 employees separated from the Company through the end of 2021 with approximately 15 additional employees separating from the Company during the first quarter of 2022. Furthermore, the Company recorded decommissioning and dismantling-related charges of $12 for the year ended December 31, 2021. The Company has completed all actions related to this program. In June 2022, the assets at the Aniline facility were sold as part of the Pascagoula Transaction.

2022 and 2020 Restructuring Programs

Management initiated severance programs in 2022 and 2020 that were largely attributable to aligning the cost structure of the Company’s businesses and corporate functions with its strategic and financial objectives. Employee separation charges recorded for the 2022 restructuring program amounted to $9 for the year ended December 31, 2022. Employee separation charges recorded for the 2020 restructuring program amounted to $(1) and $13 for the years ended December 31, 2021 and 2020, respectively. Through December 31, 2022, the cumulative amount incurred for the Company's 2022 restructuring program amounted to $9 and the related payments are expected to be substantially completed by the end of 2023. Through December 31, 2021, the cumulative amount incurred for the Company’s 2020 severance program amounted to $12. All remaining actions related to the 2020 restructuring program were completed in 2021.

Other Charges

In connection with the construction work at the Mining Solutions facility in Gomez Palacio, Durango, Mexico, the Company had previously entered into an agreement with a third-party services provider. In 2020, the Company entered into dispute resolution with the third-party services provider, resulting in a $26 charge related to probable contract termination fees, as well as immediate recognition of $11 of other related prepaid costs for a total of $37 in Other Charges. During 2021, the Company and the third-party services provider reached an agreement to terminate the contractual relationship resulting in a payment of $26 for the aforementioned contract termination fees and, in exchange, the Company received title to approximately $22 of assets classified as construction-in-process, of which only approximately $9 were expected to be used by the Company when construction resumed. Accordingly, approximately $13 was recognized in impairment charges in 2021, offset by $22 of the liability recorded in 2020 being reversed in 2021, resulting in a net $9 gain in Other Charges. Additionally, during the year ended December 31, 2021, the Company incurred $2 of freight charges associated with transportation of the impaired assets. In December 2021, the assets at the Mining Solutions facility in Gomez Palacio, Durango, Mexico were sold as part of the Mining Solutions Transaction.

Other Asset-related Charges

Titanium Technologies

In the year ended December 31, 2022, the Company recorded asset-related charges of $5 resulting from the conflict between Russia and Ukraine and the Company's decision to suspend its business with Russian entities.

Advanced Performance Materials

In the year ended December 31, 2020, in connection with various property, plant, and equipment and other asset impairments, the Company recorded asset-related charges of $10.

The following table sets forth the change in the Company’s employee separation-related liabilities associated with its restructuring programs for the years ended December 31, 2022 and 2021.


	Site Closures			2022, 2020, and 2019 Restructuring Programs			Total
Balance at January 1, 2021	$	2		$	5		$	7
Credits to income		(1	)		(1	)		(2	)
Payments		—			(4	)		(4	)
Balance at December 31, 2021		1			—			1
Charges to income		—			9			9
Payments		(1	)		(3	)		(4	)
Balance at December 31, 2022	$	—		$	6		$	6

At December 31, 2022 and 2021, there were no significant outstanding liabilities related to the Company’s decommissioning and other restructuring-related charges.

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 578	$ 608	$ 219
Hedging activities:
Unrealized gain (loss) on net investment hedge, pre-tax	53	73	(88)
Unrealized gain (loss) on net investment hedge, tax	(13)	(18)	22
Unrealized gain (loss) on net investment hedge, after-tax	40	55	(66)
Unrealized gain (loss) on cash flow hedge, pre-tax	25	12	(8)
Unrealized gain (loss) on cash flow hedge, tax	(4)	(2)	1
Unrealized gain (loss) on cash flow hedge, after-tax	21	10	(7)
Reclassifications to net income - cash flow hedge, pre-tax	(24)	4	(3)
Reclassifications to net income - cash flow hedge, tax	4	(1)
Reclassifications to net income - cash flow hedge, after-tax	(20)	3	(3)
Hedging activities, net, pre-tax	54	89	(99)
Hedging activities, net, tax	(13)	(21)	23
Hedging activities, net, after-tax	41	68	(76)
Cumulative translation adjustment, pre-tax	(32)	(116)	111
Cumulative translation adjustment, after-tax	(32)	(116)	111
Defined benefit plans:
Net (loss) gain, pre-tax	(2)	(22)	4
Net (loss) gain, tax	1	6	(1)
Net (loss) gain, after-tax	(1)	(16)	3
Prior service benefit (cost), pre-tax	2		(1)
Prior service benefit (cost), after-tax	2		(1)
Curtailment gain, pre-tax			4
Curtailment gain, tax			(1)
Curtailment gain, after-tax			3
Effect of foreign exchange rates, pre-tax	7	6	(9)
Effect of foreign exchange rates, after-tax	7	6	(9)
Amortization of actuarial loss, pre-tax	8	7	9
Amortization of actuarial loss, tax	(2)	(2)	(2)
Amortization of actuarial loss, after-tax	6	5	7
Amortization of prior service gain, pre- tax	(2)	(2)	(3)
Amortization of prior service gain, after-tax	(2)	(2)	(3)
Settlement loss, pre-tax		1	5
Settlement loss, tax			(1)
Settlement loss, after-tax		1	4
Defined benefit plans, net, pre-tax	13	(10)	9
Defined benefit plans, net, tax	(1)	4	(5)
Defined benefit plans, net, after-tax	12	(6)	4
Other comprehensive(loss) income, after-tax	21	(54)	39
Comprehensive income, after-tax	599	554	258
Comprehensive income attributable to Chemours, after-tax	$ 599	$ 554	$ 258

Background and Description of the Business

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Background and Description of the Business

Note 1. Background and Description of the Business

The Chemours Company (“Chemours”, or the “Company”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. The Company delivers customized solutions with a wide range of industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. The Company’s principal products include titanium dioxide (“TiO2”) pigment, refrigerants, industrial fluoropolymer resins, and performance chemicals and intermediates. Chemours manages and reports its operating results through its three reportable segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment is a leading, global provider of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency and protection across a variety of applications. The Thermal & Specialized Solutions segment is a leading, global provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a leading, global provider of high-end polymers and advanced materials that deliver unique attributes, including low friction coefficients, extreme temperature resistance, weather resistance, ultraviolet and chemical resistance, and electrical insulation. The Other Segment includes the Performance Chemicals and Intermediates business and Mining Solutions business (prior to the business sale in 2021).

Chemours has manufacturing facilities, sales centers, administrative offices, and warehouses located throughout the world. Chemours’ operations are primarily located in the U.S., Canada, Mexico, Brazil, the Netherlands, Belgium, China, Taiwan, Japan, Switzerland, Singapore, Hong Kong, India, and France. At December 31, 2022, the Company operated 29 major production facilities globally, of which eight were dedicated to Titanium Technologies, eight were dedicated to Thermal & Specialized Solutions, 10 were dedicated to Advanced Performance Materials, and three supported multiple segments.

Chemours began operating as an independent company on July 1, 2015 (the “Separation Date”) after separating from E.I. DuPont de Nemours and Company (“EID”) (the “Separation”). The Separation was completed pursuant to a separation agreement and other agreements with EID, including an employee matters agreement, a tax matters agreement, a transition services agreement, and an intellectual property cross-license agreement. These agreements govern the relationship between Chemours and EID following the Separation and provided for the allocation of various assets, liabilities, rights, and obligations at the Separation Date. On August 31, 2017, EID completed a merger with The Dow Chemical Company (“Dow”). Following their merger, EID and Dow engaged in a series of reorganization steps and, in 2019, separated into three publicly-traded companies named Dow Inc., DuPont de Nemours, Inc. (“DuPont”), and Corteva, Inc. (“Corteva”). Effective January 1, 2023, EID changed its name to EIDP, Inc.

Unless the context otherwise requires, references herein to “The Chemours Company”, “Chemours”, “the Company”, “our Company”, “we”, “us”, and “our” refer to The Chemours Company and its consolidated subsidiaries. References herein to “EID” refer to EIDP, Inc., formerly known as EID, which is Chemours’ former parent company and is now a subsidiary of Corteva.

Inventories

12 Months Ended

Dec. 31, 2022

Inventory, Net [Abstract]

Inventories

Note 12. Inventories

The following table sets forth the components of the Company’s inventories at December 31, 2022 and 2021.


	December 31,
	2022			2021
Finished products	$	910		$	704
Semi-finished products		218			192
Raw materials, stores, and supplies		654			475
Inventories before LIFO adjustment		1,782			1,371
Less: Adjustment of inventories to LIFO basis		(378	)		(272	)
Total inventories	$	1,404		$	1,099

Inventory values, before LIFO adjustment, are generally determined by the average cost method, which approximates current cost. Inventories are valued under the LIFO method at substantially all of the Company’s U.S. locations, which comprised $835 and $650 (or 47% and 47%, respectively) of inventories before the LIFO adjustments at December 31, 2022 and 2021, respectively. The remainder of the Company’s inventory held in international locations and certain U.S. locations is valued under the average cost method.

During 2021, inventory reductions in the Company’s Titanium Technologies segment resulted in liquidations of LIFO inventory layers carried at lower costs prevailing in prior years as compared to current-year costs. During the year ended December 31, 2021, the benefit to net income (loss) attributable to Chemours from the liquidation of LIFO inventory was $8 or $0.05 on basic earnings (loss) per share of common stock.

Restructuring, Asset-Related, and Other Charges - Schedule of Restructuring Program (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring and Related Activities [Abstract]
Employee separation charges	$ 9	$ (2)	$ 17
Decommissioning and other charges	2	8	41
Total restructuring and other charges	11	6	58
Asset-related charges	5	0	22
Total restructuring, asset-related, and other charges	$ 16	$ 6	$ 80

Accounts and Notes Receivable, Net - (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts Notes And Loans Receivable [Line Items]
Bad debt expense	$ 9	$ 2	$ 3

Other Liabilities

12 Months Ended

Dec. 31, 2022

Other Liabilities Disclosure [Abstract]

Other Liabilities

21. Other Liabilities

The following table sets forth the components of the Company’s other liabilities at December 31, 2022 and 2021.


	December 31,
	2022		2021
Employee-related costs (1)	$	82	$	94
Accrued litigation (2)		55		50
Asset retirement obligations (2)		73		62
Miscellaneous (3)		109		63
Total other liabilities	$	319	$	269

(1)

Employee-related costs primarily represents liabilities associated with the Company’s long-term employee benefit plans.

(2)

Represents the long-term portions of accrued litigation and asset retirement obligations (see “Note 22 – Commitments and Contingent Liabilities”).

(3)

Miscellaneous primarily includes an accrued workers compensation indemnification liability of $33 and $32 at December 31, 2022 and 2021, respectively. Miscellaneous also includes long-term income tax liabilities from uncertain tax positions at December 31, 2022 (see "Note 9 – Income Taxes").

Long-term Employee Benefits (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Employer base salary based on age and service	$ 0.1
Net periodic pension cost	9.0	$ 6.0	$ 14.0
Employer contributions during period	31.0	$ 28.0	$ 27.0
Global Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan net actuarial gain	145.0
Defined benefit plan gain partially offset by losses due to impact of inflation and salary scale assumptions	64.0
Actuarial gain from increases in discount rates	209.0
Defined benefit plan loss due to volatile equity and bond performance	$ 147.0
Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Employees with guaranteed annual contribution ranging	1.00%
Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Employees with guaranteed annual contribution ranging	3.00%
Chemours [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution percent of match	100.00%
Employer matching contribution percent of employees' gross pay	6.00%

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

3. Summary of Significant Accounting Policies

Preparation of Financial Statements

The consolidated financial statements have been prepared in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences, facts, and circumstances available at the time and various other assumptions that management believes are reasonable. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of Chemours and its subsidiaries, as well as entities in which a controlling interest is maintained. For those consolidated subsidiaries in which the Company’s ownership is less than 100%, the outside shareholders’ interests are shown as non-controlling interests. Investments in companies in which Chemours, directly or indirectly, owns 20% to 50% of the voting stock, or has the ability to exercise significant influence over the operating and financial policies of the investee, are accounted for using the equity method of accounting. As a result, Chemours’ share of the earnings or losses of such equity affiliates is included in the consolidated statements of operations, and Chemours’ share of such equity affiliates’ equity is included in the consolidated balance sheets.

The Company assesses the requirements related to the consolidation of any variable interest entity (“VIE”), including a qualitative assessment of power and economics that considers which entity has the power to direct the activities that most significantly impact the VIE’s economic performance, and has the right to receive any benefits or the obligation to absorb any losses of the VIE. No such VIE was consolidated by the Company for the periods presented.

All intercompany accounts and transactions were eliminated in the preparation of the accompanying consolidated financial statements.

Revenue Recognition

Chemours recognizes revenue using a five-step model, resulting in revenue being recognized as performance obligations within a contract have been satisfied. The steps within that model include: (i) identifying the existence of a contract with a customer; (ii) identifying the performance obligations within the contract; (iii) determining the contract’s transaction price; (iv) allocating the transaction price to the contract’s performance obligations; and, (v) recognizing revenue as the contract’s performance obligations are satisfied. A contract with a customer exists when: (i) the Company enters into an enforceable agreement that defines each party’s rights regarding the goods or services to be transferred, and the related payment terms; (ii) the agreement has commercial substance; and, (iii) it is probable that the Company will collect the consideration to which it is entitled in the exchange. A performance obligation is a promise in a contract to transfer a distinct good or service, or a series of distinct goods or services, to a customer. The transaction price is the customary amount of consideration that the Company expects to be entitled to in exchange for a transfer of the promised goods or services to a customer, excluding any amounts collected by the Company on behalf of third parties (e.g., sales and use taxes). Judgment is required to apply the principles-based, five-step model for revenue recognition. Management is required to make certain estimates and assumptions about the Company’s contracts with its customers, including, among others, the nature and extent of its performance obligations, its transaction price amounts and any allocations thereof, the critical events which constitute satisfaction of its performance obligations, and when control of any promised goods or services is transferred to its customers.

The Company’s revenue from contracts with customers is reflected in the consolidated statements of operations as net sales, the vast majority of which represents product sales that consist of a single performance obligation. Product sales to customers are made under a purchase order (“PO”), or in certain cases, in accordance with the terms of a master services agreement (“MSA”) or similar arrangement, which documents the rights and obligations of each party to the contract. When a customer submits a PO for product or requests product under an MSA, a contract for a specific quantity of distinct goods at a specified price is created, and the Company’s performance obligation under the contract is satisfied when control of the product is transferred to the customer, which is indicated by shipment of the product and the transfer of title and the risk of loss to the customer. Revenue is recognized on consignment sales when control transfers to the customer, generally at the point of customer usage of the product. The transaction price for product sales is generally the amount specified in the PO or in the request under an MSA; however, as is common in Chemours’ industry, the Company offers variable consideration in the form of rebates, volume discounts, early payment discounts, pricing based on formulas or indices, price matching, and guarantees to certain customers. Such amounts are included in the Company’s estimated transaction price using either the expected value method or the most-likely amount, depending on the nature of the variable consideration included in the contract. The Company regularly assesses its customers’ creditworthiness, and product sales are made based on established credit limits. Payment terms for the Company’s invoices are typically less than 90 days.

The Company also licenses the right to access certain of its trademarks to customers under specified terms and conditions in certain arrangements, which is recognized as a component of net sales in the consolidated statements of operations. Under such arrangements, the Company may receive a royalty payment for a trademark license that is entered into on a stand-alone basis or incorporated into an overall product sales arrangement. Royalty income is generally based on customer sales and recognized under the sales-based exception as the customer sale occurs. When minimum guaranteed royalty amounts are included in the transaction price, the Company recognizes royalty income ratably over the license period for the minimum amount. When there is no consideration specified for the use of the Company’s trademark, the entire transaction price is recognized in connection with the transfer of control of product. Royalty income resulting from the right to use the Company’s technology is considered outside the scope of revenue recognition under GAAP as it is not a part of the Company’s ongoing major or central activities, and is recognized as a component of other income (expense), net in the consolidated statements of operations in accordance with agreed-upon terms at the point or points in time that performance obligations are satisfied.

Consistent with the fact that the vast majority of the Company’s payment terms are less than 90 days from the point at which control of the promised goods or services is transferred, no adjustments have been made for the effects of a significant financing component. Additionally, the Company has elected to recognize the incremental costs associated with obtaining contracts as an expense when incurred if the amortization period of the assets that the Company would have recognized is one year or less. Amounts billed to customers for shipping and handling fees are considered a fulfillment cost and are included in net sales, and the costs incurred by the Company for the delivery of goods are classified as a component of the cost of goods sold in the consolidated statements of operations.

Research and Development Expense

Research and development (“R&D”) costs are expensed as incurred. R&D expenses include costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, enhancement of existing products, and regulatory approval of new and existing products.

Provision for (Benefit from) Income Taxes

The provision for (benefit from) income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for (benefit from) income taxes represents income taxes paid or payable for the current year, plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax bases of Chemours’ assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. The Company’s deferred tax assets and liabilities are presented on a net basis by jurisdictional filing group. Net deferred tax assets are presented as a component of other assets, while net deferred tax liabilities are presented as a component of deferred income taxes on the Company’s consolidated balance sheets. Valuation allowances are recorded to reduce deferred tax assets when it is more-likely-than-not that a tax benefit will not be realized.

Chemours recognizes income tax positions that meet the more-likely-than-not threshold and accrues any interest related to unrecognized income tax positions in the provision for (benefit from) income taxes in the consolidated statements of operations. The Company also recognizes income tax-related penalties in the provision for (benefit from) income taxes.

Earnings Per Share

Chemours presents both basic earnings per share and diluted earnings per share. Basic earnings per share excludes dilution and is computed by dividing the total net income (loss) attributable to Chemours by the weighted-average number of shares outstanding for the period. Diluted earnings per share reflects the dilution that could occur if the Company’s outstanding stock-based compensation awards, including any unvested restricted shares, were vested and exercised, thereby resulting in the issuance of common stock as determined under the treasury stock method. In periods where the Company incurs a net loss, stock-based compensation awards are excluded from the calculation of earnings per share as their inclusion would have an anti-dilutive effect.

Cash and Cash Equivalents

Cash and cash equivalents generally include cash, time deposits, or highly liquid investments with maturities of three months or less at the time of acquisition.

Accounts and Notes Receivable and Allowance for Doubtful Accounts

Accounts and notes receivables are recognized net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects the best estimate of losses inherent in Chemours’ accounts and notes receivable portfolio, which is determined by assessing expected credit losses on the basis of historical experience, specific allowances for known troubled accounts, and other available evidence. Accounts and notes receivable are written off when management determines that they are uncollectible.

Inventories

Chemours’ inventories are valued at the lower of cost or market or net realizable value, where applicable. Cost of inventories held at substantially all U.S. locations are determined using the last-in, first-out (“LIFO”) method, while cost of inventories held outside the U.S. are determined using the average cost method. The elements of cost in inventories include raw materials, direct labor, and manufacturing overhead. Stores and supplies are valued at the lower of cost or net realizable value, and cost is generally determined by the average cost method.

Property, Plant, and Equipment

Property, plant, and equipment is carried at cost and is depreciated using the straight-line method. Substantially all equipment and buildings are depreciated over useful lives ranging from 15 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over five to seven years. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the consolidated balance sheets and are included in the determination of any gain or loss on such disposals.

Repair and maintenance costs that materially add to the value of the asset or prolong its useful life are capitalized and depreciated based on their extension to the asset’s useful life. Capitalized repair and maintenance costs are recorded on the consolidated balance sheets as a component of other assets.

Impairment of Long-lived Assets

Chemours evaluates the carrying value of its long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. For the purposes of recognition or measurement of an impairment charge, the assessment is performed on the asset or asset group at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. To determine the level at which the assessment is performed, Chemours considers factors such as revenue dependency, shared costs, and the extent of vertical integration. The carrying value of a long-lived asset is considered impaired when the total projected undiscounted cash flows from the use and eventual disposition of the asset or asset group are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The fair value methodology used is an estimate of fair market value, which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by means other than sale are classified as held for use until their disposal. Long-lived assets to be disposed of by sale are classified as held for sale and are reported at the lower of carrying amount or fair market value, less the estimated cost to sell. Depreciation and amortization are discontinued for any long-lived assets classified as held for sale.

Leases

The Company’s lease assets and lease liabilities are recognized on the lease commencement date in an amount that represents the present value of future lease payments. Operating leases are included in operating lease right-of-use assets, other accrued liabilities, and operating lease liabilities on the Company’s consolidated balance sheets. Finance leases are included in property, plant, and equipment, net, short-term and current maturities of long-term debt, and long-term debt, net, on the Company’s consolidated balance sheets. The Company’s incremental borrowing rate, which is based on information available at the adoption date of January 1, 2019 for existing leases and the commencement date for leases commencing after the adoption date, is used to determine the present value of lease payments. The Company combines lease components with non-lease components for most classes of assets, except for certain manufacturing facilities or when the non-lease component is significant to the lease component.

The Company does not recognize leases with an initial term of 12 months or less on its consolidated balance sheets and will recognize those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. Certain leases contain variable payments which are based on usage or operating costs, such as utilities and maintenance. These payments are not included in the measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred. Leases with the options to extend their term or terminate early are reflected in the lease term when it is reasonably certain that the Company will exercise such options.

Goodwill and Other Intangible Assets

The excess of the purchase price over the estimated fair value of the net assets acquired in a business combination, including any identified intangible assets, is recorded as goodwill. Chemours tests its goodwill for impairment at least annually on October 1; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Goodwill is evaluated for impairment at the reporting unit level, which is defined as an operating segment, or one level below an operating segment. A reporting unit is the level at which discrete financial information is available and reviewed by business management on a regular basis. An impairment exists when the carrying value of a reporting unit exceeds its fair value. The amount of impairment loss recognized in the consolidated statements of operations is equal to the excess of a reporting unit’s carrying value over its fair value, which is limited to the total amount of goodwill allocated to the reporting unit.

Chemours has the option to first qualitatively assess whether it is more-likely-than-not that an impairment exists for a reporting unit. Such qualitative factors include, among other things, prevailing macroeconomic conditions, industry and market conditions, changes in costs associated with raw materials, labor, or other inputs, the Company’s overall financial performance, and certain other entity-specific events that impact Chemours’ reporting units. When performing a quantitative test, the Company weights the results of an income-based valuation technique, the discounted cash flows method, and a market-based valuation technique, the guideline public companies method, to determine its reporting units’ fair values.

Definite-lived intangible assets, such as purchased and licensed technology, patents, trademarks, customer lists and allowance units are amortized over their estimated useful lives, generally for periods ranging up to 20 years. The reasonableness of the useful lives of these assets is periodically evaluated.

Investments in Affiliates

The Company uses the equity method of accounting for its investments in and earnings of affiliates. The Company considers whether the fair value of any of its equity method investments has declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. If the Company considers any such decline to be other than temporary, based on various factors, a write-down would be recorded to the estimated fair value.

Restricted Cash and Restricted Cash Equivalents

The Company classifies cash and cash equivalents that are legally or contractually restricted for withdrawal or usage as restricted cash and restricted cash equivalents. Chemours restricted cash and restricted cash equivalents includes cash and cash equivalents deposited in an escrow account as per the terms of the Company’s Memorandum of Understanding (“MOU”) agreement which is further discussed in “Note 22 – Commitments and Contingent Liabilities”.

Environmental Liabilities and Expenditures

Chemours accrues for environmental remediation matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Where the available information is only sufficient to establish a range of probable liability, and no point within the range is more likely than any other, the lower end of the range has been used.

Estimated liabilities are determined based on existing remediation laws and technologies and the Company’s planned remedial responses, which are derived from environmental studies, sampling, testing, and analyses. Inherent uncertainties exist in such evaluations, primarily due to unknown environmental conditions, changing governmental regulations regarding liability, and emerging remediation technologies. These liabilities, which are undiscounted, are adjusted periodically as remediation efforts progress and as additional technological, regulatory, and legal information becomes available.

Environmental liabilities and expenditures include claims for matters that are liabilities of EID and its subsidiaries, which Chemours may be required to indemnify pursuant to the Separation-related agreements executed prior to the Separation. These accrued liabilities are undiscounted and do not include claims against third parties.

Costs related to environmental remediation are charged to expense in the period that the associated liability is accrued and are reflected as a component of the cost of goods sold for on-site remediation costs or as a component of selling, general, and administrative expense for off-site remediation costs in the consolidated statements of operations. Other environmental costs are also charged to expense in the period incurred, unless they extend the useful life of the property, increase the property’s capacity, and/or reduce or prevent contamination from future operations, in which case they are capitalized and amortized. Pursuant to the binding MOU entered into between Chemours, DuPont, Corteva, and EID, as further discussed in “Note 22 – Commitments and Contingent Liabilities”, costs specific to potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities are subject to a cost-sharing arrangement between the parties. Any recoveries of Qualified Spend (as further described in “Note 22 – Commitments and Contingent Liabilities” and as defined in the MOU) from DuPont and/or Corteva under the cost-sharing arrangement will be recognized as an offset to the Company’s cost of goods sold or selling, general, and administrative expense, as applicable, when realizable. Any Qualified Spend incurred by DuPont and/or Corteva under the cost-sharing arrangement will be recognized in the Company’s cost of goods sold or selling, general, and administrative expense, as applicable, when the amounts of such costs are probable and estimable.

Asset Retirement Obligations

Chemours records its asset retirement obligations at their fair value at the time the liability is incurred. Fair value is measured using the expected future cash outflows discounted at Chemours’ credit-adjusted, risk-free interest rate, which is considered to be a Level 3 input within the fair value hierarchy. Accretion expense is recognized as an operating expense within the cost of goods sold in the consolidated statements of operations, using the credit-adjusted, risk-free interest rate in effect when the liability was recognized. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived asset and are depreciated over the estimated remaining useful life of the asset, generally for periods ranging from two to 25 years.

Insurance

Chemours insures for certain risks where permitted by law or regulation, including workers’ compensation, vehicle liability, and employee-related benefits. Liabilities associated with these risks are estimated in part by considering any historical claims experience, demographic factors, and other actuarial assumptions. For certain other risks, the Company uses a combination of third-party insurance and self-insurance, reflecting its comprehensive review of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Litigation

Chemours accrues for litigation matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Where the available information is only sufficient to establish a range of probable liability, and no point within the range is more likely than any other, the lower end of the range has been used. When a material loss contingency is reasonably possible, but not probable, the Company does not record a liability, but instead discloses the nature of the matter and an estimate of the loss or range of loss, to the extent such estimate can be made. Litigation-related liabilities and expenditures included in the consolidated financial statements include legal matters that are liabilities of EID and its subsidiaries, which Chemours may be required to indemnify pursuant to the Separation-related agreements executed prior to the Separation. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period that services are rendered.

Treasury Stock

Chemours accounts for repurchases of the Company’s common stock as treasury stock using the cost method, whereby the entire cost of the acquired common stock is recorded as treasury stock. The cost of treasury stock re-issued is determined using the first-in, first-out (“FIFO”) method.

Stock-based Compensation

Chemours’ stock-based compensation consists of stock options, restricted stock units (“RSUs”), and performance share units (“PSUs”) awarded to employees and non-employee directors. Stock options and PSUs are measured at their fair value on the grant date or date of modification, as applicable. RSUs are measured at the stock price on the grant date or date of modification, as applicable. The Company recognizes compensation expense on a straight-line basis over the requisite service and/or performance period, as applicable. Forfeitures of awards are accounted as a reduction in stock-based compensation expense in the period such awards are forfeited.

Financial Instruments

In the ordinary course of business, Chemours enters into contractual arrangements to reduce its exposure to foreign currency and interest rate risks. The Company has established a financial risk management program, which currently includes four distinct risk management instruments: (i) foreign currency forward contracts, which are used to minimize the volatility in the Company’s earnings related to foreign exchange gains and losses resulting from remeasuring its monetary assets and liabilities that are denominated in non-functional currencies; (ii) foreign currency forward contracts, which are used to mitigate the risks associated with fluctuations in the euro against the U.S. dollar for forecasted U.S. dollar-denominated inventory purchases in certain of the Company’s international subsidiaries that use the euro as their functional currency; (iii) interest rate swaps, which are used to mitigate the volatility in the Company’s cash payments for interest due to fluctuations in London Interbank Offered Rate ("LIBOR"), as is applicable to the portion of the Company’s senior secured term loan facility denominated in U.S. dollars; and, (iv) euro-denominated debt, which is used to reduce the volatility in stockholders’ equity caused by changes in foreign currency exchange rates of the euro with respect to the U.S. dollar for certain of its international subsidiaries that use the euro as their functional currency. The Company’s financial risk management program reflects varying levels of exposure coverage and time horizons based on an assessment of risk. The program operates within Chemours’ financial risk management policies and guidelines, and the Company does not enter into derivative financial instruments for trading or speculative purposes.

The Company’s foreign currency forward contracts that are used as a net monetary assets and liabilities hedge are not part of a cash flow hedge program or a fair value hedge program, and have not been designated as a hedge. For these instruments, all gains and losses resulting from the revaluation of derivative assets and liabilities are recognized in other income (expense), net in the consolidated statements of operations during the period in which they occur, and any such gains or losses are intended to be offset by any gains or losses on the underlying asset or liability. For the Company’s foreign currency forward contracts that have been designated under a cash flow hedge program, all gains and losses resulting from the revaluation of the derivative instruments are recognized as a component of accumulated other comprehensive loss on the consolidated balance sheets during the period in which they occur, and are reclassified to the cost of goods sold in the consolidated statements of operations during the period in which the underlying transactions affect earnings, or when it becomes probable that the forecasted transactions will not occur. For the Company’s interest rate swaps that have been designated under a cash flow hedge program, all gains and losses resulting from the revaluation of the derivative instruments are recognized as a component of accumulated other comprehensive loss on the consolidated balance sheets during the period in which they occur, and are reclassified to interest expense, net in the consolidated statements of operations during the period in which the underlying transaction affects earnings. For the Company’s euro-denominated debt instruments, which are designated as a net investment hedge, changes due to remeasurement are included in accumulated other comprehensive loss on the consolidated balance sheets. Chemours’ uses the spot method to evaluate the effectiveness of its net investment hedge.

Financial instruments are reported on a gross basis on the consolidated balance sheets.

Foreign Currency Translation

Chemours identifies its separate and distinct foreign entities and groups them into two categories: (i) extensions of the parent (U.S. dollar functional currency); and, (ii) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated, and a judgment is made to determine the functional currency. Chemours changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances clearly indicate that the functional currency has changed.

During the periods covered by the consolidated financial statements, part of Chemours’ business operated within foreign entities. For foreign entities where the U.S. dollar is the functional currency, all foreign currency-denominated asset and liability amounts are remeasured into U.S. dollars at end-of-period exchange rates, with the exception of inventories, prepaid expenses, property, plant, and equipment, goodwill, and other intangible assets. These aforementioned assets are remeasured at historical exchange rates. Foreign currency-denominated revenue and expense amounts are measured at exchange rates in effect during the period, with the exception of expenses related to any balance sheet amounts remeasured at historical exchange rates. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in other income (expense), net in the consolidated statements of operations in the period in which they occurred.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into U.S. dollars at end-of-period exchange rates, and the resulting translation adjustments are reported as a component of accumulated other comprehensive loss on the consolidated balance sheets. Assets and liabilities denominated in currencies other than the functional currency are remeasured into the functional currency prior to translation into U.S. dollars, and the resulting exchange gains or losses are included in other income (expense), net in the consolidated statements of operations in the period in which they occurred. Revenues and expenses are translated into U.S. dollars at average exchange rates in effect during the period.

Defined Benefit Plans

Chemours has defined benefit plans covering certain of its employees outside of the U.S. The benefits of these plans, which primarily relate to pension, are accrued over the employees’ service periods. The Company uses actuarial methods and assumptions in the valuation of its defined benefit obligations and the determination of any net periodic pension income or expense. Any differences between actual and expected results, or changes in the value of defined benefit obligations and plan assets, if any, are not recognized in earnings as they occur. Rather, they are systematically recognized over subsequent periods.

Fair Value Measurement

Fair value is defined as the exit price, the price that would be received to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date. Under the accounting for fair value measurements and disclosures, a fair value hierarchy was established to prioritize the valuation inputs used to measure fair value. The hierarchy gives highest priority to unadjusted, quoted prices in active markets for identical assets and liabilities (i.e., Level 1 measurements) and lowest priority to unobservable inputs (i.e., Level 3 measurements). A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

Chemours applies the following valuation hierarchy in measuring the fair values of its assets and liabilities:

•

Level 1 – Quoted prices in active markets for identical assets and liabilities;

•

Level 2 – Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable, such as interest rate and yield curves, and market-corroborated inputs); and,

•

Level 3 – Unobservable inputs for the asset or liability, which are valued based on management’s estimates of assumptions that market participants would use in pricing the asset or liability.

Assets and Liabilities Held for Sale

The Company classifies long-lived assets or disposal groups as held for sale in the period when the following held for sale criteria are met: (i) the Company commits to a plan to sell; (ii) the long-lived asset or disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such long-lived assets or disposal groups; (iii) an active program to locate a buyer and other actions required to complete the plan to sell have been initiated; (iv) the sale is probable within one year; (v) the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. Long-lived assets and disposal groups classified as held for sale are measured at the lower of their carrying amount or fair value less costs to sell. The Company ceases depreciation and amortization for a disposal group upon it being classified as held for sale.

Recent Accounting Pronouncements

Accounting Guidance Issued and Not Yet Adopted

Accounting for Contract Assets and Contract Liabilities from Contracts with Customers

In October 2021, the Financial Accounting Standards Board ("FASB") issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), which requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Topic 606 as if the acquirer had originated the contracts. The guidance will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2021-08 on January 1, 2023, the effect of which will not be material to its financial position, results of operations and cash flows. The Company will apply the provisions of ASU 2021-08 after adoption to future acquisitions, if any.

Disclosure of Supplier Finance Program Obligations

In September 2022, the FASB issued ASU 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations ("ASU 2022-04"), which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose qualitative and quantitative information about their programs, including key terms and activity during the period. The guidance will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted, and should be applied retrospectively to each period in which a balance sheet is presented subject to certain exceptions. The Company is currently evaluating the disclosure requirement of this standard that will be required to be included in its consolidated financial statements.

Facilitation of the Effects of Reference Rate Reform on Financial Reporting

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period of time to ease the potential burden associated with accounting for contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. In December 2022, the FASB issued ASU 2022-06, Deferral of the Sunset Date of Topic 848 ("ASU 2022-06"), which extended the expiration date of ASU 2020-04 to December 31, 2024. The Company does not expect the impacts of adopting ASU 2020-04 to be material to its financial position, results of operations and cash flows.

Recently Adopted Accounting Guidance

Disclosures by Business Entities About Government Assistance

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities About Government Assistance (“ASU 2021-10”), which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. The Company adopted ASU 2021-10 during the year ended December 31, 2022. Government grant transactions during the year ended December 31, 2022 were de minimis.

Geographic and Segment Information - Schedule of Net Sales and Property, Plant and Equipment, Net by Geographical Area (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues From External Customers And Long Lived Assets [Line Items]
Net sales	$ 6,794	$ 6,345	$ 4,969
Property, Plant, and Equipment, Net	3,171	3,154	3,474
North America [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Net sales	2,949	2,317	1,914
Property, Plant, and Equipment, Net	2,320	2,309	2,461
Asia Pacific [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Net sales	1,787	1,827	1,384
Property, Plant, and Equipment, Net	127	128	121
Europe, the Middle East, and Africa [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Net sales	1,313	1,412	1,086
Property, Plant, and Equipment, Net	249	322	324
Latin America [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Net sales	745	789	585
Property, Plant, and Equipment, Net	$ 475	$ 395	$ 568

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Schedule of Debt Principal Maturities

Financial Instruments - Schedule of Derivative Assets and Liabilities At Fair Value (Details) - Fair Value, Measurements, Recurring [Member] - Fair Value, Inputs, Level 2 [Member] - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Asset derivatives	$ 2	$ 6
Liability derivatives	5	1
Not Designated as Hedging Instrument [Member] \| Accounts and notes receivable - trade, net [Member] \| Foreign currency forward contracts [Member]
Derivatives, Fair Value [Line Items]
Asset derivatives		1
Not Designated as Hedging Instrument [Member] \| Other accrued liabilities [Member] \| Foreign currency forward contracts [Member]
Derivatives, Fair Value [Line Items]
Liability derivatives	1	1
Designated as Hedging Instrument [Member] \| Accounts and notes receivable - trade, net [Member] \| Foreign currency forward contracts [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Asset derivatives	2	$ 5
Designated as Hedging Instrument [Member] \| Other accrued liabilities [Member] \| Foreign currency forward contracts [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Liability derivatives	$ 4

Financial Instruments - Schedule of Pre-tax Charge Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Accumulated Other Comprehensive Loss	$ 53	$ 73	$ (88)
Foreign currency forward contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Accumulated Other Comprehensive Loss	17	10	(4)
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Accumulated Other Comprehensive Loss	8	2	(4)
Euro Denominated Debt [Member] \| Designated as Hedging Instrument [Member] \| Net Investment Hedge [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Accumulated Other Comprehensive Loss	53	73	(88)
Cost of Goods Sold [Member] \| Foreign currency forward contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Derivative Instruments	19	(2)	3
Interest Expense, Net [Member] \| Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Derivative Instruments	5	(2)
Other Income (Expense), Net [Member] \| Foreign currency forward contracts [Member] \| Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized In Derivative Instruments	$ 2	$ (15)	$ 29

Debt - Accounts Receivable Securitization Facility - Narrative (Details) - USD ($)				3 Months Ended	12 Months Ended
	Mar. 05, 2021	Mar. 09, 2020	Jul. 12, 2019	Mar. 31, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Line of Credit Facility [Line Items]
Net repayments of securitization					$ 0	$ 0	$ 122,000,000
Proceeds from accounts receivable securitization facility					0	0	$ 12,000,000
Securitization Facility [Member] \| Special Purpose Entity [Member]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 125,000,000
Increase in borrowing capacity			$ 200,000,000
Net repayments of securitization				$ 110,000,000
Receivable from securitization facility				$ 125,000,000	46,000,000	76,000,000
Percentage of fair value of sales receivables		100.00%
Percentage of fair value on additional purchases of receivables		100.00%
Proceeds from accounts receivable securitization facility					1,481,000,000	1,364,000,000
Accounts receivable from securitization, amount derecognized					1,481,000,000	1,389,000,000
Fees associated with securitization facility					$ 3,000,000	$ 3,000,000
Securitization Facility [Member] \| Special Purpose Entity [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Increase in borrowing capacity	$ 125,000,000
Securitization Facility [Member] \| Special Purpose Entity [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Increase in borrowing capacity	$ 150,000,000

Leases - Schedule of Cash Flows Related to Company's Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 56	$ 70	$ 91
Operating cash flows from finance leases	4	4	4
Financing cash flows from finance leases	11	10	6
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities	$ 65	45	23
Leased assets obtained in exchange for new finance lease liabilities		$ 14	$ 19

Debt (Tables)

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Components of Debt

The following table sets forth the components of the Company’s debt at December 31, 2022 and 2021.


	December 31,
	2022			2021
Senior secured term loans:
Tranche B-2 U.S. dollar term loan due April 2025	$	766		$	776
Tranche B-2 euro term loan due April 2025 (€333 at December 31, 2022 and €337 at December 31, 2021)		355			381
Senior unsecured notes:
4.000% due May 2026 (€441 at December 31, 2022 and €450 at December 31, 2021)		470			510
5.375% due May 2027		495			500
5.750% due November 2028		783			800
4.625% due November 2029		620			650
Finance lease liabilities		61			72
Financing obligation (1)		91			93
Total debt principal		3,641			3,782
Less: Unamortized issue discounts		(4	)		(5	)
Less: Unamortized debt issuance costs		(22	)		(28	)
Less: Short-term and current maturities of long-term debt		(25	)		(25	)
Long-term debt, net	$	3,590		$	3,724

(1)

At December 31, 2022 and 2021, financing obligation relates to the financed portion of the Chemours Discovery Hub. Refer to “Note 14 – Leases” for further details.

The following table sets forth the Company’s debt principal maturities for the next five years and thereafter.


2023	$	13
2024		13
2025		1,095
2026		470
2027		495
Thereafter		1,403
Total principal maturities on debt	$	3,489

Estimated Fair Values of Senior Debt Issues


	December 31, 2022					December 31, 2021
	Carrying Value			Fair Value		Carrying Value			Fair Value
Senior secured term loans:
Tranche B-2 U.S. dollar term loan due April 2025	$	766		$	755	$	776		$	769
Tranche B-2 euro term loan due April 2025 (€333 at December 31, 2022 and €337 at December 31, 2021)		355			345		381			378
Senior unsecured notes:
4.000% due May 2026 (€441 at December 31, 2022 and €450 at December 31, 2021)		470			422		510			518
5.375% due May 2027		495			459		500			538
5.750% due November 2028		783			702		800			846
4.625% due November 2029		620			509		650			645
Total senior debt principal		3,489		$	3,192		3,617		$	3,694
Less: Unamortized issue discounts		(4	)				(5	)
Less: Unamortized debt issuance costs		(22	)				(28	)
Total senior debt, net	$	3,463				$	3,584

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

Equity Method Investments and Joint Ventures [Abstract]

Investments in Affiliates

12 Months Ended

Dec. 31, 2022

Investments in Affiliates

Note 16. Investments in Affiliates

The Company holds investments in companies where it, directly or indirectly, owns 20% to 50% of the voting stock, or has the ability to exercise significant influence over the operating and financial policies of the investee.

The following table sets forth the jurisdiction, carrying value, and ownership percentages of the Company’s investments in affiliates at December 31, 2022 and 2021.


		December 31, 2022			December 31, 2021
Investee	Jurisdiction	Carrying Value		Ownership	Carrying Value		Ownership
Chemours-Mitsui Fluorochemicals Company, Ltd.	Japan	$	87	50.0%	$	98	50.0%
The Chemours Chenguang Fluoromaterials Company Limited	China		36	50.0%		33	50.0%
Changshu 3F Zhonghao New Chemical Materials Co., Ltd.	China		52	10.0%		38	10.0%
		$	175		$	169

The following table sets forth the changes in the Company’s investments in affiliates for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Balance at January 1,	$	169		$	167		$	162
Equity in earnings of affiliates		55			43			23
Dividends		(33	)		(30	)		(25	)
Currency translation and other		(16	)		(11	)		7
Balance at December 31,	$	175		$	169		$	167

The Company engages in transactions with its equity method investees in the ordinary course of business. For the years ended December 31, 2022, 2021 and 2020, net sales to the Company’s equity method investees amounted to $193, $144, and $98, respectively, and purchases from the Company’s equity method investees amounted to $218, $180, and $133, respectively.

Geographic and Segment Information - Reconciliation of Segment Adjusted EBITDA from Segments to Consolidated Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting [Abstract]
Segment Adjusted EBITDA	$ 1,573	$ 1,533	$ 1,063
Corporate and Other expenses (excluding items below)	(212)	(220)	(184)
Interest expense, net	(163)	(185)	(210)
Depreciation and amortization	(291)	(317)	(320)
Non-operating pension and other post-retirement employee benefit income	5	9	1
Exchange (losses) gains, net	(15)	3	(26)
Restructuring, asset-related, and other charges	(15)	(6)	(80)
Gain (loss) on extinguishment of debt	7	(21)	(22)
Gain on sales of assets and businesses, net	21	115	8
Natural disasters and catastrophic events		(21)
Transaction costs		(4)	(2)
Qualified spend recovery	58	20
Legal and environmental charges	(227)	(230)	(49)
Income before income taxes	$ 741	$ 676	$ 179

Property, Plant, and Equipment, Net

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property, Plant, and Equipment, Net

Note 13. Property, Plant, and Equipment, Net

The following table sets forth the components of the Company’s property, plant, and equipment, net at December 31, 2022 and 2021.


	December 31,
	2022			2021
Equipment	$	7,745		$	7,559
Buildings		1,180			1,168
Construction-in-progress		324			361
Land		102			108
Mineral rights		36			36
Property, plant, and equipment		9,387			9,232
Less: Accumulated depreciation		(6,216	)		(6,078	)
Total property, plant, and equipment, net	$	3,171		$	3,154

Property, plant, and equipment, net included gross assets under finance leases of $91 and $95 at December 31, 2022 and 2021, respectively.

Interest expense capitalized as part of property, plant, and equipment, net amounted to $7, $5, and $4 for the years ended December 31, 2022, 2021 and 2020, respectively.

Depreciation expense amounted to $286, $309, and $313 for the years ended December 31, 2022, 2021 and 2020, respectively.

Commitments and Contingent Liabilities - Schedule of Environmental Remediation Liabilities (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

Current Liabilities [Member]

$ 668

$ 562

Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]

Accrued Environmental Loss Contingencies, Current

Non Current Liabilities [Member]

Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]

Accrued Environmental Loss Contingencies, Noncurrent

Chambers Works, Deepwater, New Jersey [Member]

Fayetteville Works, Fayetteville, North Carolina [Member]

$ 30

$ 27

Pompton Lakes, New Jersey [Member]

^[1]

465

359

USS Lead, East Chicago, Indiana [Member]

Washington Works, West Virginia [Member]

All other sites [Member]

Other Liabilities Disclosure [Abstract]

$ 98

$ 99

[1]	For more information on this matter refer to “Fayetteville Works, Fayetteville, North Carolina” within this “Note 22 – Commitments and Contingent Liabilities”.

Other Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Other Liabilities

The following table sets forth the components of the Company’s other liabilities at December 31, 2022 and 2021.


	December 31,
	2022		2021
Employee-related costs (1)	$	82	$	94
Accrued litigation (2)		55		50
Asset retirement obligations (2)		73		62
Miscellaneous (3)		109		63
Total other liabilities	$	319	$	269

(1)

Employee-related costs primarily represents liabilities associated with the Company’s long-term employee benefit plans.

(2)

Represents the long-term portions of accrued litigation and asset retirement obligations (see “Note 22 – Commitments and Contingent Liabilities”).

(3)

Financial Instruments

12 Months Ended

Dec. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments

Note 26. Financial Instruments

Net Monetary Assets and Liabilities Hedge – Foreign Currency Forward Contracts

At December 31, 2022, the Company had 9 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $180 and an average maturity of one month. At December 31, 2021, the Company had 12 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $254, and an average maturity of one month. Chemours recognized a net gain of $2, a net loss of $15, and a net gain of $29 for the years ended December 31, 2022, 2021 and 2020, respectively, in other income (expense), net.

Cash Flow Hedge – Foreign Currency Forward Contracts

At December 31, 2022, the Company had 153 foreign currency forward contracts outstanding under its cash flow hedge program with an aggregate notional U.S. dollar equivalent of $180, and an average maturity of four months. At December 31, 2021, the Company had 175 foreign currency forward contracts outstanding under its cash flow hedge program with an aggregate notional U.S. dollar equivalent of $195, and an average maturity of four months. Chemours recognized a pre-tax gain of $17, a pre-tax gain of $10, and a pre-tax loss of $4 for the years ended December 31, 2022, 2021 and 2020, respectively, within accumulated other comprehensive loss. For the year ended December 31, 2022, $19 of gain was reclassified to the cost of goods sold from accumulated other comprehensive loss. For the years ended December 31, 2021 and 2020, $2 of loss and $3 of gain was reclassified to the cost of goods sold from accumulated other comprehensive loss, respectively.

The Company expects to reclassify approximately $4 of net pre-tax gain, based on current foreign currency exchange rates, from accumulated other comprehensive loss to the cost of goods sold over the next 12 months.

Cash Flow Hedge – Interest Rate Swaps

In 2020, the Company entered into interest rate swaps, the objective of which is to mitigate the volatility in the Company’s cash payments for interest related to the portion of its senior secured term loan facility denominated in U.S. dollars, which bears a variable interest rate equal to, at the election of the Company, adjusted LIBOR plus 1.75% or adjusted base rate plus 0.75%, subject to an adjusted LIBOR or an adjusted base rate floor of 0.00% or 1.00%, respectively.

At December 31, 2021, the Company had three interest rate swaps outstanding under its cash flow hedge program with an aggregate notional U.S. dollar equivalent of $400; each of the interest rate swaps mature on March 31, 2023. In September 2022, the Company terminated all of its outstanding interest rate swaps, which resulted in a cash settlement of $8. Chemours recognized a pre-tax gain of $8, a pre-tax gain of $2 and a pre-tax loss of $4 for the years ended December 31, 2022, 2021 and 2020 within accumulated other comprehensive loss, respectively. For the years ended December 31, 2022, 2021 and 2020, $5 of gain, $2 and less than $1 of loss were reclassified to interest expense, net from accumulated other comprehensive loss, respectively.

The Company expects to reclassify approximately $4 of pre-tax gain from accumulated other comprehensive loss to interest expense, net through March 2023.

Net Investment Hedge – Foreign Currency Borrowings

The Company recognized a pre-tax gain of $53, a pre-tax gain of $73 and a pre-tax loss of $88 for the years ended December 31, 2022, 2021 and 2020, respectively, on its net investment hedge within accumulated other comprehensive loss. No amounts were reclassified from accumulated other comprehensive loss for the Company’s net investment hedges during the years ended December 31, 2022, 2021 and 2020.

Fair Value of Derivative Instruments

The following table sets forth the fair value of the Company’s derivative assets and liabilities at December 31, 2022 and 2021.


		Fair Value Using Level 2 Inputs
	Balance Sheet Location	December 31, 2022		December 31, 2021
Asset derivatives:
Foreign currency forward contracts not designated as a hedging instrument	Accounts and notes receivable, net (Note 11)	$	—	$	1
Foreign currency forward contracts designated as a cash flow hedge	Accounts and notes receivable, net (Note 11)		2		5
Interest rate swaps designated as a cash flow hedge	Accounts and notes receivable, net (Note 11)		—		—
Total asset derivatives		$	2	$	6

Liability derivatives:
Foreign currency forward contracts not designated as a hedging instrument	Other accrued liabilities (Note 19)	$	1	$	1
Foreign currency forward contracts designated as a cash flow hedge	Other accrued liabilities (Note 19)		4		—
Total liability derivatives		$	5	$	1

The Company’s foreign currency forward contracts and interest rate swaps are classified as Level 2 financial instruments within the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data, and are subjected to tolerance and/or quality checks.

Summary of Financial Instruments

The following table sets forth the pre-tax changes in fair value of the Company’s financial instruments for the years ended December 31, 2022, 2021 and 2020.


	Gain (Loss) Recognized In
										Accumulated Other
	Cost of			Interest			Other Income			Comprehensive
Year Ended December 31,	Goods Sold			Expense, Net			(Expense), Net			Loss
2022
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	2		$	—
Foreign currency forward contracts designated as a cash flow hedge		19			—			—			17
Interest rate swaps designated as a cash flow hedge		—			5			—			8
Euro-denominated debt designated as a net investment hedge		—			—			—			53

2021
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	(15	)	$	—
Foreign currency forward contracts designated as a cash flow hedge		(2	)		—			—			10
Interest rate swaps designated as a cash flow hedge		—			(2	)		—			2
Euro-denominated debt designated as a net investment hedge		—			—			—			73

2020
Foreign currency forward contracts not designated as a hedging instrument	$	—		$	—		$	29		$	—
Foreign currency forward contracts designated as a cash flow hedge		3			—			—			(4	)
Interest rate swaps designated as a cash flow hedge		—			—			—			(4	)
Euro-denominated debt designated as a net investment hedge		—			—			—			(88	)

Net Sales

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Net Sales

Note 5. Net Sales

Disaggregation of Net Sales

The following table sets forth a disaggregation of the Company’s net sales by geographic region and segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Net sales by geographic region (1)
North America:
Titanium Technologies	$	1,285	$	1,019	$	776
Thermal & Specialized Solutions		974		635		520
Advanced Performance Materials		619		494		407
Other Segment		71		169		211
Total North America		2,949		2,317		1,914
Asia Pacific:
Titanium Technologies		928		1,049		778
Thermal & Specialized Solutions		178		160		134
Advanced Performance Materials		657		595		450
Other Segment		24		23		22
Total Asia Pacific		1,787		1,827		1,384
Europe, the Middle East, and Africa:
Titanium Technologies		695		829		528
Thermal & Specialized Solutions		320		313		331
Advanced Performance Materials		281		254		202
Other Segment		17		16		25
Total Europe, the Middle East, and Africa		1,313		1,412		1,086
Latin America (2):
Titanium Technologies		472		458		320
Thermal & Specialized Solutions		208		149		120
Advanced Performance Materials		61		54		45
Other Segment		4		128		100
Total Latin America		745		789		585
Total net sales	$	6,794	$	6,345	$	4,969

(1)

Net sales are attributed to countries based on customer location.

(2)

Latin America includes Mexico.

The following table sets forth a disaggregation of the Company’s net sales by product group and segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Net sales by product group and segment
Titanium dioxide and other minerals	$	3,380	$	3,355	$	2,402
Total Titanium Technologies		3,380		3,355		2,402
Refrigerants		1,352		973		889
Foam, propellants, and other		328		284		216
Total Thermal & Specialized Solutions		1,680		1,257		1,105
Advanced materials		1,125		977		782
Performance solutions		493		420		322
Total Advanced Performance Materials		1,618		1,397		1,104
Mining solutions		—		237		203
Performance chemicals and intermediates		116		99		155
Total Other Segment		116		336		358
Total net sales	$	6,794	$	6,345	$	4,969

Substantially all of the Company’s net sales are derived from goods and services transferred at a point in time. The Company’s net sales from trademark licensing royalties were not significant for the years ended December 31, 2022, 2021 and 2020.

Contract Balances

The Company’s assets and liabilities from contracts with customers constitute accounts receivable - trade, deferred revenue, and customer rebates. An amount for accounts receivable - trade is recorded when the right to consideration under a contract becomes unconditional. An amount for deferred revenue is recorded when consideration is received prior to the conclusion that a contract exists, or when a customer transfers consideration prior to the Company satisfying its performance obligations under a contract. Customer rebates represent an expected refund liability to a customer based on a contract. In contracts with customers where a rebate is offered, it is generally applied retroactively based on the achievement of a certain sales threshold. As revenue is recognized, the Company estimates whether or not the sales threshold will be achieved to determine the amount of variable consideration to include in the transaction price.

The following table sets forth the Company’s contract balances from contracts with customers at December 31, 2022 and 2021.


	December 31,
	2022		2021
Contract assets:
Accounts receivable - trade, net (Note 11)	$	509	$	644
Contract liabilities:
Deferred revenue	$	5	$	5
Customer rebates (Note 19)		90		83

Changes in the Company’s deferred revenue balances resulting from additions for advance payments and deductions for amounts recognized in net sales during the years ended December 31, 2022 and 2021 were not significant. For the years ended December 31, 2022 and 2021, the amount of net sales recognized from performance obligations satisfied in prior periods (e.g., due to changes in transaction price) was not significant.

There were no material contract asset balances or capitalized costs associated with obtaining or fulfilling customer contracts as of December 31, 2022 and 2021.

Remaining Performance Obligations

Certain of the Company’s master services agreements or other arrangements contain take-or-pay clauses, whereby customers are required to purchase a fixed minimum quantity of product during a specified period, or pay the Company for such orders, even if not requested by the customer. The Company considers these take-or-pay clauses to be an enforceable contract, and as such, the legally-enforceable minimum amounts under such an arrangement are considered to be outstanding performance obligations on contracts with an original expected duration greater than one year. At December 31, 2022, Chemours had $31 of remaining performance obligations. The Company expects to recognize approximately 91% of its remaining performance obligations as revenue in 2023 and the remainder in 2024. The Company applies the allowable practical expedient and does not include remaining performance obligations that have original expected durations of one year or less, or amounts for variable consideration allocated to wholly-unsatisfied performance obligations or wholly-unsatisfied distinct goods that form part of a single performance obligation, if any. Amounts for contract renewals that are not yet exercised by December 31, 2022 are also excluded.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Long-term Employee Benefits (Change in Benefit Obligation and Plan Assets) (Details) - Pension Plan [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Employer contributions	$ 10	$ 17	$ 20
Foreign [Member]
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	575	584
Service cost	14	15	15
Interest cost	7	5	6
Plan participants’ contributions	2	2
Actuarial (gain) loss	(145)	19
Benefits paid	(5)	(4)
Plan amendments	(2)
Settlements and transfers	(4)	(11)
Currency translation	(35)	(35)
Benefit obligation at end of year	407	575	584
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	585	604
Actual return on plan assets	(129)	17
Employer contributions	10	17
Plan participants’ contributions	2	2
Benefits paid	(5)	(4)
Settlements and transfers	(4)	(11)
Currency translation	(37)	(40)
Fair value of plan assets at end of year	422	585	$ 604
Total funded status at end of year	$ 15	$ 10

Commitments and Contingent Liabilities - Schedule of Current and Long-term Components of Environmental Remediation Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Current environmental remediation	$ 194	$ 173
Long-term environmental remediation	474	389
Total environmental remediation	$ 668	$ 562

Accounts Payable

12 Months Ended

Dec. 31, 2022

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

Accounts Payable

Note 18. Accounts Payable

The following table sets forth the components of the Company’s accounts payable at December 31, 2022 and 2021.


	December 31,
	2022		2021
Trade payables	$	1,228	$	1,141
VAT and other payables		23		21
Total accounts payable	$	1,251	$	1,162

Goodwill and Other Intangible Assets, Net - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

$ 69

$ 56

(56)

(50)

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

Allowance Units [Member]

^[1]

^[1]

(1)

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

^[1]

Customer Lists [Member]

(2)

Customer Relationships [Member]

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

(21)

(16)

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

Patents [Member]

(19)

Purchased and Licensed Technology [Member]

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

(3)

Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]

Other [Member]

(10)

Property, Plant and Equipment [Abstract]

$ 0

[1]	Allowance units represent rights purchased for the production and/or importation of regulated materials.

Inventories (Tables)

12 Months Ended

Dec. 31, 2022

Inventory, Net [Abstract]

Schedule of Inventories

The following table sets forth the components of the Company’s inventories at December 31, 2022 and 2021.


	December 31,
	2022			2021
Finished products	$	910		$	704
Semi-finished products		218			192
Raw materials, stores, and supplies		654			475
Inventories before LIFO adjustment		1,782			1,371
Less: Adjustment of inventories to LIFO basis		(378	)		(272	)
Total inventories	$	1,404		$	1,099

Property, Plant, and Equipment, Net (Tables)

12 Months Ended

Dec. 31, 2022

Summary of Property, Plant, and Equipment, Net

The following table sets forth the components of the Company’s property, plant, and equipment, net at December 31, 2022 and 2021.


	December 31,
	2022			2021
Equipment	$	7,745		$	7,559
Buildings		1,180			1,168
Construction-in-progress		324			361
Land		102			108
Mineral rights		36			36
Property, plant, and equipment		9,387			9,232
Less: Accumulated depreciation		(6,216	)		(6,078	)
Total property, plant, and equipment, net	$	3,171		$	3,154

Stock-based Compensation - Stock Option Activity (Details) - Stock Option [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning balance, shares	6,967	7,359	6,056
Granted, shares	1,031	1,153	2,778
Exercised, shares	(3,041)	(1,376)	(1,124)
Forfeited, shares	(202)	(107)	(186)
Expired, shares	(87)	(62)	(165)
Outstanding, ending balance, shares	4,668	6,967	7,359	6,056
Exercisable, shares	2,189
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding, weighted average exercise price, beginning balance (in dollars per share)	$ 20.32	$ 19.21	$ 20.92
Granted, weighted average exercise price (in dollars per share)	25.98	24.35	14.42
Exercised, weighted average exercise price (in dollars per share)	16.76	17.01	14.23
Forfeited, weighted average exercise price (in dollars per share)	21.29	20.62	23.84
Expired, weighted average exercise price (in dollars per share)	32.78	36.71	29.99
Outstanding, weighted average exercise price, ending balance (in dollars per share)	23.61	$ 20.32	$ 19.21	$ 20.92
Exercisable, weighted average exercise price (in dollars per share)	$ 25.71
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term	7 years 29 days	6 years 7 months 6 days	6 years 2 months 15 days	4 years 8 months 15 days
Options exercisable, weighted average remaining contractual term	5 years 9 months 10 days
Options outstanding, aggregate intrinsic value	$ 42,668	$ 101,261	$ 63,894	$ 19,087
Options exercisable, aggregate intrinsic value	$ 20,561

Equity

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Equity

Note 23. Equity

2018 Share Repurchase Program

On August 1, 2018, the Company’s board of directors approved a share repurchase program authorizing the purchase of shares of Chemours’ issued and outstanding common stock in an aggregate amount not to exceed $750, plus any associated fees or costs in connection with the Company’s share repurchases activity (the “2018 Share Repurchase Program”). On February 13, 2019, the Company’s board of directors increased the authorization amount of the 2018 Share Repurchase Program from $750 to $1,000. Under the 2018 Share Repurchase Program, shares of Chemours’ common stock can be purchased in the open market from time to time, subject to management’s discretion, as well as general business and market conditions. On May 19, 2022, the Company completed the aggregate $1,000 in authorized purchases of Chemours’ issued and outstanding common stock under the 2018 Share Repurchase Program, which amounted to a cumulative 28,603,784 shares purchased at an average share price of $34.96 per share. All common shares purchased under the 2018 Share Repurchase Program are held as treasury stock and accounted for using the cost method.

The following table sets forth the Company’s share repurchase activity under the 2018 Share Repurchase Program for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Total number of shares purchased		7,824,039		5,533,746		-
Total paid for shares purchased	$	251	$	177	$	-
Average price paid per share	$	32.06	$	31.99	$	-

2022 Share Repurchase Program

On April 27, 2022, the Company’s board of directors approved a share repurchase program authorizing the purchase of shares of Chemours’ issued and outstanding common stock in an aggregate amount not to exceed $750, plus any associated fees or costs in connection with the Company’s share repurchase activity (the “2022 Share Repurchase Program”). Under the 2022 Share Repurchase Program, shares of Chemours’ common stock can be purchased in the open market from time to time, subject to management’s discretion, as well as general business and market conditions. The Company’s 2022 Share Repurchase Program became effective on April 27, 2022 and is scheduled to continue through the earlier of its expiration on December 31, 2025 or the completion of repurchases up to the approved amount. The program may be suspended or discontinued at any time. All common shares purchased under the 2022 Share Repurchase Program are expected to be held as treasury stock and accounted for using the cost method.‌

The following table sets forth the Company’s share repurchase activity under the 2022 Share Repurchase Program for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Total number of shares purchased		8,234,314		-		-
Total paid for shares purchased	$	241	$	-	$	-
Average price paid per share	$	29.24	$	-	$	-

The Company purchased an aggregate 16,058,353 shares of Chemours’ issued and outstanding common stock under the 2018 and 2022 Share Repurchase Programs during the year ended December 31, 2022, respectively, which amounted to $492 at an average share price of $30.61.

Through December 31, 2022, under the 2022 Share Repurchase Program, the Company purchased a cumulative 8,234,314 shares of Chemours’ issued and outstanding common stock, which amounted to $241 at an average share price of $29.24 per share. The aggregate amount of Chemours’ common stock that remained available for purchase under the 2022 Share Repurchase Program at December 31, 2022 was $509.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Summary of Asset Retirement Obligations

The following table sets forth the activity in the Company’s asset retirement obligations for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Balance at January 1,	$	76		$	76		$	76
Obligations incurred or acquired		—			—			12
Increase (decrease) in estimated cash outflows		2			1			(14	)
Accretion expense		10			2			4
Settlements and payments		(5	)		(3	)		(2	)
Balance at December 31,	$	83		$	76		$	76

Current portion	$	10		$	14		$	13
Non-current portion		73			62			63

Schedule of Components of Accrued Litigation

The following table sets forth the components of the Company’s accrued litigation at December 31, 2022 and 2021.


	December 31,
	2022		2021
Asbestos	$	35	$	33
PFOA (1)		45		23
All other matters (2)		16		30
Total accrued litigation	$	96	$	86

(1)

At December 31, 2022, PFOA includes $20 associated with the Company’s portion of the potential loss in the single matter not included in the Leach settlement. For information regarding this matter, refer to “PFOA” within this “Note 22 – Commitments and Contingent Liabilities”.

(2)

At December 31, 2021, all other matters includes $25, which was paid in January 2022, associated with the Company’s portion of the costs to enter into the Settlement Agreement, Limited Release, Waiver and Covenant Not to Sue reflecting Chemours, DuPont, Corteva, EID and the State of Delaware’s agreement to settle and fully resolve claims alleged against the companies. For information regarding this matter, refer to “PFAS” within this “Note 22 – Commitments and Contingent Liabilities”.

Schedule of Current and Long-term Components of Accrued Litigation and Balance Sheet Locations

The following table sets forth the current and long-term components of the Company’s accrued litigation and their balance sheet locations at December 31, 2022 and 2021.


		December 31,
	Balance Sheet Location	2022		2021
Accrued Litigation:
Current accrued litigation (1)	Other accrued liabilities (Note 19)	$	41	$	36
Long-term accrued litigation	Other liabilities (Note 21)		55		50
Total accrued litigation		$	96	$	86

(1)

At December 31, 2021, current accrued litigation includes $25, which was paid in January 2022, associated with the Company’s portion of the costs to enter into the Settlement Agreement, Limited Release, Waiver and Covenant Not to Sue reflecting Chemours, DuPont, Corteva, EID, and the State of Delaware’s agreement to settle and fully resolve claims alleged against the companies. For information regarding this matter, refer to “PFAS” within this “Note 22 – Commitments and Contingent Liabilities”.

Schedule of Environmental Remediation Liabilities

The following table sets forth the Company’s environmental remediation liabilities at December 31, 2022 and 2021 for the five sites that are deemed the most significant, together with the aggregate liabilities for all other sites.


	December 31,
	2022		2021
Chambers Works, Deepwater, New Jersey	$	30	$	27
Fayetteville Works, Fayetteville, North Carolina (1)		465		359
Pompton Lakes, New Jersey		41		42
USS Lead, East Chicago, Indiana		17		24
Washington Works, West Virginia		17		11
All other sites		98		99
Total environmental remediation	$	668	$	562

(1)

For more information on this matter refer to “Fayetteville Works, Fayetteville, North Carolina” within this “Note 22 – Commitments and Contingent Liabilities”.

Schedule of Current and Long-term Components of Environmental Remediation Liabilities

following table sets forth the current and long-term components of the Company’s environmental remediation liabilities at December 31, 2022 and 2021.


	December 31,
	2022		2021
Current environmental remediation	$	194	$	173
Long-term environmental remediation		474		389
Total environmental remediation	$	668	$	562

Schedule of On-Site and Off-Site Components of Accrued Environmental Remediation Liabilities Related to PFAS

following table sets forth the on-site and off-site components of the Company’s accrued environmental remediation liabilities related to PFAS at Fayetteville at December 31, 2022 and 2021.


	December 31,
	2022		2021
On-site remediation	$	264	$	289
Off-site groundwater remediation		201		70
Total Fayetteville environmental remediation	$	465	$	359

Schedule of Current and Long-term Components of Accrued Environmental Remediation Liabilities

The following table sets forth the current and long-term components of the Company’s accrued environmental remediation liabilities related to PFAS at Fayetteville at December 31, 2022 and 2021.


	December 31,
	2022		2021
Current environmental remediation	$	139	$	114
Long-term environmental remediation		326		245
Total Fayetteville environmental remediation	$	465	$	359

Other Income (Expense), Net - Components of Other Income (Expense) (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Mining Solutions [Member] \| Chemical Solutions [Member] \| Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Component of Other Income [Line Items]
Gain on sale of asset		$ 112
Beaumont Land Sale [Member]
Component of Other Income [Line Items]
Gain on sale of asset	$ 5
Pascagoula [Member]
Component of Other Income [Line Items]
Gain on sale of asset	$ 18
Oakley California Site [Member]
Component of Other Income [Line Items]
Gain on sale of asset			$ 6

Research and Development Expense (Tables)

12 Months Ended

Dec. 31, 2022

Research and Development [Abstract]

Summary of R&D Expense by Segment

The following table sets forth the Company’s R&D expense by segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Titanium Technologies	$	34	$	36	$	31
Thermal & Specialized Solutions		25		20		18
Advanced Performance Materials		54		46		41
Other Segment		1		2		2
Corporate and Other		4		3		1
Total research and development expense	$	118	$	107	$	93

Goodwill and Other Intangible Assets, Net

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets, Net

Note 15. Goodwill and Other Intangible Assets, Net

Goodwill

The following table sets forth the changes in the carrying amount of the Company’s goodwill by segment for the years ended December 31, 2022 and 2021.


	Titanium Technologies		Thermal & Specialized Solutions		Advanced Performance Materials		Other Segment			Total
Balance at January 1, 2021	$	13	$	33	$	56	$	51		$	153
Divestitures		—		—		—		(51	)		(51	)
Balance at December 31, 2021		13		33		56		—			102
Balance at December 31, 2022	$	13	$	33	$	56	$	—		$	102

Chemours consists of four operating segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions (included in Other Segment). The Company defines its reporting units as operating units or one level below its operating segments. In 2022 and in 2021 following the Mining Solutions Transaction, the Company had three reporting units for goodwill testing, which align with the Company's operating segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. For the year ended December 31, 2021, $51 of goodwill was allocated to the disposal group in determining the gain on sale of the Mining Solutions business. For the year ended December 31, 2022, the Company did not have any impairments to or transfers of its goodwill balances. The Company tested the goodwill balances attributable to each of its reporting units for potential impairment on October 1, 2022, 2021, and 2020, the dates of Chemours’ annual goodwill assessments. No goodwill impairments were recorded for the years ended December 31, 2022, 2021 and 2020, as the fair values of the Company’s reporting units that carry goodwill exceeded each respective reporting unit’s carrying amount on October 1, 2022, 2021 and 2020.

The total accumulated impairment losses included in the Company’s goodwill balance at December 31, 2022 and 2021 amounted to $4.

Other Intangible Assets, Net

The following table sets forth the gross carrying amounts and accumulated amortization of the Company’s other intangible assets by major class at December 31, 2022 and 2021.


	December 31, 2022							December 31, 2021
	Cost		Accumulated Amortization			Net		Cost		Accumulated Amortization			Net
Allowance units (1)	$	13	$	(1	)	$	12	$	—	$	—		$	—
Customer lists		2		(2	)		—		2		(2	)		—
Customer relationships		22		(21	)		1		22		(16	)		6
Patents		19		(19	)		—		19		(19	)		—
Purchased and licensed technology		3		(3	)		—		3		(3	)		—
Other		10		(10	)		—		10		(10	)		—
Total other intangible assets	$	69	$	(56	)	$	13	$	56	$	(50	)	$	6

(1)

Allowance units represent rights purchased for the production and/or importation of regulated materials.

The aggregate pre-tax amortization expense for definite-lived intangible assets was $5, $8, and $7 for the years ended December 31, 2022, 2021 and 2020, respectively. The estimated annual aggregate pre-tax amortization expense for 2023 is $10. Less than $1 of pre-tax amortization expense is estimated annually for 2024, 2025, 2026, and 2027. Definite-lived intangible assets are amortized over their estimated useful lives, generally for periods ranging up to 20 years. The reasonableness of the useful lives of these assets is periodically evaluated. The Company does not have any indefinite-lived intangible assets.

Accounts Payable (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Accounts Payable

The following table sets forth the components of the Company’s accounts payable at December 31, 2022 and 2021.


	December 31,
	2022		2021
Trade payables	$	1,228	$	1,141
VAT and other payables		23		21
Total accounts payable	$	1,251	$	1,162

Investments in Affiliates - Schedule of Changes in Investments in Affiliates (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Beginning Balance	$ 169	$ 167	$ 162
Equity in earnings of affiliates	55	43	23
Dividends	(33)	(30)	(25)
Currency translation and other	(16)	(11)	7
Ending Balance	$ 175	$ 169	$ 167

Accounts and Notes Receivable, Net - Schedule of Allowance for Doubtful Accounts (Parenthetical) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Bad debt write-offs		$ 1,000,000	$ 1,000,000
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Bad debt write-offs	$ 1,000,000

Inventories - Schedule of Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory, Net [Abstract]
Finished products	$ 910	$ 704
Semi-finished products	218	192
Raw materials, stores, and supplies	654	475
Inventories before LIFO adjustment	1,782	1,371
Less: Adjustment of inventories to LIFO basis	(378)	(272)
Total inventories	$ 1,404	$ 1,099

Equity - Narrative (Details) - Common Stock [Member] - USD ($)		8 Months Ended	12 Months Ended		46 Months Ended
	Apr. 27, 2022	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	May 19, 2022	Feb. 13, 2019	Aug. 01, 2018
2018 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Stock repurchase program, authorized amount					$ 1,000,000,000	$ 1,000,000,000	$ 750,000,000
Average price paid per share			$ 32.06	$ 31.99	$ 34.96
Total number of shares purchased			7,824,039	5,533,746	28,603,784
Total amount for shares purchased			$ 251,000,000	$ 177,000,000
Stock Repurchased During Period, Shares			7,824,039	5,533,746	28,603,784
2018 Share Repurchase Program [Member] \| Maximum [Member]
Equity Class Of Treasury Stock [Line Items]
Stock repurchase program, authorized amount							$ 750,000,000
2022 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Average price paid per share		$ 29.24	$ 29.24
Total number of shares purchased		8,234,314	8,234,314
Total amount for shares purchased		$ 241,000,000	$ 241,000,000
Stock repurchase program effective date	Apr. 27, 2022
Stock Repurchased During Period, Shares		8,234,314	8,234,314
Stock repurchase program expiration date	Dec. 31, 2025
Remaining available amount of common stock under the share repurchase program		$ 509,000,000	$ 509,000,000
2022 Share Repurchase Program [Member] \| Maximum [Member]
Equity Class Of Treasury Stock [Line Items]
Stock repurchase program, authorized amount	$ 750,000,000
2018 and 2022 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Average price paid per share			$ 30.61
Total number of shares purchased			16,058,353
Total amount for shares purchased			$ 492,000,000
Stock Repurchased During Period, Shares			16,058,353

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock , par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	810,000,000	810,000,000
Common stock, shares Issued (in shares)	195,375,810	191,860,159
Common stock, shares outstanding (in shares)	148,504,030	161,046,732
Treasury stock (in shares)	46,871,780	30,813,427

Debt - Components of Debt (Details) € in Millions, $ in Millions	Dec. 31, 2022 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 USD ($)	Aug. 18, 2021 USD ($)
Debt Instrument [Line Items]
Finance lease liabilities		$ 61		$ 72
Financing obligation		91		93
Total debt principal		3,641		3,782
Less: Unamortized issue discounts		(4)		(5)
Less: Unamortized debt issuance costs		(22)		(28)
Less: Short-term and current maturities of long-term debt		(25)		(25)
Long-term debt, net		3,590		3,724
Senior Secured Tranche B-2 U.S Dollar Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt		766		776
Senior Secured Tranche B-2 Euro Term Loan Due April 2025 [Member]
Debt Instrument [Line Items]
Long-term debt	€ 333	355	€ 337	381
4.000% Senior Unsecured Notes Due May 2026 [Member]
Debt Instrument [Line Items]
Long-term debt	€ 441	470	€ 450	510
5.375% Senior Unsecured Notes Due May 2027 [Member]
Debt Instrument [Line Items]
Long-term debt		495		500
5.750% Senior Unsecured Notes Due November 2028 [Member]
Debt Instrument [Line Items]
Long-term debt		783		800
4.625% Senior Unsecured Notes Due November 2029 [Member]
Debt Instrument [Line Items]
Long-term debt		$ 620		$ 650	$ 650

Income Taxes - Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Statutory U.S. federal income tax rate	21.00%	21.00%	21.00%
State income taxes, net of federal benefit	1.00%	0.40%	(6.10%)
Lower effective tax rate on international operations, net	(2.20%)	(2.80%)	(19.00%)
Foreign-derived intangible income deduction	0.00%	(1.80%)
Goodwill	0.00%	1.50%
Depletion	(0.80%)	(1.00%)	(3.40%)
Exchange gains	(1.10%)	(1.90%)
Provision to return and other adjustments	(0.30%)	(1.60%)	(20.60%)
Valuation allowance	0.50%	(2.40%)	7.30%
Stock-based compensation	(1.20%)	(0.60%)
R&D credit	(0.90%)	(0.90%)	(3.80%)
Uncertain tax positions	4.90%	(0.40%)	(0.50%)
Other, net	1.10%	0.60%	2.80%
Total effective tax rate	22.00%	10.10%	(22.30%)

Earnings Per Share of Common Stock - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Average number of stock options	1,077,922	1,500,577	3,839,845

Acquisitions and Divestitures - Narrative (Details) - USD ($) $ in Millions				12 Months Ended
	Jun. 09, 2022	May 24, 2022	Dec. 01, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jul. 26, 2021
Acquisitions And Divestitures [Line Items]
Cash divested			$ 13
Transaction costs					$ 4	$ 2
Beaumont Land Sale [Member]
Acquisitions And Divestitures [Line Items]
Sale of business, purchase price consideration in cash				$ 17
Cash proceeds received		$ 17
Pre-tax gain (loss) on sale				5
Mining Solutions [Member] \| Chemical Solutions [Member] \| Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Acquisitions And Divestitures [Line Items]
Sale of business, purchase price consideration in cash							$ 520
Cash proceeds received			$ 508
Transaction costs					21
Pre-tax gain (loss) on sale					$ 112
Aniline Business [Member]
Acquisitions And Divestitures [Line Items]
Cash proceeds received	$ 16
Pascagoula [Member]
Acquisitions And Divestitures [Line Items]
Pre-tax gain (loss) on sale				$ 18

Accounts and Notes Receivable, Net (Tables)

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

The following table sets forth the components of the Company’s accounts and notes receivable, net at December 31, 2022 and 2021.


	December 31,
	2022		2021
Accounts receivable - trade, net (1)	$	509	$	644
VAT, GST, and other taxes (2)		88		41
Other receivables (3)		29		35
Total accounts and notes receivable, net	$	626	$	720

(1)

Accounts receivable - trade, net includes trade notes receivable of $3 and $17 and is net of allowances for doubtful accounts of $10 and $5 at December 31, 2022 and 2021, respectively. Such allowances are equal to the estimated uncollectible amounts.

(2)

Value added tax (“VAT”) and goods and services tax (“GST”) for various jurisdictions.

(3)

Other receivables consist of derivative instruments, advances, other deposits including receivables under the terms of the MOU. For details of the MOU, see “Note 22 – Commitments and Contingent Liabilities”.

Schedule of Allowance for Doubtful Accounts

The following table sets forth the change in the Company's allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Balance at January 1,	$	5		$	7		$	5
Additions charged to expenses		9			2			3
Deductions from reserves (1)		(4	)		(4	)		(1	)
Balance at December 31,	$	10		$	5		$	7

(1)

Bad debt write-offs were less than $1, $1, and $1 for the years ended December 31, 2022, 2021 and 2020, respectively.

Debt - Maturities and Fair Value - Narrative (Details) - Senior Secured Revolving Credit Facility [Member]	Apr. 03, 2018
Debt Instrument [Line Items]
Percentage per annum for quarterly principal payments	1.00%
Additional principal repayment, percentage of excess cash flow, stepdown level one	25.00%
Additional principal repayment, percentage of excess cash flow, stepdown level two	0.00%
Target leverage ratio one	3.50
Target leverage ratio two	1.00
Maximum [Member]
Debt Instrument [Line Items]
Additional principal repayment, percentage of excess cash flows	50.00%

Income Taxes - Effective Income Tax Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Statutory U.S. federal income tax rate	$ 156	$ 142	$ 38
State income taxes, net of federal benefit	7	3	(11)
Lower effective tax rate on international operations, net	(16)	(19)	(34)
Foreign-derived intangible income deduction	0	(12)	0
Goodwill	0	10
Depletion	(6)	(7)	(6)
Exchange gains	(8)	(13)
Provision to return and other adjustments	(2)	(11)	(37)
Valuation allowance	4	(16)	13
Stock-based compensation	(9)	(4)
R&D credit	(7)	(6)	(7)
Uncertain tax positions	36	(3)	(1)
Other, net	8	4	5
Total provision for (benefit from) income taxes	$ 163	$ 68	$ (40)

Commitments and Contingent Liabilities - Schedule of Components of Accrued Litigation (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

$ 96

$ 86

Asbestos [Member]

PFOA [Member]

All Other Matters [Member]

^[1]

^[2]

$ 16

$ 30

[1]

[2]

Net Sales - Narrative (Details1) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01	Dec. 31, 2022
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations original expected period	1 year
Topic 606 [Member]
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Percentage of remaining performance obligations as revenue	91.00%
Remaining performance obligations original expected period	1 year

Commitments and Contingent - Schedule of Components of Accrued Environmental Remediation Liabilities Related to PFAS (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

Fayetteville Works, Fayetteville, North Carolina [Member]

$ 668

$ 562

Fayetteville Works, Fayetteville, North Carolina [Member] | On-site Remediation [Member]

^[1]

465

359

Fayetteville Works, Fayetteville, North Carolina [Member] | Off-site Groundwater Remediation [Member]

264

289

Schedule of Net Sales and Property, Plant and Equipment, Net by Geographical Area

$ 201

$ 70

[1]	For more information on this matter refer to “Fayetteville Works, Fayetteville, North Carolina” within this “Note 22 – Commitments and Contingent Liabilities”.

Long-term Employee Benefits (Amounts Recognized in Accumulated Other Comprehensive Loss) (Details) - Pension Plan [Member] - Foreign [Member] - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss	$ 132	$ 148	$ 143
Prior service credit	(9)	(9)	(12)
Total amount recognized in accumulated other comprehensive loss	$ 123	$ 139	$ 131

Property, Plant, and Equipment, Net - Summary of Property, Plant, and Equipment, Net (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Property, plant, and equipment	$ 9,387	$ 9,232
Less: Accumulated depreciation	(6,216)	(6,078)
Property, plant, and equipment, net	3,171	3,154	$ 3,474
Equipment [Member]
Property Plant And Equipment [Line Items]
Property, plant, and equipment	7,745	7,559
Building [Member]
Property Plant And Equipment [Line Items]
Property, plant, and equipment	1,180	1,168
Construction-in-progress [Member]
Property Plant And Equipment [Line Items]
Property, plant, and equipment	324	361
Land [Member]
Property Plant And Equipment [Line Items]
Property, plant, and equipment	102	108
Mineral rights [Member]
Property Plant And Equipment [Line Items]
Property, plant, and equipment	$ 36	$ 36

Geographic and Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

The following table sets forth the geographic locations of the Company’s net sales for the years ended and property, plant, and equipment, net as of December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022				2021				2020
	Net Sales (1)		Property, Plant, and Equipment, Net		Net Sales (1)		Property, Plant, and Equipment, Net		Net Sales (1)		Property, Plant, and Equipment, Net
North America	$	2,949	$	2,320	$	2,317	$	2,309	$	1,914	$	2,461
Asia Pacific		1,787		127		1,827		128		1,384		121
Europe, the Middle East, and Africa		1,313		249		1,412		322		1,086		324
Latin America (2)		745		475		789		395		585		568
Total	$	6,794	$	3,171	$	6,345	$	3,154	$	4,969	$	3,474

(1)

Net sales are attributed to countries based on customer location.

(2)

Latin America includes Mexico.

Schedule of Segment Information

following table sets forth certain summary financial information for the Company’s reportable segments as of, and for the years ended December 31, 2022, 2021 and 2020.


Year Ended December 31,	Titanium Technologies		Thermal & Specialized Solutions		Advanced Performance Materials		Other Segment (1)		Segment Total
2022
Net sales to external customers (2)	$	3,380	$	1,680	$	1,618	$	116	$	6,794
Adjusted EBITDA		601		603		367		2		1,573
Depreciation and amortization		125		55		82		8		270
Equity in earnings of affiliates		—		24		31		—		55
Total assets		2,384		1,238		1,742		124		5,488
Investments in affiliates		—		82		93		—		175
Purchases of property, plant, and equipment		149		30		115		6		300

2021
Net sales to external customers (2)	$	3,355	$	1,257	$	1,397	$	336	$	6,345
Adjusted EBITDA		799		401		284		49		1,533
Depreciation and amortization		126		59		86		16		287
Equity in earnings of affiliates		—		15		28		—		43
Total assets		2,318		1,124		1,621		149		5,212
Investments in affiliates		—		72		97		—		169
Purchases of property, plant, and equipment		104		26		103		39		272

2020
Net sales to external customers (2)	$	2,402	$	1,105	$	1,104	$	358	$	4,969
Adjusted EBITDA		498		344		146		75		1,063
Depreciation and amortization		128		53		88		21		290
Equity in earnings of affiliates		—		6		17		—		23
Total assets		2,130		1,041		1,520		531		5,222
Investments in affiliates		—		66		101		—		167
Purchases of property, plant, and equipment		89		28		109		25		251

(1)

On July 26, 2021, the Company entered into the Mining Solutions Transaction which closed on December 1, 2021. For further information see “Note 4 – Acquisitions and Divestitures”.

(2)

Segment net sales to external customers are provided by product group in “Note 5 – Net Sales”.

Summary of Reconciliation for Summary Financial Information for Reportable Segments

The following table sets forth a reconciliation for instances in which the above summary financial information for the Company’s reportable segments does not sum to consolidated amounts.


Year Ended December 31,	Segment Total		Corporate and Other		Total Consolidated
2022
Depreciation and amortization	$	270	$	21	$	291
Total assets		5,488		2,152		7,640
Purchases of property, plant, and equipment		300		7		307

2021
Depreciation and amortization	$	287	$	30	$	317
Total assets		5,212		2,338		7,550
Purchases of property, plant, and equipment		272		5		277

2020
Depreciation and amortization	$	290	$	30	$	320
Total assets		5,222		1,860		7,082
Purchases of property, plant, and equipment		251		16		267

Reconciliation of Segment Adjusted EBITDA from Segments to Consolidated Income (Loss) Before Income Taxes

following table sets forth a reconciliation of Segment Adjusted EBITDA to the Company’s consolidated income (loss) before income taxes for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Segment Adjusted EBITDA	$	1,573		$	1,533		$	1,063
Corporate and Other expenses (excluding items below)		(212	)		(220	)		(184	)
Interest expense, net		(163	)		(185	)		(210	)
Depreciation and amortization		(291	)		(317	)		(320	)
Non-operating pension and other post-retirement employee benefit income		5			9			1
Exchange (losses) gains, net		(15	)		3			(26	)
Restructuring, asset-related, and other charges (1)		(15	)		(6	)		(80	)
Gain (loss) on extinguishment of debt		7			(21	)		(22	)
Gain on sales of assets and businesses, net (2)		21			115			8
Natural disasters and catastrophic events (3)		—			(21	)		—
Transaction costs (4)		—			(4	)		(2	)
Qualified spend recovery (5)		58			20			—
Legal and environmental charges, net (6,7)		(227	)		(230	)		(49	)
Income before income taxes	$	741		$	676		$	179

(1)

In 2022, restructuring, asset-related, and other charges primarily includes asset charges and write-offs resulting from the conflict between Russia and Ukraine and the Company’s decision to suspend its business with Russian entities. In 2021, restructuring, asset-related, and other charges primarily includes a net $9 gain resulting from contract termination with a third-party services provider at the Company’s previously owned Mining Solutions facility in Gomez Palacio, Durango, Mexico.

(2)

Refer to “Note 8 – Other Income (Expense), Net” for further details.

(3)

In 2021, natural disasters and catastrophic events pertains to the total cost of plant repairs and utility charges in excess of historical averages caused by Winter Storm Uri.

(4)

2021 includes costs associated with the Company’s accounting, legal, and bankers’ transaction costs incurred in connection with the sale of its Mining Solutions business.

(5)

Qualified spend recovery represents costs and expenses that were previously excluded from Adjusted EBITDA, reimbursable by DuPont and/or Corteva as part of the Company's cost-sharing agreement under the terms of the MOU which is discussed in further detail in "Note 22 – Commitments and Contingent Liabilities".

(6)

Legal charges pertains to litigation settlements, PFOA drinking water treatment accruals, and other legal charges. For the year ended December 31, 2022, legal charges primarily include proceeds from a settlement in a patent infringement matter relating to certain copolymer patents associated with the Company’s Advanced Performance Materials segment and $20 associated with the Company's portion of the potential loss in the single matter not included in the Leach settlement. For the year ended December 31, 2021, legal charges primarily include $25 associated with the Company’s portion of the costs to enter into a Settlement Agreement, Limited Release, Waiver and Covenant Not to Sue reflecting Chemours, DuPont, Corteva, EID and the State of Delaware’s agreement to settle and fully resolve claims alleged against the companies. The year ended December 31, 2020 includes $29 of charges in connection with the Company’s portion of the costs to settle PFOA multi-district litigation in Ohio. Refer to “Note 22 – Commitments and Contingent Liabilities” for further details.

(7)

Environmental charges pertains to management’s assessment of estimated liabilities associated with certain environmental remediation expenses at various sites. For the years ended December 31, 2022 and 2021, environmental charges primarily include $196 and $169, respectively, related to on-site and off-site remediation costs at Fayetteville. Refer to “Note 22 – Commitments and Contingent Liabilities” for further details.

Long-term Employee Benefits (Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Total weighted-average allocation	100.00%	100.00%
Pension Plan [Member] \| Foreign [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets	$ 422	$ 585	$ 604
Pension Plan [Member] \| Foreign [Member] \| Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Total weighted-average allocation	11.00%	8.00%
Total pension assets at fair value	$ 48	$ 46
Pension Plan [Member] \| Foreign [Member] \| Cash and Cash Equivalents [Member] \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	48	46
Pension Plan [Member] \| Foreign [Member] \| Cash and Cash Equivalents [Member] \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	$ 0	$ 0
Pension Plan [Member] \| Foreign [Member] \| Equity securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total weighted-average allocation	36.00%	37.00%
Total pension assets at fair value	$ 151	$ 217
Pension Plan [Member] \| Foreign [Member] \| Equity securities [Member] \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	31	44
Pension Plan [Member] \| Foreign [Member] \| Equity securities [Member] \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	$ 120	$ 173
Pension Plan [Member] \| Foreign [Member] \| Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Total weighted-average allocation	53.00%	55.00%
Pension Plan [Member] \| Foreign [Member] \| Total Pension Assets at Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets	$ 401	$ 557
Pension Plan [Member] \| Foreign [Member] \| Total Pension Assets at Fair Value [Member] \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets	109	129
Pension Plan [Member] \| Foreign [Member] \| Total Pension Assets at Fair Value [Member] \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets	292	428
Pension Plan [Member] \| Foreign [Member] \| Pooled Mortgage Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets	21	28
Pension Plan [Member] \| Foreign [Member] \| Government Issued [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	47	74
Pension Plan [Member] \| Foreign [Member] \| Government Issued [Member] \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	7	10
Pension Plan [Member] \| Foreign [Member] \| Government Issued [Member] \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	40	64
Pension Plan [Member] \| Foreign [Member] \| Corporate Issued [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	113	147
Pension Plan [Member] \| Foreign [Member] \| Corporate Issued [Member] \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	23	29
Pension Plan [Member] \| Foreign [Member] \| Corporate Issued [Member] \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	90	118
Pension Plan [Member] \| Foreign [Member] \| Derivative Financial Instruments, Assets
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	40	70
Pension Plan [Member] \| Foreign [Member] \| Derivative Financial Instruments, Assets \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	0	0
Pension Plan [Member] \| Foreign [Member] \| Derivative Financial Instruments, Assets \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	40	70
Pension Plan [Member] \| Foreign [Member] \| Other Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	2	3
Pension Plan [Member] \| Foreign [Member] \| Other Plan Assets \| Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	0	0
Pension Plan [Member] \| Foreign [Member] \| Other Plan Assets \| Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total pension assets at fair value	$ 2	$ 3

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Accounting Policies [Abstract]
Preparation of Financial Statements	Preparation of Financial Statements The consolidated financial statements have been prepared in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences, facts, and circumstances available at the time and various other assumptions that management believes are reasonable. Actual results could differ from those estimates.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Chemours and its subsidiaries, as well as entities in which a controlling interest is maintained. For those consolidated subsidiaries in which the Company’s ownership is less than 100%, the outside shareholders’ interests are shown as non-controlling interests. Investments in companies in which Chemours, directly or indirectly, owns 20% to 50% of the voting stock, or has the ability to exercise significant influence over the operating and financial policies of the investee, are accounted for using the equity method of accounting. As a result, Chemours’ share of the earnings or losses of such equity affiliates is included in the consolidated statements of operations, and Chemours’ share of such equity affiliates’ equity is included in the consolidated balance sheets. The Company assesses the requirements related to the consolidation of any variable interest entity (“VIE”), including a qualitative assessment of power and economics that considers which entity has the power to direct the activities that most significantly impact the VIE’s economic performance, and has the right to receive any benefits or the obligation to absorb any losses of the VIE. No such VIE was consolidated by the Company for the periods presented. All intercompany accounts and transactions were eliminated in the preparation of the accompanying consolidated financial statements.
Revenue Recognition	Revenue Recognition Chemours recognizes revenue using a five-step model, resulting in revenue being recognized as performance obligations within a contract have been satisfied. The steps within that model include: (i) identifying the existence of a contract with a customer; (ii) identifying the performance obligations within the contract; (iii) determining the contract’s transaction price; (iv) allocating the transaction price to the contract’s performance obligations; and, (v) recognizing revenue as the contract’s performance obligations are satisfied. A contract with a customer exists when: (i) the Company enters into an enforceable agreement that defines each party’s rights regarding the goods or services to be transferred, and the related payment terms; (ii) the agreement has commercial substance; and, (iii) it is probable that the Company will collect the consideration to which it is entitled in the exchange. A performance obligation is a promise in a contract to transfer a distinct good or service, or a series of distinct goods or services, to a customer. The transaction price is the customary amount of consideration that the Company expects to be entitled to in exchange for a transfer of the promised goods or services to a customer, excluding any amounts collected by the Company on behalf of third parties (e.g., sales and use taxes). Judgment is required to apply the principles-based, five-step model for revenue recognition. Management is required to make certain estimates and assumptions about the Company’s contracts with its customers, including, among others, the nature and extent of its performance obligations, its transaction price amounts and any allocations thereof, the critical events which constitute satisfaction of its performance obligations, and when control of any promised goods or services is transferred to its customers. The Company’s revenue from contracts with customers is reflected in the consolidated statements of operations as net sales, the vast majority of which represents product sales that consist of a single performance obligation. Product sales to customers are made under a purchase order (“PO”), or in certain cases, in accordance with the terms of a master services agreement (“MSA”) or similar arrangement, which documents the rights and obligations of each party to the contract. When a customer submits a PO for product or requests product under an MSA, a contract for a specific quantity of distinct goods at a specified price is created, and the Company’s performance obligation under the contract is satisfied when control of the product is transferred to the customer, which is indicated by shipment of the product and the transfer of title and the risk of loss to the customer. Revenue is recognized on consignment sales when control transfers to the customer, generally at the point of customer usage of the product. The transaction price for product sales is generally the amount specified in the PO or in the request under an MSA; however, as is common in Chemours’ industry, the Company offers variable consideration in the form of rebates, volume discounts, early payment discounts, pricing based on formulas or indices, price matching, and guarantees to certain customers. Such amounts are included in the Company’s estimated transaction price using either the expected value method or the most-likely amount, depending on the nature of the variable consideration included in the contract. The Company regularly assesses its customers’ creditworthiness, and product sales are made based on established credit limits. Payment terms for the Company’s invoices are typically less than 90 days. The Company also licenses the right to access certain of its trademarks to customers under specified terms and conditions in certain arrangements, which is recognized as a component of net sales in the consolidated statements of operations. Under such arrangements, the Company may receive a royalty payment for a trademark license that is entered into on a stand-alone basis or incorporated into an overall product sales arrangement. Royalty income is generally based on customer sales and recognized under the sales-based exception as the customer sale occurs. When minimum guaranteed royalty amounts are included in the transaction price, the Company recognizes royalty income ratably over the license period for the minimum amount. When there is no consideration specified for the use of the Company’s trademark, the entire transaction price is recognized in connection with the transfer of control of product. Royalty income resulting from the right to use the Company’s technology is considered outside the scope of revenue recognition under GAAP as it is not a part of the Company’s ongoing major or central activities, and is recognized as a component of other income (expense), net in the consolidated statements of operations in accordance with agreed-upon terms at the point or points in time that performance obligations are satisfied. Consistent with the fact that the vast majority of the Company’s payment terms are less than 90 days from the point at which control of the promised goods or services is transferred, no adjustments have been made for the effects of a significant financing component. Additionally, the Company has elected to recognize the incremental costs associated with obtaining contracts as an expense when incurred if the amortization period of the assets that the Company would have recognized is one year or less. Amounts billed to customers for shipping and handling fees are considered a fulfillment cost and are included in net sales, and the costs incurred by the Company for the delivery of goods are classified as a component of the cost of goods sold in the consolidated statements of operations.
Research and Development Expense	Research and Development Expense Research and development (“R&D”) costs are expensed as incurred. R&D expenses include costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, enhancement of existing products, and regulatory approval of new and existing products.
Provision for (Benefit from) Income Taxes	Provision for (Benefit from) Income Taxes The provision for (benefit from) income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for (benefit from) income taxes represents income taxes paid or payable for the current year, plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax bases of Chemours’ assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. The Company’s deferred tax assets and liabilities are presented on a net basis by jurisdictional filing group. Net deferred tax assets are presented as a component of other assets, while net deferred tax liabilities are presented as a component of deferred income taxes on the Company’s consolidated balance sheets. Valuation allowances are recorded to reduce deferred tax assets when it is more-likely-than-not that a tax benefit will not be realized. Chemours recognizes income tax positions that meet the more-likely-than-not threshold and accrues any interest related to unrecognized income tax positions in the provision for (benefit from) income taxes in the consolidated statements of operations. The Company also recognizes income tax-related penalties in the provision for (benefit from) income taxes.
Earnings Per Share	Earnings Per Share Chemours presents both basic earnings per share and diluted earnings per share. Basic earnings per share excludes dilution and is computed by dividing the total net income (loss) attributable to Chemours by the weighted-average number of shares outstanding for the period. Diluted earnings per share reflects the dilution that could occur if the Company’s outstanding stock-based compensation awards, including any unvested restricted shares, were vested and exercised, thereby resulting in the issuance of common stock as determined under the treasury stock method. In periods where the Company incurs a net loss, stock-based compensation awards are excluded from the calculation of earnings per share as their inclusion would have an anti-dilutive effect.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents generally include cash, time deposits, or highly liquid investments with maturities of three months or less at the time of acquisition.
Accounts and Notes Receivable and Allowance for Doubtful Accounts	Accounts and Notes Receivable and Allowance for Doubtful Accounts Accounts and notes receivables are recognized net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects the best estimate of losses inherent in Chemours’ accounts and notes receivable portfolio, which is determined by assessing expected credit losses on the basis of historical experience, specific allowances for known troubled accounts, and other available evidence. Accounts and notes receivable are written off when management determines that they are uncollectible.
Inventories	Inventories Chemours’ inventories are valued at the lower of cost or market or net realizable value, where applicable. Cost of inventories held at substantially all U.S. locations are determined using the last-in, first-out (“LIFO”) method, while cost of inventories held outside the U.S. are determined using the average cost method. The elements of cost in inventories include raw materials, direct labor, and manufacturing overhead. Stores and supplies are valued at the lower of cost or net realizable value, and cost is generally determined by the average cost method.
Property, Plant and Equipment	Property, Plant, and Equipment Property, plant, and equipment is carried at cost and is depreciated using the straight-line method. Substantially all equipment and buildings are depreciated over useful lives ranging from 15 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over five to seven years. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the consolidated balance sheets and are included in the determination of any gain or loss on such disposals. Repair and maintenance costs that materially add to the value of the asset or prolong its useful life are capitalized and depreciated based on their extension to the asset’s useful life. Capitalized repair and maintenance costs are recorded on the consolidated balance sheets as a component of other assets.
Impairment of Long-Lived Assets	Impairment of Long-lived Assets Chemours evaluates the carrying value of its long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. For the purposes of recognition or measurement of an impairment charge, the assessment is performed on the asset or asset group at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. To determine the level at which the assessment is performed, Chemours considers factors such as revenue dependency, shared costs, and the extent of vertical integration. The carrying value of a long-lived asset is considered impaired when the total projected undiscounted cash flows from the use and eventual disposition of the asset or asset group are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The fair value methodology used is an estimate of fair market value, which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by means other than sale are classified as held for use until their disposal. Long-lived assets to be disposed of by sale are classified as held for sale and are reported at the lower of carrying amount or fair market value, less the estimated cost to sell. Depreciation and amortization are discontinued for any long-lived assets classified as held for sale. Assets and Liabilities Held for Sale The Company classifies long-lived assets or disposal groups as held for sale in the period when the following held for sale criteria are met: (i) the Company commits to a plan to sell; (ii) the long-lived asset or disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such long-lived assets or disposal groups; (iii) an active program to locate a buyer and other actions required to complete the plan to sell have been initiated; (iv) the sale is probable within one year; (v) the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. Long-lived assets and disposal groups classified as held for sale are measured at the lower of their carrying amount or fair value less costs to sell. The Company ceases depreciation and amortization for a disposal group upon it being classified as held for sale.
Leases	Leases The Company’s lease assets and lease liabilities are recognized on the lease commencement date in an amount that represents the present value of future lease payments. Operating leases are included in operating lease right-of-use assets, other accrued liabilities, and operating lease liabilities on the Company’s consolidated balance sheets. Finance leases are included in property, plant, and equipment, net, short-term and current maturities of long-term debt, and long-term debt, net, on the Company’s consolidated balance sheets. The Company’s incremental borrowing rate, which is based on information available at the adoption date of January 1, 2019 for existing leases and the commencement date for leases commencing after the adoption date, is used to determine the present value of lease payments. The Company combines lease components with non-lease components for most classes of assets, except for certain manufacturing facilities or when the non-lease component is significant to the lease component. The Company does not recognize leases with an initial term of 12 months or less on its consolidated balance sheets and will recognize those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. Certain leases contain variable payments which are based on usage or operating costs, such as utilities and maintenance. These payments are not included in the measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred. Leases with the options to extend their term or terminate early are reflected in the lease term when it is reasonably certain that the Company will exercise such options.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The excess of the purchase price over the estimated fair value of the net assets acquired in a business combination, including any identified intangible assets, is recorded as goodwill. Chemours tests its goodwill for impairment at least annually on October 1; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Goodwill is evaluated for impairment at the reporting unit level, which is defined as an operating segment, or one level below an operating segment. A reporting unit is the level at which discrete financial information is available and reviewed by business management on a regular basis. An impairment exists when the carrying value of a reporting unit exceeds its fair value. The amount of impairment loss recognized in the consolidated statements of operations is equal to the excess of a reporting unit’s carrying value over its fair value, which is limited to the total amount of goodwill allocated to the reporting unit. Chemours has the option to first qualitatively assess whether it is more-likely-than-not that an impairment exists for a reporting unit. Such qualitative factors include, among other things, prevailing macroeconomic conditions, industry and market conditions, changes in costs associated with raw materials, labor, or other inputs, the Company’s overall financial performance, and certain other entity-specific events that impact Chemours’ reporting units. When performing a quantitative test, the Company weights the results of an income-based valuation technique, the discounted cash flows method, and a market-based valuation technique, the guideline public companies method, to determine its reporting units’ fair values. Definite-lived intangible assets, such as purchased and licensed technology, patents, trademarks, customer lists and allowance units are amortized over their estimated useful lives, generally for periods ranging up to 20 years. The reasonableness of the useful lives of these assets is periodically evaluated.
Investments in Affiliates	Investments in Affiliates The Company uses the equity method of accounting for its investments in and earnings of affiliates. The Company considers whether the fair value of any of its equity method investments has declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. If the Company considers any such decline to be other than temporary, based on various factors, a write-down would be recorded to the estimated fair value.
Restricted Cash and Restricted Cash Equivalents	Restricted Cash and Restricted Cash Equivalents The Company classifies cash and cash equivalents that are legally or contractually restricted for withdrawal or usage as restricted cash and restricted cash equivalents. Chemours restricted cash and restricted cash equivalents includes cash and cash equivalents deposited in an escrow account as per the terms of the Company’s Memorandum of Understanding (“MOU”) agreement which is further discussed in “Note 22 – Commitments and Contingent Liabilities”.
Environmental Liabilities and Expenditures	Environmental Liabilities and Expenditures Chemours accrues for environmental remediation matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Where the available information is only sufficient to establish a range of probable liability, and no point within the range is more likely than any other, the lower end of the range has been used. Estimated liabilities are determined based on existing remediation laws and technologies and the Company’s planned remedial responses, which are derived from environmental studies, sampling, testing, and analyses. Inherent uncertainties exist in such evaluations, primarily due to unknown environmental conditions, changing governmental regulations regarding liability, and emerging remediation technologies. These liabilities, which are undiscounted, are adjusted periodically as remediation efforts progress and as additional technological, regulatory, and legal information becomes available. Environmental liabilities and expenditures include claims for matters that are liabilities of EID and its subsidiaries, which Chemours may be required to indemnify pursuant to the Separation-related agreements executed prior to the Separation. These accrued liabilities are undiscounted and do not include claims against third parties. Costs related to environmental remediation are charged to expense in the period that the associated liability is accrued and are reflected as a component of the cost of goods sold for on-site remediation costs or as a component of selling, general, and administrative expense for off-site remediation costs in the consolidated statements of operations. Other environmental costs are also charged to expense in the period incurred, unless they extend the useful life of the property, increase the property’s capacity, and/or reduce or prevent contamination from future operations, in which case they are capitalized and amortized. Pursuant to the binding MOU entered into between Chemours, DuPont, Corteva, and EID, as further discussed in “Note 22 – Commitments and Contingent Liabilities”, costs specific to potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities are subject to a cost-sharing arrangement between the parties. Any recoveries of Qualified Spend (as further described in “Note 22 – Commitments and Contingent Liabilities” and as defined in the MOU) from DuPont and/or Corteva under the cost-sharing arrangement will be recognized as an offset to the Company’s cost of goods sold or selling, general, and administrative expense, as applicable, when realizable. Any Qualified Spend incurred by DuPont and/or Corteva under the cost-sharing arrangement will be recognized in the Company’s cost of goods sold or selling, general, and administrative expense, as applicable, when the amounts of such costs are probable and estimable.
Asset Retirement Obligations	Asset Retirement Obligations Chemours records its asset retirement obligations at their fair value at the time the liability is incurred. Fair value is measured using the expected future cash outflows discounted at Chemours’ credit-adjusted, risk-free interest rate, which is considered to be a Level 3 input within the fair value hierarchy. Accretion expense is recognized as an operating expense within the cost of goods sold in the consolidated statements of operations, using the credit-adjusted, risk-free interest rate in effect when the liability was recognized. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived asset and are depreciated over the estimated remaining useful life of the asset, generally for periods ranging from two to 25 years.
Insurance	Insurance Chemours insures for certain risks where permitted by law or regulation, including workers’ compensation, vehicle liability, and employee-related benefits. Liabilities associated with these risks are estimated in part by considering any historical claims experience, demographic factors, and other actuarial assumptions. For certain other risks, the Company uses a combination of third-party insurance and self-insurance, reflecting its comprehensive review of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.
Litigation	Litigation Chemours accrues for litigation matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Where the available information is only sufficient to establish a range of probable liability, and no point within the range is more likely than any other, the lower end of the range has been used. When a material loss contingency is reasonably possible, but not probable, the Company does not record a liability, but instead discloses the nature of the matter and an estimate of the loss or range of loss, to the extent such estimate can be made. Litigation-related liabilities and expenditures included in the consolidated financial statements include legal matters that are liabilities of EID and its subsidiaries, which Chemours may be required to indemnify pursuant to the Separation-related agreements executed prior to the Separation. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period that services are rendered.
Treasury Stock	Treasury Stock Chemours accounts for repurchases of the Company’s common stock as treasury stock using the cost method, whereby the entire cost of the acquired common stock is recorded as treasury stock. The cost of treasury stock re-issued is determined using the first-in, first-out (“FIFO”) method.
Stock-based Compensation	Stock-based Compensation Chemours’ stock-based compensation consists of stock options, restricted stock units (“RSUs”), and performance share units (“PSUs”) awarded to employees and non-employee directors. Stock options and PSUs are measured at their fair value on the grant date or date of modification, as applicable. RSUs are measured at the stock price on the grant date or date of modification, as applicable. The Company recognizes compensation expense on a straight-line basis over the requisite service and/or performance period, as applicable. Forfeitures of awards are accounted as a reduction in stock-based compensation expense in the period such awards are forfeited.
Financial Instruments	Financial Instruments In the ordinary course of business, Chemours enters into contractual arrangements to reduce its exposure to foreign currency and interest rate risks. The Company has established a financial risk management program, which currently includes four distinct risk management instruments: (i) foreign currency forward contracts, which are used to minimize the volatility in the Company’s earnings related to foreign exchange gains and losses resulting from remeasuring its monetary assets and liabilities that are denominated in non-functional currencies; (ii) foreign currency forward contracts, which are used to mitigate the risks associated with fluctuations in the euro against the U.S. dollar for forecasted U.S. dollar-denominated inventory purchases in certain of the Company’s international subsidiaries that use the euro as their functional currency; (iii) interest rate swaps, which are used to mitigate the volatility in the Company’s cash payments for interest due to fluctuations in London Interbank Offered Rate ("LIBOR"), as is applicable to the portion of the Company’s senior secured term loan facility denominated in U.S. dollars; and, (iv) euro-denominated debt, which is used to reduce the volatility in stockholders’ equity caused by changes in foreign currency exchange rates of the euro with respect to the U.S. dollar for certain of its international subsidiaries that use the euro as their functional currency. The Company’s financial risk management program reflects varying levels of exposure coverage and time horizons based on an assessment of risk. The program operates within Chemours’ financial risk management policies and guidelines, and the Company does not enter into derivative financial instruments for trading or speculative purposes. The Company’s foreign currency forward contracts that are used as a net monetary assets and liabilities hedge are not part of a cash flow hedge program or a fair value hedge program, and have not been designated as a hedge. For these instruments, all gains and losses resulting from the revaluation of derivative assets and liabilities are recognized in other income (expense), net in the consolidated statements of operations during the period in which they occur, and any such gains or losses are intended to be offset by any gains or losses on the underlying asset or liability. For the Company’s foreign currency forward contracts that have been designated under a cash flow hedge program, all gains and losses resulting from the revaluation of the derivative instruments are recognized as a component of accumulated other comprehensive loss on the consolidated balance sheets during the period in which they occur, and are reclassified to the cost of goods sold in the consolidated statements of operations during the period in which the underlying transactions affect earnings, or when it becomes probable that the forecasted transactions will not occur. For the Company’s interest rate swaps that have been designated under a cash flow hedge program, all gains and losses resulting from the revaluation of the derivative instruments are recognized as a component of accumulated other comprehensive loss on the consolidated balance sheets during the period in which they occur, and are reclassified to interest expense, net in the consolidated statements of operations during the period in which the underlying transaction affects earnings. For the Company’s euro-denominated debt instruments, which are designated as a net investment hedge, changes due to remeasurement are included in accumulated other comprehensive loss on the consolidated balance sheets. Chemours’ uses the spot method to evaluate the effectiveness of its net investment hedge. Financial instruments are reported on a gross basis on the consolidated balance sheets.
Foreign Currency Translation	Foreign Currency Translation Chemours identifies its separate and distinct foreign entities and groups them into two categories: (i) extensions of the parent (U.S. dollar functional currency); and, (ii) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated, and a judgment is made to determine the functional currency. Chemours changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances clearly indicate that the functional currency has changed. During the periods covered by the consolidated financial statements, part of Chemours’ business operated within foreign entities. For foreign entities where the U.S. dollar is the functional currency, all foreign currency-denominated asset and liability amounts are remeasured into U.S. dollars at end-of-period exchange rates, with the exception of inventories, prepaid expenses, property, plant, and equipment, goodwill, and other intangible assets. These aforementioned assets are remeasured at historical exchange rates. Foreign currency-denominated revenue and expense amounts are measured at exchange rates in effect during the period, with the exception of expenses related to any balance sheet amounts remeasured at historical exchange rates. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in other income (expense), net in the consolidated statements of operations in the period in which they occurred. For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into U.S. dollars at end-of-period exchange rates, and the resulting translation adjustments are reported as a component of accumulated other comprehensive loss on the consolidated balance sheets. Assets and liabilities denominated in currencies other than the functional currency are remeasured into the functional currency prior to translation into U.S. dollars, and the resulting exchange gains or losses are included in other income (expense), net in the consolidated statements of operations in the period in which they occurred. Revenues and expenses are translated into U.S. dollars at average exchange rates in effect during the period.
Defined Benefit Plans	Defined Benefit Plans Chemours has defined benefit plans covering certain of its employees outside of the U.S. The benefits of these plans, which primarily relate to pension, are accrued over the employees’ service periods. The Company uses actuarial methods and assumptions in the valuation of its defined benefit obligations and the determination of any net periodic pension income or expense. Any differences between actual and expected results, or changes in the value of defined benefit obligations and plan assets, if any, are not recognized in earnings as they occur. Rather, they are systematically recognized over subsequent periods.
Fair Value Measurement	Fair Value Measurement Fair value is defined as the exit price, the price that would be received to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date. Under the accounting for fair value measurements and disclosures, a fair value hierarchy was established to prioritize the valuation inputs used to measure fair value. The hierarchy gives highest priority to unadjusted, quoted prices in active markets for identical assets and liabilities (i.e., Level 1 measurements) and lowest priority to unobservable inputs (i.e., Level 3 measurements). A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Chemours applies the following valuation hierarchy in measuring the fair values of its assets and liabilities: • Level 1 – Quoted prices in active markets for identical assets and liabilities; • Level 2 – Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable, such as interest rate and yield curves, and market-corroborated inputs); and, • Level 3 – Unobservable inputs for the asset or liability, which are valued based on management’s estimates of assumptions that market participants would use in pricing the asset or liability.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Guidance Issued and Not Yet Adopted Accounting for Contract Assets and Contract Liabilities from Contracts with Customers In October 2021, the Financial Accounting Standards Board ("FASB") issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), which requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Topic 606 as if the acquirer had originated the contracts. The guidance will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2021-08 on January 1, 2023, the effect of which will not be material to its financial position, results of operations and cash flows. The Company will apply the provisions of ASU 2021-08 after adoption to future acquisitions, if any. Disclosure of Supplier Finance Program Obligations In September 2022, the FASB issued ASU 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations ("ASU 2022-04"), which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose qualitative and quantitative information about their programs, including key terms and activity during the period. The guidance will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted, and should be applied retrospectively to each period in which a balance sheet is presented subject to certain exceptions. The Company is currently evaluating the disclosure requirement of this standard that will be required to be included in its consolidated financial statements. Facilitation of the Effects of Reference Rate Reform on Financial Reporting In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period of time to ease the potential burden associated with accounting for contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. In December 2022, the FASB issued ASU 2022-06, Deferral of the Sunset Date of Topic 848 ("ASU 2022-06"), which extended the expiration date of ASU 2020-04 to December 31, 2024. The Company does not expect the impacts of adopting ASU 2020-04 to be material to its financial position, results of operations and cash flows. Recently Adopted Accounting Guidance Disclosures by Business Entities About Government Assistance In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities About Government Assistance (“ASU 2021-10”), which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. The Company adopted ASU 2021-10 during the year ended December 31, 2022. Government grant transactions during the year ended December 31, 2022 were de minimis.

Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Environmental and other liabilities	$ 188	$ 162
Employee related and benefit items	49	64
Other assets and accrual liabilities	133	111
Tax attribute carryforwards	73	91
Operating lease liability	57	56
Total deferred tax assets	500	484
Less: Valuation allowance	(12)	(8)
Total deferred tax assets, net	488	476
Deferred tax liabilities:
Property, plant, and equipment and intangible assets	(257)	(244)
LIFO inventories	(30)	(18)
Operating lease asset	(55)	(53)
Other liabilities	(55)	(40)
Total deferred tax liabilities	(397)	(355)
Deferred tax assets, net	$ 91	$ 121

Geographic and Segment Information

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Geographic and Segment Information

29. Geographic and Segment Information

Geographic Information

The following table sets forth the geographic locations of the Company’s net sales for the years ended and property, plant, and equipment, net as of December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022				2021				2020
	Net Sales (1)		Property, Plant, and Equipment, Net		Net Sales (1)		Property, Plant, and Equipment, Net		Net Sales (1)		Property, Plant, and Equipment, Net
North America	$	2,949	$	2,320	$	2,317	$	2,309	$	1,914	$	2,461
Asia Pacific		1,787		127		1,827		128		1,384		121
Europe, the Middle East, and Africa		1,313		249		1,412		322		1,086		324
Latin America (2)		745		475		789		395		585		568
Total	$	6,794	$	3,171	$	6,345	$	3,154	$	4,969	$	3,474

(1)

Net sales are attributed to countries based on customer location.

(2)

Latin America includes Mexico.

Segment Information

Chemours operates through its three reportable segments, which were organized based on their similar economic characteristics, the nature of products and production processes, end-use markets, channels of distribution, and regulatory environments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Other Segment includes the Company’s Performance Chemicals and Intermediates business and Mining Solutions business (prior to the business sale in 2021). Corporate costs and certain legal and environmental expenses, stock-based compensation expenses, and foreign exchange gains and losses arising from the remeasurement of balances in currencies other than the functional currency of the Company’s legal entities are reflected in Corporate and Other.

Beginning with reports filed in the first quarter of 2022, the Company changed its methodology used to allocate certain corporate function expenses to the operating segments to provide the Company's Chief Operating Decision Maker (“CODM”) with a more meaningful representation of segment profitability. This allocation methodology change reflects corporate function resource usage by each operating segment based on certain commercial drivers, in addition to the cost drivers, as well as consideration of the Company's recent sale of the Mining Solutions business in 2021. The historical segment information, including adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”), has been recast to conform to the current segment presentation.

Adjusted EBITDA is the primary measure of segment profitability used by the Company’s CODM and is defined as income (loss) before income taxes, excluding the following:

•

interest expense, depreciation, and amortization;

•

non-operating pension and other post-retirement employee benefit costs, which represents the non-service cost component of net periodic pension (income) costs;

•

exchange (gains) losses included in other income (expense), net;

•

restructuring, asset-related, and other charges;

•

(gains) losses on sales of assets and businesses; and,

•

other items not considered indicative of the Company’s ongoing operational performance and expected to occur infrequently, including Qualified Spend reimbursable by DuPont and/or Corteva as part of the Company's cost-sharing agreement under the terms of the MOU that were previously excluded from Adjusted EBITDA.

The following table sets forth certain summary financial information for the Company’s reportable segments as of, and for the years ended December 31, 2022, 2021 and 2020.


Year Ended December 31,	Titanium Technologies		Thermal & Specialized Solutions		Advanced Performance Materials		Other Segment (1)		Segment Total
2022
Net sales to external customers (2)	$	3,380	$	1,680	$	1,618	$	116	$	6,794
Adjusted EBITDA		601		603		367		2		1,573
Depreciation and amortization		125		55		82		8		270
Equity in earnings of affiliates		—		24		31		—		55
Total assets		2,384		1,238		1,742		124		5,488
Investments in affiliates		—		82		93		—		175
Purchases of property, plant, and equipment		149		30		115		6		300

2021
Net sales to external customers (2)	$	3,355	$	1,257	$	1,397	$	336	$	6,345
Adjusted EBITDA		799		401		284		49		1,533
Depreciation and amortization		126		59		86		16		287
Equity in earnings of affiliates		—		15		28		—		43
Total assets		2,318		1,124		1,621		149		5,212
Investments in affiliates		—		72		97		—		169
Purchases of property, plant, and equipment		104		26		103		39		272

2020
Net sales to external customers (2)	$	2,402	$	1,105	$	1,104	$	358	$	4,969
Adjusted EBITDA		498		344		146		75		1,063
Depreciation and amortization		128		53		88		21		290
Equity in earnings of affiliates		—		6		17		—		23
Total assets		2,130		1,041		1,520		531		5,222
Investments in affiliates		—		66		101		—		167
Purchases of property, plant, and equipment		89		28		109		25		251

(1)

On July 26, 2021, the Company entered into the Mining Solutions Transaction which closed on December 1, 2021. For further information see “Note 4 – Acquisitions and Divestitures”.

(2)

Segment net sales to external customers are provided by product group in “Note 5 – Net Sales”.

The following table sets forth a reconciliation for instances in which the above summary financial information for the Company’s reportable segments does not sum to consolidated amounts.


Year Ended December 31,	Segment Total		Corporate and Other		Total Consolidated
2022
Depreciation and amortization	$	270	$	21	$	291
Total assets		5,488		2,152		7,640
Purchases of property, plant, and equipment		300		7		307

2021
Depreciation and amortization	$	287	$	30	$	317
Total assets		5,212		2,338		7,550
Purchases of property, plant, and equipment		272		5		277

2020
Depreciation and amortization	$	290	$	30	$	320
Total assets		5,222		1,860		7,082
Purchases of property, plant, and equipment		251		16		267

The following table sets forth a reconciliation of Segment Adjusted EBITDA to the Company’s consolidated income (loss) before income taxes for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Segment Adjusted EBITDA	$	1,573		$	1,533		$	1,063
Corporate and Other expenses (excluding items below)		(212	)		(220	)		(184	)
Interest expense, net		(163	)		(185	)		(210	)
Depreciation and amortization		(291	)		(317	)		(320	)
Non-operating pension and other post-retirement employee benefit income		5			9			1
Exchange (losses) gains, net		(15	)		3			(26	)
Restructuring, asset-related, and other charges (1)		(15	)		(6	)		(80	)
Gain (loss) on extinguishment of debt		7			(21	)		(22	)
Gain on sales of assets and businesses, net (2)		21			115			8
Natural disasters and catastrophic events (3)		—			(21	)		—
Transaction costs (4)		—			(4	)		(2	)
Qualified spend recovery (5)		58			20			—
Legal and environmental charges, net (6,7)		(227	)		(230	)		(49	)
Income before income taxes	$	741		$	676		$	179

(1)

(2)

Refer to “Note 8 – Other Income (Expense), Net” for further details.

(3)

In 2021, natural disasters and catastrophic events pertains to the total cost of plant repairs and utility charges in excess of historical averages caused by Winter Storm Uri.

(4)

2021 includes costs associated with the Company’s accounting, legal, and bankers’ transaction costs incurred in connection with the sale of its Mining Solutions business.

(5)

(6)

(7)

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

Earnings Per Share of Common Stock

Earnings Per Share of Common Stock

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Note 10. Earnings Per Share of Common Stock

The following table sets forth the reconciliations of the numerators and denominators of the Company’s basic and diluted earnings per share calculations for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Numerator:
Net income attributable to Chemours	$	578	$	608	$	219
Denominator:
Weighted-average number of common shares outstanding - basic		155,359,361		164,943,575		164,681,827
Dilutive effect of the Company’s employee compensation plans		2,943,646		3,754,864		1,664,702
Weighted-average number of common shares outstanding - diluted		158,303,007		168,698,439		166,346,529

Basic earnings per share of common stock (1)	$	3.72	$	3.69	$	1.33
Diluted earnings per share of common stock (1)		3.65		3.60		1.32

(1)

Figures may not recalculate exactly due to rounding. Basic and diluted earnings per share are calculated based on unrounded numbers.

The following table sets forth the average number of stock options that were anti-dilutive and, therefore, were not included in the Company’s diluted earnings per share calculations for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Average number of stock options		1,077,922		1,500,577		3,839,845

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Schedule of Lease Assets and Lease Liabilities and their Balance Sheet Locations

The following table sets forth the Company’s lease assets and lease liabilities and their balance sheet locations at December 31, 2022 and 2021.


		December 31,
	Balance Sheet Location	2022		2021
Lease assets:
Operating lease right-of-use assets	Operating lease right-of-use assets	$	240	$	227
Finance lease assets	Property, plant, and equipment, net (Note 13)		61		69
Total lease assets		$	301	$	296

Lease liabilities:
Current:
Operating lease liabilities	Other accrued liabilities (Note 19)	$	49	$	59
Finance lease liabilities	Short-term and current maturities of long-term debt (Note 20)		12		12
Total current lease liabilities			61		71
Non-current:
Operating lease liabilities	Operating lease liabilities		198		179
Finance lease liabilities	Long-term debt, net (Note 20)		49		60
Total non-current lease liabilities			247		239
Total lease liabilities		$	308	$	310

Schedule of Components of Company's Lease Cost

following table sets forth the components of the Company’s lease cost for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Operating lease cost	$	51	$	66	$	88
Short-term lease cost		4		7		5
Variable lease cost		16		21		20

Finance lease cost:
Amortization of lease assets		8		12		8
Interest on lease liabilities		4		4		4
Total lease cost	$	83	$	110	$	125

Schedule of Cash Flows Related to Company's Leases

The following table sets forth the cash flows related to the Company’s leases for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	56	$	70	$	91
Operating cash flows from finance leases		4		4		4
Financing cash flows from finance leases		11		10		6

Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities	$	65	$	45	$	23
Leased assets obtained in exchange for new finance lease liabilities		—		14		19

Schedule of Weighted-Average Terms and Weighted-Average Discount Rates For Company's Leases

The following table sets forth the weighted-average terms and weighted-average discount rates for the Company’s leases at December 31, 2022 and 2021.


	December 31,
	2022			2021
Weighted-average remaining lease term (years):
Operating leases		10.0			11.0
Finance leases		5.4			6.3

Weighted-average discount rate:
Operating leases		5.23	%		5.30	%
Finance leases		5.42	%		4.80	%

Schedule of Company's Lease Liabilities' Maturities for Next Five Years and Thereafter

The following table sets forth the Company’s lease liabilities’ maturities for the next five years and thereafter.


	Operating Leases		Finance Leases		Total
2023	$	61	$	14	$	75
2024		52		13		65
2025		42		13		55
2026		36		11		47
2027		23		8		31
Thereafter		91		13		104
Total lease payments		305		72		377
Less: Imputed interest		58		11		69
Present value of lease liabilities	$	247	$	61	$	308

Summary of Future Minimum Payments Related to Chemours Discovery Hub Financing Obligation

The following table sets forth the Company’s minimum future payments due for the next five years and thereafter related to the Chemours Discovery Hub financing obligation.


2023	$	7
2024		7
2025		7
2026		7
2027		7
Thereafter		140
Total payments	$	175

Accounts and Notes Receivable, Net - Schedule of Accounts and Notes Receivable (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Accounts receivable - trade, net	$ 509	$ 644
Allowance for doubtful accounts receivable	10	5
Trade Notes Receivable [Member]
Accounts Notes And Loans Receivable [Line Items]
Accounts receivable - trade, net	$ 3	$ 17

Commitments and Contingent Liabilities - Schedule of Current and Long-term Components of Accrued Environmental Remediation Liabilities (Details) - USD ($)
$ in Millions

Dec. 31, 2022

Dec. 31, 2021

Current environmental remediation

$ 194

$ 173

Long-term environmental remediation

474

389

Total environmental remediation

668

562

Fayetteville Works, Fayetteville, North Carolina [Member]

Current environmental remediation

139

114

Long-term environmental remediation

326

245

Total environmental remediation

^[1]

$ 465

$ 359

[1]	For more information on this matter refer to “Fayetteville Works, Fayetteville, North Carolina” within this “Note 22 – Commitments and Contingent Liabilities”.

Other Liabilities - Schedule of Other Liabilities (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other Liabilities, Noncurrent [Abstract]
Accrued workers compensation indemnification liability	$ 33	$ 32

Net Sales - Summary of Disaggregation of Net Sales by Geographical Region and Segment and Product Group (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	$ 6,794	$ 6,345	$ 4,969
North America [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	2,949	2,317	1,914
Asia Pacific [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,787	1,827	1,384
Europe, the Middle East, and Africa [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,313	1,412	1,086
Latin America [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	745	789	585
Topic 606 [Member] \| Transferred at a Point in Time [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	6,794	6,345	4,969
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	3,380	3,355	2,402
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,680	1,257	1,105
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,618	1,397	1,104
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	116	336	358
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| North America [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	2,949	2,317	1,914
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| North America [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,285	1,019	776
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| North America [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	974	635	520
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| North America [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	619	494	407
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| North America [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	71	169	211
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Asia Pacific [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,787	1,827	1,384
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Asia Pacific [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	928	1,049	778
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Asia Pacific [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	178	160	134
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Asia Pacific [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	657	595	450
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Asia Pacific [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	24	23	22
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Europe, the Middle East, and Africa [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,313	1,412	1,086
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Europe, the Middle East, and Africa [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	695	829	528
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Europe, the Middle East, and Africa [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	320	313	331
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Europe, the Middle East, and Africa [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	281	254	202
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Europe, the Middle East, and Africa [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	17	16	25
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Latin America [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	745	789	585
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Latin America [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	472	458	320
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Latin America [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	208	149	120
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Latin America [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	61	54	45
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Latin America [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	4	128	100
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Titanium Dioxide and Other Minerals [Member] \| Titanium Technologies [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	3,380	3,355	2,402
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Refrigerants [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,352	973	889
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Foam, Propellants, and Other [Member] \| Thermal And Specialized Solutions [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	328	284	216
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Advanced Materials [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	1,125	977	782
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Performance Solutions [Member] \| Advanced Performance Materials [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	493	420	322
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Mining Solutions [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	0	237	203
Topic 606 [Member] \| Transferred at a Point in Time [Member] \| Performance Chemicals and Intermediates [Member] \| Other Segments [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation of Net Sales	$ 116	$ 99	$ 155

Goodwill and Other Intangible Assets, Net (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The following table sets forth the changes in the carrying amount of the Company’s goodwill by segment for the years ended December 31, 2022 and 2021.


	Titanium Technologies		Thermal & Specialized Solutions		Advanced Performance Materials		Other Segment			Total
Balance at January 1, 2021	$	13	$	33	$	56	$	51		$	153
Divestitures		—		—		—		(51	)		(51	)
Balance at December 31, 2021		13		33		56		—			102
Balance at December 31, 2022	$	13	$	33	$	56	$	—		$	102

Schedule of Other Intangible Assets

The following table sets forth the gross carrying amounts and accumulated amortization of the Company’s other intangible assets by major class at December 31, 2022 and 2021.


	December 31, 2022							December 31, 2021
	Cost		Accumulated Amortization			Net		Cost		Accumulated Amortization			Net
Allowance units (1)	$	13	$	(1	)	$	12	$	—	$	—		$	—
Customer lists		2		(2	)		—		2		(2	)		—
Customer relationships		22		(21	)		1		22		(16	)		6
Patents		19		(19	)		—		19		(19	)		—
Purchased and licensed technology		3		(3	)		—		3		(3	)		—
Other		10		(10	)		—		10		(10	)		—
Total other intangible assets	$	69	$	(56	)	$	13	$	56	$	(50	)	$	6

(1)

Allowance units represent rights purchased for the production and/or importation of regulated materials.

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Other Accrued Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Other Accrued Liabilities

The following table sets forth the components of the Company’s other accrued liabilities at December 31, 2022 and 2021.


	December 31,
	2022		2021
Accrued litigation (1)	$	41	$	36
Asset retirement obligations (1)		10		14
Income taxes		19		43
Customer rebates		90		83
Accrued interest		17		17
Operating lease liabilities (2)		49		59
Miscellaneous (3)		74		73
Total other accrued liabilities	$	300	$	325

(1)

Represents the current portions of accrued litigation and asset retirement obligations (see “Note 22 – Commitments and Contingent Liabilities”).

(2)

Represents the current portion of operating lease liabilities (see “Note 14 – Leases”).

(3)

Miscellaneous primarily includes accruals related to utility expenses, property taxes, a workers compensation indemnification liability and other miscellaneous expenses.

Stock-based Compensation - Performance Share Units Activity (Details) - Performance Share Units [Member] - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning balance, shares	755	844	529
Granted, shares	316	309	542
Vested, shares	(213)	(122)	(176)
Forfeited, shares		(276)	(51)
Non-vested, ending balance, shares	858	755	844
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, weighted average grant date fair value, beginning balance (in dollars per share)	$ 26.72	$ 29.05	$ 39.53
Granted, weighted average grant date fair value (in dollars per share)	28.77	27.42	17.14
Vested, weighted average grant date fair value (in dollars per share)	43.83	52.34	35.84
Forfeited, weighted average grant date fair value (in dollars per share)		23.26	27.79
Non-vested, weighted average grant date fair value, ending balance (in dollars per share)	$ 22.48	$ 26.72	$ 29.05

Commitments and Contingent Liabilities - Schedule of Components of Accrued Litigation (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Accrued litigation	$ 96	$ 86
PFOA Multi District Litigation in Ohio [Member]
Loss Contingencies [Line Items]
Accrued litigation	$ 20
PFAS Natural Resource Damages Matters [Member] \| Chemours, DuPont, Corteva, EID [Member] \| State of Delaware [Member]
Loss Contingencies [Line Items]
Accrued litigation		$ 25

Stock-based Compensation - Narrative (Details) $ / shares in Units, $ in Millions		12 Months Ended			72 Months Ended
	Jan. 26, 2017 Period shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($) $ / shares	Dec. 31, 2022 USD ($) shares	Apr. 28, 2021 shares	Dec. 31, 2017 shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense \| $		$ 27	$ 34	$ 16
Stock Option [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense \| $		$ 8	$ 10	$ 9
Expiration period		10 years	10 years	10 years
Stock-based compensation award vesting period		3 years	3 years	3 years
Total intrinsic value of options exercised \| $		$ 45	$ 23	$ 2
Unrecognized stock-based compensation expense related to stock options \| $		$ 9			$ 9
Unrecognized stock-based compensation expense period for recognition		1 year 9 months 29 days
Restricted Stock Units (RSUs) [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense \| $		$ 11	$ 12	$ 7
Stock-based compensation award vesting period		3 years
Unrecognized stock-based compensation expense period for recognition		8 months 15 days
Shares issued upon conversion of equity award		1			1
Unrecognized compensation cost related to equity awards other than options \| $		$ 12			$ 12
Weighted-average fair value at grant date (in dollars per share) \| $ / shares		$ 28.08	$ 26.30	$ 17.01
Performance Share Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense \| $		$ 8	$ 12
Stock-based compensation award vesting period		3 years
Shares issued upon conversion of equity award		1			1
Percentage of target award available for grant		100.00%	100.00%	100.00%
Weighted-average fair value at grant date (in dollars per share) \| $ / shares		$ 28.77	$ 27.42	$ 17.14
Number of additional shares to be awarded		1,120,000
Performance Share Units [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of target award available for grant		0.00%
Performance Share Units [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of target award available for grant		250.00%
Stock-based compensation expense (benefit) \| $				$ (1)
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common stock shares reserved for issuance	7,000,000
Consecutive offering periods	12 months
Number of purchase periods in offer period \| Period	2
Percentage of common stock discount rate equal to the fair value	95.00%
Stock purchased under employee stock purchase plan, Shares					292,000
Stock purchased under employee stock purchase plan, Value \| $					$ 7
Chemours Equity and Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares authorized for grants (in shares)							19,000,000
Shares reserved for grants (in shares)							0
Amendment and Restatement of Equity Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares authorized for grants (in shares)						22,050,000
Shares reserved for grants (in shares)		10,000,000			10,000,000
Increase in the shares reserved for grant (in shares)						3,050,000
Chemours Company Equity and Incentive Plan (the "Prior Plan") [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares issued upon conversion of equity stock option awards granted						1
Shares issued upon conversion of equity stock other than option awards granted						1.5

Accumulated Other Comprehensive Loss

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Accumulated Other Comprehensive Loss

25. Accumulated Other Comprehensive Loss

The following table sets forth the changes and after-tax balances of the Company’s accumulated other comprehensive loss for the years ended December 31, 2022, 2021 and 2020.


	Net Investment Hedge			Cash Flow Hedge			Cumulative Translation Adjustment			Defined Benefit Plans			Total
Balance at January 1, 2020	$	(10	)	$	2		$	(231	)	$	(110	)	$	(349	)
Other comprehensive income (loss)		(66	)		(10	)		111			4			39
Balance at December 31, 2020		(76	)		(8	)		(120	)		(106	)		(310	)
Other comprehensive income (loss)		55			13			(116	)		(6	)		(54	)
Balance at December 31, 2021		(21	)		5			(236	)		(112	)		(364	)
Other comprehensive income (loss)		40			1			(32	)		12			21
Balance at December 31, 2022	$	19		$	6		$	(268	)	$	(100	)	$	(343	)

Geographic and Segment Information - Narrative (Details)	12 Months Ended
	Dec. 31, 2022 Segment
Segments, Geographical Areas [Abstract]
Number of reportable segments	3

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 6,794	$ 6,345	$ 4,969
Cost of goods sold	5,178	4,964	3,902
Gross profit	1,616	1,381	1,067
Selling, general, and administrative expense	710	592	527
Research and development expense	118	107	93
Restructuring, asset-related, and other charges	16	6	80
Total other operating expenses	844	705	700
Equity in earnings of affiliates	55	43	23
Interest expense, net	(163)	(185)	(210)
Gain (loss) on extinguishment of debt	7	(21)	(22)
Other income , net	70	163	21
Income before income taxes	741	676	179
Provision for (benefit from) income taxes	163	68	(40)
Net income	578	608	219
Net income attributable to Chemours	$ 578	$ 608	$ 219
Per share data
Basic earnings per share of common stock	$ 3.72	$ 3.69	$ 1.33
Diluted earnings per share of common stock	$ 3.65	$ 3.60	$ 1.32

Restructuring, Asset-Related, and Other Charges (Tables)

12 Months Ended

Dec. 31, 2022

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Program

The following table sets forth the components of the Company’s restructuring, asset-related, and other charges for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Restructuring and other charges:
Employee separation charges	$	9	$	(2	)	$	17
Decommissioning and other charges		2		8			41
Total restructuring and other charges		11		6			58
Asset-related charges		5		—			22
Total restructuring, asset-related, and other charges	$	16	$	6		$	80

The following table sets forth the impacts of the Company’s restructuring programs to segment earnings for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Restructuring and other charges:
Plant and product line closures:
Other Segment	$	2	$	13		$	4
Corporate and Other		—		—			1
Total plant and product line closures		2		13			5
2022, 2020, and 20191 restructuring programs:
Titanium Technologies		1		—			3
Thermal & Specialized Solutions		1		—			2
Advanced Performance Materials		3		(1	)		5
Other Segment		—		—			1
Corporate and Other		4		—			4
Total restructuring programs		9		(1	)		15
Other charges:
Titanium Technologies		—		—			1
Advanced Performance Materials		—		1			—
Other Segment		—		(7	)		37
Total other charges		—		(6	)		38
Total restructuring and other charges		11		6			58
Asset-related charges:
Titanium Technologies		5		—			—
Advanced Performance Materials		—		—			10
Other Segment		—		—			8
Corporate and Other		—		—			4
Total asset-related charges		5		—			22
Total restructuring, asset-related, and other charges	$	16	$	6		$	80

(1)

Year ended December 31, 2020 includes $3 of employee separation charges relating to the 2019 restructuring program. All remaining actions related to this program were completed in 2020.

Schedule of Restructuring Charges

The following table sets forth the change in the Company’s employee separation-related liabilities associated with its restructuring programs for the years ended December 31, 2022 and 2021.


	Site Closures			2022, 2020, and 2019 Restructuring Programs			Total
Balance at January 1, 2021	$	2		$	5		$	7
Credits to income		(1	)		(1	)		(2	)
Payments		—			(4	)		(4	)
Balance at December 31, 2021		1			—			1
Charges to income		—			9			9
Payments		(1	)		(3	)		(4	)
Balance at December 31, 2022	$	—		$	6		$	6

Equity - Schedule of Share Repurchase Activity (Details) - Common Stock [Member] - USD ($) $ / shares in Units, $ in Millions	8 Months Ended	12 Months Ended		46 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	May 19, 2022
2018 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Total number of shares purchased		7,824,039	5,533,746	28,603,784
Total amount for shares purchased		$ 251	$ 177
Average price paid per share		$ 32.06	$ 31.99	$ 34.96
2022 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Total number of shares purchased	8,234,314	8,234,314
Total amount for shares purchased	$ 241	$ 241
Average price paid per share	$ 29.24	$ 29.24

Net Sales (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Net Sales by Geographical Region and Segment and Product Group

The following table sets forth a disaggregation of the Company’s net sales by geographic region and segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Net sales by geographic region (1)
North America:
Titanium Technologies	$	1,285	$	1,019	$	776
Thermal & Specialized Solutions		974		635		520
Advanced Performance Materials		619		494		407
Other Segment		71		169		211
Total North America		2,949		2,317		1,914
Asia Pacific:
Titanium Technologies		928		1,049		778
Thermal & Specialized Solutions		178		160		134
Advanced Performance Materials		657		595		450
Other Segment		24		23		22
Total Asia Pacific		1,787		1,827		1,384
Europe, the Middle East, and Africa:
Titanium Technologies		695		829		528
Thermal & Specialized Solutions		320		313		331
Advanced Performance Materials		281		254		202
Other Segment		17		16		25
Total Europe, the Middle East, and Africa		1,313		1,412		1,086
Latin America (2):
Titanium Technologies		472		458		320
Thermal & Specialized Solutions		208		149		120
Advanced Performance Materials		61		54		45
Other Segment		4		128		100
Total Latin America		745		789		585
Total net sales	$	6,794	$	6,345	$	4,969

(1)

Net sales are attributed to countries based on customer location.

(2)

Latin America includes Mexico.

The following table sets forth a disaggregation of the Company’s net sales by product group and segment for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Net sales by product group and segment
Titanium dioxide and other minerals	$	3,380	$	3,355	$	2,402
Total Titanium Technologies		3,380		3,355		2,402
Refrigerants		1,352		973		889
Foam, propellants, and other		328		284		216
Total Thermal & Specialized Solutions		1,680		1,257		1,105
Advanced materials		1,125		977		782
Performance solutions		493		420		322
Total Advanced Performance Materials		1,618		1,397		1,104
Mining solutions		—		237		203
Performance chemicals and intermediates		116		99		155
Total Other Segment		116		336		358
Total net sales	$	6,794	$	6,345	$	4,969

Summary of Contract Balances from Contracts with Customers

The following table sets forth the Company’s contract balances from contracts with customers at December 31, 2022 and 2021.


	December 31,
	2022		2021
Contract assets:
Accounts receivable - trade, net (Note 11)	$	509	$	644
Contract liabilities:
Deferred revenue	$	5	$	5
Customer rebates (Note 19)		90		83

Restructuring, Asset-Related, and Other Charges - Narrative (Details) $ in Millions	3 Months Ended	12 Months Ended			36 Months Ended	87 Months Ended
	Mar. 31, 2022 Employee	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) Employee	Dec. 31, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Asset-related charges		$ 5	$ 0	$ 22
Environmental remediation liabilities		269	269	71
Employee separation related liabilities		6	1	7	$ 6	$ 6
Employee separation charges		9	(2)	17
2019 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Employee separation charges				3
2020 Severance Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges					$ 12
2020 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Employee separation charges			(1)	13
2022 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges		9
Employee separation charges		9
Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges		2	13	5
Corporate and Other [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges		0	0	4
Corporate and Other [Member] \| Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0	0	1
Chemical Solutions [Member] \| Operating Segments [Member] \| Niagara Falls, NY [Member] \| Decommissioning Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges			2	2
Chemical Solutions [Member] \| Operating Segments [Member] \| Niagara Falls, NY [Member] \| Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges						$ 42
Chemical Solutions [Member] \| Operating Segments [Member] \| Pascagoula, Mississippi [Member] \| Decommissioning Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 12
Chemical Solutions [Member] \| Operating Segments [Member] \| Pascagoula, Mississippi [Member] \| Plant and Product Line Closures [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges				10
Property, plant, and equipment and other asset impairments				6
Environmental remediation liabilities				$ 4
Environmental remediation liabilities paid over a period				16 years
Employee separation related liabilities				$ 2
Number of employees eliminated as a result of restructuring activities \| Employee	15		20
Chemical Solutions [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Other charges				37
Gain loss on other charges			$ 9
Chemical Solutions [Member] \| Contract Termination Fees [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Other charges				26
Payment of contract termination fees			26
Chemical Solutions [Member] \| Other Related Prepaid Costs [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Other charges				11
Chemical Solutions [Member] \| Construction-in-Process [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Reversal of liability recorded			22
Chemical Solutions [Member] \| Construction Resumes [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Other charges			9
Chemical Solutions [Member] \| Impairment Charges [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges			13
Chemical Solutions [Member] \| Freight Charges associated with Transportation of Impaired Assets [Member] \| Mining Solutions [Member]
Restructuring Cost and Reserve [Line Items]
Other charges			2
Titanium Technologies [Member] \| Operating Segments [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges		5	0	0
Advanced Performance Materials [Member] \| Operating Segments [Member]
Restructuring Cost and Reserve [Line Items]
Asset-related charges		$ 0	$ 0	$ 10

Supplemental Cash Flow Information

12 Months Ended

Dec. 31, 2022

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

Note 28. Supplemental Cash Flow Information


	December 31,
	2022		2021
Cash and cash equivalents	$	1,102	$	1,451
Restricted cash and restricted cash equivalents (1)		202		100
Cash, cash equivalents, restricted cash and restricted cash equivalents	$	1,304	$	1,551

(1)

Leases - Schedule of Lease Assets and Lease Liabilities and their Balance Sheet Locations (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Lease assets:
Operating lease right-of-use assets	$ 240	$ 227
Finance lease assets	$ 61	$ 69
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, Plant, and Equipment, Net	Property, Plant, and Equipment, Net
Total lease assets	$ 301	$ 296
Current:
Operating lease liabilities	$ 49	$ 59
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities	Other accrued liabilities
Finance lease liabilities	$ 12	$ 12
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Short-term and current maturities of long-term debt	Short-term and current maturities of long-term debt
Total current lease liabilities	$ 61	$ 71
Non-current:
Operating lease liabilities	198	179
Finance lease liabilities	$ 49	$ 60
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt, net	Long-term debt, net
Total non-current lease liabilities	$ 247	$ 239
Total lease liabilities	$ 308	$ 310

Debt - Senior Unsecured Notes - Narrative (Details) $ / shares in Units, € in Millions, $ in Millions							12 Months Ended
	Aug. 18, 2021 USD ($)	Aug. 04, 2021 $ / shares	Nov. 27, 2020 USD ($)	Nov. 12, 2020 $ / shares	Jun. 06, 2018 EUR (€)	May 23, 2017 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2022 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 USD ($)	Aug. 20, 2021 USD ($)	Dec. 01, 2020 USD ($)	Jun. 06, 2018 USD ($)	May 12, 2015 USD ($)
Debt Instrument [Line Items]
Debt instrument net issue discount											$ 4		$ 5
Repurchase price obligation, percentage of principal amount redeemed in event of change of control	101.00%
Repurchase price obligation, percentage of principal amount redeemed	100.00%
Gain (loss) on extinguishment of debt							$ 7	$ (21)	$ (22)
Debt instrument redemption price percentage of principal amount with net cash proceeds	35.00%
Debt instrument redemption price percentage of principal amount excluding redemption date	104.625%
First MDL Settlement [Member]
Debt Instrument [Line Items]
Settlement payments						$ 335
4.000% Senior Unsecured Notes Due May 2026 [Member]
Debt Instrument [Line Items]
Long-term debt										€ 441	$ 470	€ 450	$ 510
Debt instrument interest rate										4.00%	4.00%	4.00%	4.00%
5.750% Senior Unsecured Notes Due November 2028 [Member]
Debt Instrument [Line Items]
Long-term debt											$ 783		$ 800
Debt instrument interest rate										5.75%	5.75%	5.75%	5.75%
4.625% Senior Unsecured Notes Due November 2029 [Member]
Debt Instrument [Line Items]
Long-term debt	$ 650										$ 620		$ 650
Debt instrument interest rate	4.625%									4.625%	4.625%	4.625%	4.625%
Net proceeds from issuance of long term debt	$ 642
Underwriting fees and other related expenses	8
Obligation threshold for debt to become guaranteed	100
7.000% Senior Unsecured Notes Due May 2025 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate																	7.00%
Gain (loss) on extinguishment of debt								$ 20
Tender offer aggregate purchase price														$ 782
Tender offer early participation premium														18
Tender offer accrued interest														$ 14
Debt instrument purchased or redeemed remaining aggregate principal amount	$ 750
7.000% Senior Unsecured Notes Due May 2025 [Member] \| Tender Offer Purchase Price One [Member]
Debt Instrument [Line Items]
Tender offer purchase price per share \| $ / shares		$ 1,025.00
Tender offer principal amount price per share		1,000.00
Tender offer expiration date		Aug. 17, 2021
7.000% Senior Unsecured Notes Due May 2025 [Member] \| Tender Offer Purchase Price Two [Member]
Debt Instrument [Line Items]
Tender offer purchase price per share \| $ / shares		$ 995.00
Tender offer principal amount price per share		1,000.00
Tender offer expiration date		Aug. 31, 2021
Senior unsecured notes [Member] \| 2026 Euro Notes [Member]
Debt Instrument [Line Items]
Net proceeds from offering \| €					€ 445
Senior unsecured notes [Member] \| 2028 Notes [Member]
Debt Instrument [Line Items]
Net proceeds from offering			$ 790
Senior unsecured notes [Member] \| Redemption of 2023 Dollar Notes [Member]
Debt Instrument [Line Items]
Gain (loss) on extinguishment of debt									$ 22
Senior unsecured notes [Member] \| Dollar Tender Offer [Member]
Debt Instrument [Line Items]
Tender offer aggregate purchase price															$ 926
Tender offer early participation premium															16
Tender offer accrued interest															$ 2
Senior unsecured notes [Member] \| 6.625% Senior Notes Due May 2023 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate																	6.625%
Senior unsecured notes [Member] \| 6.625% Senior Notes Due May 2023 [Member] \| 2028 Notes [Member]
Debt Instrument [Line Items]
Debt instrument outstanding amount			908
Senior unsecured notes [Member] \| 6.625% Senior Notes Due May 2023 [Member] \| Dollar Tender Offer [Member] \| Tender Offer Purchase Price One [Member]
Debt Instrument [Line Items]
Tender offer purchase price per share \| $ / shares				$ 1,017.94
Tender offer principal amount price per share				1,000.00
Tender offer expiration date				Nov. 25, 2020
Senior unsecured notes [Member] \| 6.625% Senior Notes Due May 2023 [Member] \| Dollar Tender Offer [Member] \| Tender Offer Purchase Price Two [Member]
Debt Instrument [Line Items]
Tender offer purchase price per share \| $ / shares				$ 987.94
Tender offer principal amount price per share				1,000.00
Tender offer expiration date				Dec. 10, 2020
Senior unsecured notes [Member] \| Senior Notes 6.125% Due May 2023 [Member]
Debt Instrument [Line Items]
Debt instrument outstanding amount																	$ 250
Senior unsecured notes [Member] \| 2027 Notes [Member]
Debt Instrument [Line Items]
Long-term debt						$ 500
Debt instrument interest rate						5.375%
Debt instrument maturity date						May 31, 2027
Net proceeds from issuance of long term debt						$ 489
Debt instrument net issue discount						5
Underwriting fees and other related expenses						6
Obligation threshold for debt to become guaranteed						$ 100
Repurchase price obligation, percentage of principal amount redeemed in event of change of control						101.00%
Repurchase price obligation, percentage of principal amount redeemed						100.00%
Senior unsecured notes [Member] \| 4.000% Senior Unsecured Notes Due May 2026 [Member] \| 2026 Euro Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, face amount \| €					€ 450
Debt instrument interest rate					4.00%											4.00%
Debt instrument maturity date					May 31, 2026
Senior unsecured notes, payment terms							The 2026 Euro Notes require payment of principal at maturity and payments of interest semi-annually in cash and in arrears on May 15 and November 15 of each year.
Repurchase price obligation, percentage of principal amount redeemed in event of change of control					101.00%											101.00%
Repurchase price obligation, percentage of principal amount redeemed					100.00%
Debt instrument redemption price percentage of principal amount with net cash proceeds					35.00%											35.00%
Debt instrument redemption price percentage of principal amount excluding redemption date					104.00%											104.00%
Senior unsecured notes [Member] \| 4.000% Senior Unsecured Notes Due May 2026 [Member] \| Minimum [Member] \| 2026 Euro Notes [Member]
Debt Instrument [Line Items]
Obligation threshold for debt to become guaranteed																$ 100
Senior unsecured notes [Member] \| 5.750% Senior Unsecured Notes Due November 2028 [Member] \| 2028 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, face amount			$ 800
Debt instrument interest rate			5.75%
Debt instrument maturity date			Nov. 30, 2028
Senior unsecured notes, payment terms							The 2028 Notes require payment of principal at maturity and interest semi-annually in cash and in arrears on May 15 and November 15 of each year.
Underwriting fees and other related expenses			$ 10
Repurchase price obligation, percentage of principal amount redeemed in event of change of control			101.00%
Repurchase price obligation, percentage of principal amount redeemed			100.00%
Debt instrument redemption price percentage of principal amount with net cash proceeds			35.00%
Debt instrument redemption price percentage of principal amount excluding redemption date			105.75%
Senior unsecured notes [Member] \| 5.750% Senior Unsecured Notes Due November 2028 [Member] \| Minimum [Member] \| 2028 Notes [Member]
Debt Instrument [Line Items]
Obligation threshold for debt to become guaranteed			$ 100

Long-term Employee Benefits

12 Months Ended

Dec. 31, 2022

Retirement Benefits, Description [Abstract]

Long-term Employee Benefits

27. Long-term Employee Benefits

Plans Covering Employees in the U.S.

Chemours established a defined contribution plan, which covered all eligible U.S. employees. The purpose of the plan is to encourage employees to save for their future retirement needs. The plan is a tax-qualified contributory profit-sharing plan, with cash or deferred arrangement, and any eligible employee of Chemours may participate. Chemours matches 100% of the first 6% of the employee’s contribution election, and the plan’s matching contributions vest immediately upon contribution. In 2021, the Company enhanced its previous discretionary retirement savings contribution to provide eligible employees with a guaranteed annual contribution ranging from 1% to 3% for the first $0.1 of base salary based on age and years of service.

Plans Covering Employees Outside the U.S.

Pension coverage for employees of Chemours’ non-U.S. subsidiaries is provided, to the extent deemed appropriate, through separate plans established after the Separation and comparable to the EID plans in those countries. Obligations under such plans are either funded by depositing funds with trustees, covered by insurance contracts, or unfunded.

The following table sets forth the Company’s net periodic pension (cost) income and amounts recognized in other comprehensive income (loss) for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Service cost	$	(14	)	$	(15	)	$	(15	)
Interest cost		(7	)		(5	)		(6	)
Expected return on plan assets		18			20			17
Amortization of actuarial loss		(8	)		(7	)		(9	)
Amortization of prior service gain		2			2			3
Settlement loss		—			(1	)		(5	)
Curtailment gain		—			—			1
Total net periodic pension cost	$	(9	)	$	(6	)	$	(14	)

Net (loss) gain	$	(2	)	$	(22	)	$	4
Prior service benefit (cost)		2			—			(1	)
Amortization of actuarial loss		8			7			9
Amortization of prior service gain		(2	)		(2	)		(3	)
Settlement loss		—			1			5
Curtailment gain		—			—			4
Effect of foreign exchange rates		7			6			(9	)
Benefit (cost) recognized in other comprehensive income		13			(10	)		9
Total changes in plan assets and benefit obligations recognized in other comprehensive income	$	4		$	(16	)	$	(5	)

The following table sets forth the pre-tax amounts recognized in accumulated other comprehensive loss at years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Net loss	$	132		$	148		$	143
Prior service credit		(9	)		(9	)		(12	)
Total amount recognized in accumulated other comprehensive loss	$	123		$	139		$	131

The following table sets forth summarized information on the Company’s pension plans at December 31, 2022 and 2021.


	December 31,
	2022			2021
Change in benefit obligation:
Benefit obligation at beginning of year	$	575		$	584
Service cost		14			15
Interest cost		7			5
Plan participants’ contributions		2			2
Actuarial (gain) loss		(145	)		19
Benefits paid		(5	)		(4	)
Plan amendments		(2	)		—
Settlements and transfers		(4	)		(11	)
Currency translation		(35	)		(35	)
Benefit obligation at end of year		407			575
Change in plan assets:
Fair value of plan assets at beginning of year		585			604
Actual return on plan assets		(129	)		17
Employer contributions		10			17
Plan participants’ contributions		2			2
Benefits paid		(5	)		(4	)
Settlements and transfers		(4	)		(11	)
Currency translation		(37	)		(40	)
Fair value of plan assets at end of year		422			585
Total funded status at end of year	$	15		$	10

The following table sets forth the net amounts recognized in the Company’s consolidated balance sheets at December 31, 2022 and 2021.


	December 31,
	2022			2021
Non-current assets	$	50		$	55
Current liabilities		(1	)		(1	)
Non-current liabilities		(34	)		(44	)
Total net amount recognized	$	15		$	10

The accumulated benefit obligation for all pension plans was $357 and $493 as of December 31, 2022 and 2021, respectively.

For the year ended December 31, 2022, the liability component of the Company’s global pension plans generated a net actuarial gain of $145, mainly driven by $209 gain as a result of increases in discount rates. The gain was partially offset by $64 of losses primarily due to the impact of inflation and salary scale assumptions.

The asset component of the Company’s global pension plans realized a loss of $147 due to volatile equity and bond performance.


	December 31,
Pension plans with projected benefit obligation in excess of plan assets	2022		2021
Projected benefit obligation	$	121	$	142
Accumulated benefit obligation		104		119
Fair value of plan assets		86		97


	December 31,
Pension plans with accumulated benefit obligation in excess of plan assets	2022		2021
Projected benefit obligation	$	121	$	142
Accumulated benefit obligation		104		119
Fair value of plan assets		86		97

Assumptions

The Company generally utilizes discount rates that are developed by matching the expected cash flows of each benefit plan to various yield curves constructed from a portfolio of high-quality, fixed income instruments provided by the plans’ actuaries as of the measurement date. The expected rate of return on plan assets reflects economic assumptions applicable to each country.

The following tables set forth the assumptions that have been used to determine the Company’s benefit obligations and net benefit cost at December 31, 2022 and 2021.


	December 31,
Weighted-average assumptions used to determine benefit obligations	2022			2021
Discount rate		3.6	%		1.4	%
Rate of compensation increase (1)		3.5	%		3.4	%
Interest crediting rate (2)		2.5	%		1.0	%

(1)

The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant’s entire career at Chemours.

(2)


	December 31,
Weighted-average assumptions used to determine net benefit cost	2022			2021
Discount rate		1.4	%		1.0	%
Rate of compensation increase (1)		3.4	%		2.5	%
Expected return on plan assets		1.0	%		1.2	%

(1)

The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant’s entire career at Chemours.

Plan Assets

Each pension plan’s assets are invested through either an insurance vehicle, a master trust fund, or a stand-alone pension fund. The strategic asset allocation for each plan is selected by management, together with the pension board, where appropriate, reflecting the results of comprehensive asset and liability modeling. For assets under its control, Chemours establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in countries are selected in accordance with the laws and practices of those countries.

The following table sets forth the weighted-average allocation for the Company’s pension plan assets at December 31, 2022 and 2021.


	December 31,
	2022			2021
Cash and cash equivalents		11	%		8	%
U.S. and non-U.S. equity securities		36	%		37	%
Fixed income securities		53	%		55	%
Total weighted-average allocation		100	%		100	%

Fixed income securities include corporate-issued, government-issued, and asset-backed securities. Corporate debt investments encompass a range of credit risk and industry diversification.

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although Chemours believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

The following tables set forth the fair values of the Company’s pension assets by level within the fair value hierarchy at December 31, 2022 and 2021.


	Fair Value Measurements at December 31, 2022
	Total		Level 1		Level 2
Asset category:
Debt - government issued	$	47	$	7	$	40
Debt - corporate issued		113		23		90
U.S. and non-U.S. equities		151		31		120
Derivatives - asset position		40		—		40
Cash and cash equivalents		48		48		—
Other		2		—		2
Total pension assets at fair value		401	$	109	$	292
Pooled mortgage funds (1)		21
Total pension assets	$	422

(1)


	Fair Value Measurements at December 31, 2021
	Total		Level 1		Level 2
Asset category:
Debt - government issued	$	74	$	10	$	64
Debt - corporate issued		147		29		118
U.S. and non-U.S. equities		217		44		173
Derivatives - asset position		70		—		70
Cash and cash equivalents		46		46		—
Other		3		—		3
Total pension assets at fair value		557	$	129	$	428
Pooled mortgage funds (1)		28
Total pension assets	$	585

(1)

Pooled mortgage funds consist of funds that invest in residential mortgages. These funds generally allow for monthly redemption with 30 days' notice. Timing for redemption could be delayed based on the priority of the Company's request and the availability of funds. Interests in these funds are valued using the NAV per share practical expedient and are not classified in the fair value hierarchy.

For pension plan assets classified as Level 1 instruments within the fair value hierarchy, total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension plan assets classified as Level 2 instruments within the fair value hierarchy, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established, recognized vendors of market data and subjected to tolerance and/or quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates, and implied volatilities obtained from various market sources. With the exception of pooled mortgage funds, pooled funds are valued at the per-unit NAV as determined by the fund manager based on the value of the underlying traded securities.

Cash Flows – Defined Benefit Plans

Employer Contributions

For the years ended December 31, 2022, 2021 and 2020, Chemours contributed $10, $17, and $20, respectively, to its defined benefit plans.

Chemours expects to contribute $11 to its pension plans in 2023. The Company’s future contributions to its defined benefit pension plans are dependent on market-based discount rates, and, as stated in “Note 2 – Basis of Presentation” to these consolidated financial statements, may differ due to the impacts of the COVID-19 pandemic on the macroeconomic environment and other factors.

Future Benefit Payments

The following table sets forth the benefit payments that are expected to be paid by the plans over the next five years and the five years thereafter.


2023	$	11
2024		13
2025		14
2026		15
2027		18
2028 to 2032		111

Cash Flows – Defined Contribution Plan

Employer Contributions

For the years ended December 31, 2022, 2021 and 2020, Chemours contributed $31, $28, and $27, respectively, to its defined contribution plan.

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI https://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Leases - Build-to-suit Lease Obligation - Narrative (Details) - Discovery Hub [Member] $ in Millions	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Oct. 31, 2017 ft²
Lessee Lease Description [Line Items]
Build to suit lease area of land \| ft²			312,000
Build to suit lease liability reclassified as financing obligation	$ 93	$ 93
Build to suit lease asset capitalized in property, plant and equipment	$ 84	$ 88

Long-term Employee Benefits (Summary of Projected Benefit Obligations and Accumulated Benefit Obligations in Excess of Plan Assets) (Details) - Pension Plan [Member] - Foreign [Member] - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Pension plans with projected benefit obligation in excess of plan assets
Projected benefit obligation	$ 121	$ 142
Accumulated benefit obligation	104	119
Fair value of plan assets	86	97
Pension plans with accumulated benefit obligation in excess of plan assets
Projected benefit obligation	121	142
Accumulated benefit obligation	104	119
Fair value of plan assets	$ 86	$ 97

Debt - Other - Narrative (Details) - Financing Arrangement [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Funds borrowed for insurance premiums	$ 16	$ 11
Repayments to financing company	$ 16	$ 5

Debt - Schedule of Debt Principal Maturities (Details) - Senior Debt [Member] $ in Millions	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
2023	$ 13
2024	13
2025	1,095
2026	470
2027	495
Thereafter	1,403
Total principal maturities on debt	$ 3,489

Long-term Employee Benefits (Amounts Recognized in Balance Sheet) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Non-current assets	$ 50	$ 55
The accumulated benefit obligation for all pension plans	357	493
Pension Plan [Member] \| Foreign [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-current assets	50	55
Current liabilities	(1)	(1)
Non-current liabilities	(34)	(44)
Total net amount recognized	$ 15	$ 10

Commitments and Contingent Liabilities - Schedule of Current and Long-term Components of Accrued Litigation and Balance Sheet Locations (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Accrued litigation	$ 41	$ 36
PFAS Natural Resource Damages Matters [Member] \| Chemours, DuPont, Corteva, EID [Member] \| State of Delaware [Member]
Loss Contingencies [Line Items]
Accrued litigation		$ 25

Goodwill and Other Intangible Assets, Net - Schedule of Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Goodwill	$ 102,000,000	$ 102,000,000
Divestitures	0
Operating Segments [Member]
Goodwill [Roll Forward]
Goodwill	102,000,000	102,000,000	$ 153,000,000
Divestitures		(51,000,000)
Titanium Technologies [Member] \| Operating Segments [Member]
Goodwill [Roll Forward]
Goodwill	13,000,000	13,000,000	13,000,000
Thermal & Specialized Solutions [Member] \| Operating Segments [Member]
Goodwill [Roll Forward]
Goodwill	33,000,000	33,000,000	33,000,000
Advanced Performance Materials [Member] \| Operating Segments [Member]
Goodwill [Roll Forward]
Goodwill	$ 56,000,000	56,000,000	56,000,000
Other Segment [Member] \| Operating Segments [Member]
Goodwill [Roll Forward]
Goodwill			$ 51,000,000
Divestitures		$ 51,000,000

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Stock-based Compensation - Weighted Average Assumptions of Stock Option (Details) - Stock Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate	1.61%	0.91%	0.94%
Expected term (years)	6 years	6 years	6 years
Volatility	56.71%	63.85%	53.18%
Dividend yield	3.85%	4.16%	6.93%
Fair value per stock option	$ 9.89	$ 9.78	$ 3.74

Accounts and Notes Receivable, Net - Schedule of Accounts and Notes Receivable (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Accounts receivable - trade, net	$ 509	$ 644
VAT, GST and other taxes	88	41
Other receivables	29	35
Total accounts and notes receivable, net	$ 626	$ 720

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income	$ 578	$ 608	$ 219
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	291	317	320
Gain on sales of assets and businesses, net	(21)	(115)	(8)
Equity in earnings of affiliates, net	(22)	(11)	0
(Gain) loss on extinguishment of debt	(7)	21	22
Amortization of debt issuance costs and issue discounts	9	9	9
Deferred tax provision (benefit)	20	(77)	(120)
Asset-related charges	5	0	22
Stock-based compensation expense	27	34	16
Net periodic pension cost	9	6	14
Defined benefit plan contributions	(10)	(17)	(21)
Other operating charges and credits, net	(21)	18	(22)
Decrease (increase) in operating assets:
Accounts and notes receivable	91	(225)	175
Inventories and other operating assets	(390)	(202)	126
(Decrease) increase in operating liabilities:
Accounts payable and other operating liabilities	195	454	55
Cash provided by operating activities	754	820	807
Cash flows from investing activities
Purchases of property, plant, and equipment	(307)	(277)	(267)
Proceeds from sales of assets and businesses, net of cash divested	33	508	5
Foreign exchange contract settlements, net	3	(12)	27
Other investing activities	(13)	1	1
Cash (used for) provided by investing activities	(284)	220	(234)
Cash flows from financing activities
Proceeds from issuance of debt	0	650	800
Proceeds from accounts receivable securitization facility	0	0	12
Repayments on accounts receivable securitization facility	0	0	(122)
Proceeds from revolving loan	0	0	300
Repayments on revolving loan	0	0	(300)
Debt repayments	(68)	(854)	(943)
Payments related to extinguishment of debt	0	(18)	(16)
Payments of debt issuance costs	(1)	(11)	(10)
Payments on finance leases	(11)	(10)	(6)
Deferred acquisition-related consideration	0	0	(10)
Purchases of treasury stock, at cost	(495)	(173)	0
Proceeds from exercised stock options	51	23	16
Payments related to tax withheld on vested stock awards	(6)	(2)	(2)
Payments of dividends to the Company's common shareholders	(154)	(164)	(164)
Distributions to non-controlling interest shareholders	(1)	(1)	(4)
Cash used for financing activities	(685)	(560)	(449)
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents	(32)	(34)	38
(Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents	(247)	446	162
Cash, cash equivalents, restricted cash, and restricted cash equivalents at January 1,	1,551	1,105	943
Cash, cash equivalents, restricted cash, and restricted cash equivalents at December 31,	1,304	1,551	1,105
Cash paid during the year for:
Interest, net of amounts capitalized	164	180	208
Income taxes, net of refunds	131	149	78
Non-cash investing and financing activities:
Purchases of property, plant, and equipment included in accounts payable	79	89	31
Non-cash financing arrangements	0	0	16
Treasury stock repurchased, not settled	$ 1	$ 4	$ 0

Geographic and Segment Information - Summary of Reconciliation for Summary Financial Information for Reportable Segments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Depreciation and amortization	$ 291	$ 317	$ 320
Total assets	7,640	7,550	7,082
Purchases of property, plant, and equipment	307	277	267
Segment Total [Member]
Segment Reporting Information [Line Items]
Depreciation and amortization	270	287	290
Total assets	5,488	5,212	5,222
Purchases of property, plant, and equipment	300	272	251
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Depreciation and amortization	21	30	30
Total assets	2,152	2,338	1,860
Purchases of property, plant, and equipment	$ 7	$ 5	$ 16

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Investments in Affiliates - Schedule of Investments in Affiliates (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investments in Affiliates
Investments in affiliates	$ 175	$ 169	$ 167	$ 162
Chemours-Mitsui Fluorochemicals Company, Ltd. [Member] \| Japan [Member]
Investments in Affiliates
Investments in affiliates	$ 87	$ 98
Ownership	50.00%	50.00%
The Chemours Chenguang Fluoromaterials Company Limited [Member] \| China [Member]
Investments in Affiliates
Investments in affiliates	$ 36	$ 33
Ownership	50.00%	50.00%
Changshu 3F Zhonghao New Chemical Materials Co., Ltd. [Member] \| China [Member]
Investments in Affiliates
Investments in affiliates	$ 52	$ 38
Ownership	10.00%	10.00%

Investments in Affiliates - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity Method Investee [Member]
Investments in Affiliates
Net sales	$ 193	$ 144	$ 98
Purchases	$ 218	$ 180	$ 133
Consolidated Subsidiaries [Member] \| Minimum [Member]
Investments in Affiliates
Voting stock ownership percentage	20.00%
Consolidated Subsidiaries [Member] \| Maximum [Member]
Investments in Affiliates
Voting stock ownership percentage	50.00%

Income Taxes - Summary of Valuation Allowance (Details) - Valuation Allowance of Deferred Tax Assets [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at January 1,	$ 8	$ 24	$ 10
Charges to income tax expense	4		14
Release of valuation allowance		(16)
Balance at December 31,	$ 12	$ 8	$ 24

Research and Development Expense - Summary of R&D Expense by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Research and Development [Line Items]
Total research and development expense	$ 118	$ 107	$ 93
Titanium Technologies [Member]
Research and Development [Line Items]
Total research and development expense	34	36	31
Thermal & Specialized Solutions [Member]
Research and Development [Line Items]
Total research and development expense	25	20	18
Advanced Performance Materials [Member]
Research and Development [Line Items]
Total research and development expense	54	46	41
Other Segment [Member]
Research and Development [Line Items]
Total research and development expense	1	2	2
Corporate and Other [Member]
Research and Development [Line Items]
Total research and development expense	$ 4	$ 3	$ 1

Income Taxes - Summary of Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
U.S. operations (including exports)	$ 217	$ 44	$ (136)
International operations	524	632	315
Income before income taxes	$ 741	$ 676	$ 179

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Weighted Average Assumptions of Stock Options

The following table sets forth the weighted-average assumptions used at the respective grant dates to determine the fair values of the Company’s stock option awards granted during the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Risk-free interest rate		1.61	%		0.91	%		0.94	%
Expected term (years)		6.00			6.00			6.00
Volatility		56.71	%		63.85	%		53.18	%
Dividend yield		3.85	%		4.16	%		6.93	%
Fair value per stock option	$	9.89		$	9.78		$	3.74

Schedule of Stock Options Activity

following table sets forth Chemours’ stock option activity for the years ended December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Exercise Price (per Share)		Weighted-average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value (in Thousands)
Outstanding, December 31, 2019		6,056		$	20.92		4.71	$	19,087
Granted		2,778			14.42
Exercised		(1,124	)		14.23
Forfeited		(186	)		23.84
Expired		(165	)		29.99
Outstanding, December 31, 2020		7,359		$	19.21		6.21	$	63,894
Granted		1,153			24.35
Exercised		(1,376	)		17.01
Forfeited		(107	)		20.62
Expired		(62	)		36.71
Outstanding, December 31, 2021		6,967		$	20.32		6.60	$	101,261
Granted		1,031			25.98
Exercised		(3,041	)		16.76
Forfeited		(202	)		21.29
Expired		(87	)		32.78
Outstanding, December 31, 2022		4,668		$	23.61		7.08	$	42,668
Exercisable, December 31, 2022		2,189		$	25.71		5.78	$	20,561

Schedule of Restricted Stock Units Activity

The following table sets forth non-vested RSUs at December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2019		546		$	29.95
Granted		585			17.01
Vested		(161	)		38.68
Forfeited		(60	)		25.78
Non-vested, December 31, 2020		910		$	20.51
Granted		461			26.30
Vested		(188	)		24.33
Forfeited		(24	)		19.96
Non-vested, December 31, 2021		1,159		$	22.20
Granted		388			28.08
Vested		(473	)		20.97
Forfeited		(77	)		21.75
Non-vested, December 31, 2022		997		$	25.10

Schedule of Performance Share Units Activity

The following table sets forth non-vested PSUs at 100% of target amounts at December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2019		529		$	39.53
Granted		542			17.14
Vested		(176	)		35.84
Forfeited		(51	)		27.79
Non-vested, December 31, 2020		844		$	29.05
Granted		309			27.42
Vested		(122	)		52.34
Forfeited		(276	)		23.26
Non-vested, December 31, 2021		755		$	26.72
Granted		316			28.77
Vested		(213	)		43.83
Forfeited		—			—
Non-vested, December 31, 2022		858		$	22.48

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,102	$ 1,451
Accounts and notes receivable, net	626	720
Inventories	1,404	1,099
Prepaid expenses and other	82	75
Total current assets	3,214	3,345
Property, plant, and equipment	9,387	9,232
Less: Accumulated depreciation	(6,216)	(6,078)
Property, plant, and equipment, net	3,171	3,154
Operating lease right-of-use assets	240	227
Goodwill	102	102
Other intangible assets, net	13	6
Investments in affiliates	175	169
Restricted cash and restricted cash equivalents	202	100
Other assets	523	447
Total assets	7,640	7,550
Current liabilities:
Accounts payable	1,251	1,162
Compensation and other employee-related cost	121	173
Short-term and current maturities of long-term debt	25	25
Current environmental remediation	194	173
Other accrued liabilities	300	325
Total current liabilities	1,891	1,858
Long-term debt, net	3,590	3,724
Operating lease liabilities	198	179
Long-term environmental remediation	474	389
Deferred income taxes	61	49
Other liabilities	319	269
Total liabilities	6,533	6,468
Commitments and contingent liabilities
Equity
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 195,375,810 shares issued and 148,504,030 shares outstanding at December 31, 2022; 191,860,159 shares issued and 161,046,732 shares outstanding at December 31, 2021)	2	2
Treasury stock, at cost (46,871,780 shares at December 31, 2022; 30,813,427 shares at December 31, 2021)	(1,738)	(1,247)
Additional paid-in capital	1,016	944
Retained earnings	2,170	1,746
Accumulated other comprehensive loss	(343)	(364)
Total Chemours stockholders’ equity	1,107	1,081
Non-controlling interests		1
Total equity	1,107	1,082
Total liabilities and equity	$ 7,640	$ 7,550

Basis of Presentation

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Note 2. Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). In the opinion of management, all adjustments (consisting of normal, recurring adjustments) considered necessary for a fair presentation of the Company’s financial position and results of operations have been included for the periods presented herein. The notes that follow are an integral part of the Company’s consolidated financial statements.

Certain prior period amounts have been reclassified to conform to the current period presentation, the effect of which was not material to the Company’s consolidated financial statements.

Leases

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Leases

Note 14. Leases

The Company leases certain office space, laboratory space, equipment, railcars, tanks, barges, tow boats, and warehouses. Lease expense is recognized over the term of these leases on a straight-line basis. The Company’s leases have remaining terms of up to 24 years. Some leases of equipment contain immaterial amounts of residual value guarantees. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.

The following table sets forth the Company’s lease assets and lease liabilities and their balance sheet locations at December 31, 2022 and 2021.


		December 31,
	Balance Sheet Location	2022		2021
Lease assets:
Operating lease right-of-use assets	Operating lease right-of-use assets	$	240	$	227
Finance lease assets	Property, plant, and equipment, net (Note 13)		61		69
Total lease assets		$	301	$	296

Lease liabilities:
Current:
Operating lease liabilities	Other accrued liabilities (Note 19)	$	49	$	59
Finance lease liabilities	Short-term and current maturities of long-term debt (Note 20)		12		12
Total current lease liabilities			61		71
Non-current:
Operating lease liabilities	Operating lease liabilities		198		179
Finance lease liabilities	Long-term debt, net (Note 20)		49		60
Total non-current lease liabilities			247		239
Total lease liabilities		$	308	$	310

The following table sets forth the components of the Company’s lease cost for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Operating lease cost	$	51	$	66	$	88
Short-term lease cost		4		7		5
Variable lease cost		16		21		20

Finance lease cost:
Amortization of lease assets		8		12		8
Interest on lease liabilities		4		4		4
Total lease cost	$	83	$	110	$	125

The following table sets forth the cash flows related to the Company’s leases for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	56	$	70	$	91
Operating cash flows from finance leases		4		4		4
Financing cash flows from finance leases		11		10		6

Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities	$	65	$	45	$	23
Leased assets obtained in exchange for new finance lease liabilities		—		14		19

The following table sets forth the weighted-average terms and weighted-average discount rates for the Company’s leases at December 31, 2022 and 2021.


	December 31,
	2022			2021
Weighted-average remaining lease term (years):
Operating leases		10.0			11.0
Finance leases		5.4			6.3

Weighted-average discount rate:
Operating leases		5.23	%		5.30	%
Finance leases		5.42	%		4.80	%

The following table sets forth the Company’s lease liabilities’ maturities for the next five years and thereafter.


	Operating Leases		Finance Leases		Total
2023	$	61	$	14	$	75
2024		52		13		65
2025		42		13		55
2026		36		11		47
2027		23		8		31
Thereafter		91		13		104
Total lease payments		305		72		377
Less: Imputed interest		58		11		69
Present value of lease liabilities	$	247	$	61	$	308

The Chemours Discovery Hub

In October 2017, Chemours executed a build-to-suit lease agreement to construct a new 312,000-square-foot R&D facility located in the Science, Technology, and Advanced Research campus of the University of Delaware in Newark, Delaware (“Chemours Discovery Hub”). Chemours was deemed to be the owner for accounting purposes during construction of the facility. Construction was completed in the fourth quarter of 2019, and, upon its completion, Chemours evaluated whether a sale occurred for purposes of sale-leaseback accounting treatment. The Company determined that this transaction did not qualify for sale-leaseback accounting, and, as a result, the leasing arrangement is considered to be a financing transaction. At completion of the construction, the build-to-suit lease liability was reclassified as a financing obligation within long-term debt, net, and the build-to-suit lease asset was capitalized in property, plant and equipment, net. At December 31, 2022 and 2021, a financing obligation of $93 and $93, respectively, and property, plant, and equipment of $84 and $88, respectively, are recorded on the Company’s consolidated balance sheet.

The following table sets forth the Company’s minimum future payments due for the next five years and thereafter related to the Chemours Discovery Hub financing obligation.


2023	$	7
2024		7
2025		7
2026		7
2027		7
Thereafter		140
Total payments	$	175

Income Taxes - Summary of open tax years by significant jurisdiction (Details)	12 Months Ended
	Dec. 31, 2022
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| China [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2015
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| India [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2015
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| Mexico [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2016
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| Netherlands [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2020
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| Taiwan [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2015
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| Singapore [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2019
Non-U.S Jurisdiction [Member] \| Earliest Tax Year [Member] \| Switzerland [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2019
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| China [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| India [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| Mexico [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| Netherlands [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| Taiwan [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| Singapore [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
Non-U.S Jurisdiction [Member] \| Latest Tax Year [Member] \| Switzerland [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022
U.S Federal [Member] \| Earliest Tax Year [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2017
U.S Federal [Member] \| Latest Tax Year [Member]
Income Tax Contingency [Line Items]
Tax years open to examination	2022

Other Assets (Tables)

12 Months Ended

Dec. 31, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Assets

The following table sets forth the components of the Company’s other assets at December 31, 2022 and 2021.


	December 31,
	2022		2021
Capitalized repair and maintenance costs	$	240	$	195
Pension assets (1)		50		55
Deferred income taxes		152		171
Miscellaneous (2)		81		26
Total other assets	$	523	$	447

Pension assets represents the funded status of certain of the Company’s long-term employee benefit plans.

Financial Instruments - Narrative (Details)	12 Months Ended
Financial Instruments - Narrative (Details)	Dec. 31, 2022 USD ($) Contract	Dec. 31, 2021 USD ($) InterestRateSwap Contract	Dec. 31, 2020 USD ($)
Designated as Hedging Instrument [Member] \| Net Investment Hedge [Member]
Derivative [Line Items]
Recognized gain (loss) on derivative, pre-tax	$ 53,000,000	$ 73,000,000	$ (88,000,000)
Reclassification on derivative, pre-tax	$ 0	$ 0	0
Foreign currency forward contracts [Member]
Derivative [Line Items]
Number of forward exchange currency contracts \| Contract	9	12
Derivative notional value	$ 180,000,000	$ 254,000,000
Average maturity period of derivative contract	1 month	1 month
Foreign currency forward contracts [Member] \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative gains (losses)	$ 2,000,000	$ (15,000,000)	$ 29,000,000
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Foreign currency forward contracts [Member] \| Not Designated as Hedging Instrument [Member] \| Other Income (Expense), Net [Member]
Derivative [Line Items]
Gain (loss) reclassification on derivative cash flow hedge	$ 2,000,000	$ (15,000,000)	$ 29,000,000
Foreign currency forward contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivative [Line Items]
Number of forward exchange currency contracts \| Contract	153	175
Derivative notional value	$ 180,000,000	$ 195,000,000
Average maturity period of derivative contract	4 months	4 months
Derivative cash flow hedge net pre-tax gain from accumulated other comprehensive loss to cost of goods sold to be reclassified with in twelve months	$ 4,000,000
Recognized gains (losses) on derivative cash flow hedge, pre-tax	17,000,000	$ 10,000,000	(4,000,000)
Foreign currency forward contracts [Member] \| Designated as Hedging Instrument [Member] \| Cost of Goods Sold [Member] \| Cash Flow Hedge [Member]
Derivative [Line Items]
Gain (loss) reclassification on derivative cash flow hedge	19,000,000	(2,000,000)	3,000,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member]
Derivative [Line Items]
Derivative notional value		$ 400,000,000
Number of interest rate swaps \| InterestRateSwap		3
Cash settlement of derivative instrument	8,000,000
Interest rate swaps maturity date		Mar. 31, 2023
Recognized gains (losses) on derivative cash flow hedge, pre-tax	8,000,000	$ 2,000,000	$ (4,000,000)
Amount expects to reclassify of net loss from accumulated other comprehensive loss to interest expense, net	4,000,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member] \| London Interbank Offered Rate (LIBOR) [Member] \| Maximum [Member] \| Senior Secured Term Loan Facility [Member]
Derivative [Line Items]
Variable interest			1.75%
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member] \| London Interbank Offered Rate (LIBOR) [Member] \| Minimum [Member] \| Senior Secured Term Loan Facility [Member]
Derivative [Line Items]
Variable interest			0.00%
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member] \| Base Rate [Member] \| Maximum [Member] \| Senior Secured Term Loan Facility [Member]
Derivative [Line Items]
Variable interest			0.75%
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedge [Member] \| Base Rate [Member] \| Minimum [Member] \| Senior Secured Term Loan Facility [Member]
Derivative [Line Items]
Variable interest			1.00%
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Interest Expense [Member] \| Cash Flow Hedge [Member]
Derivative [Line Items]
Gain (loss) reclassification on derivative cash flow hedge	$ 5,000,000	$ (2,000,000)
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Interest Expense [Member] \| Cash Flow Hedge [Member] \| Maximum [Member]
Derivative [Line Items]
Gain (loss) reclassification on derivative cash flow hedge			$ 1,000,000

Net Sales - Narrative (Details) - Topic 606 [Member] $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Disaggregation Of Revenue [Line Items]
Remaining performance obligations	$ 31
Revenue, practical expedient, financing component	true

Other Accrued Liabilities - Schedule of Other Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accrued Liabilities, Current [Abstract]
Accrued litigation	$ 41	$ 36
Asset retirement obligations	10	14	$ 13
Income taxes	19	43
Customer rebates	90	83
Accrued interest	17	17
Operating lease liabilities	49	59
Miscellaneous	74	73
Total other accrued liabilities	$ 300	$ 325

Restructuring, Asset-Related, and Other Charges - Restructuring Program Schedule (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning	$ 1	$ 7
Credits to income	9	(2)
Payments	(4)	(4)
Restructuring reserve, ending	6	1
Site Closures [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning	1	2
Credits to income	0	(1)
Payments	(1)	0
Restructuring reserve, ending	0	1
2022, 2020 and 2019 Restructuring Programs [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning	0	5
Credits to income	9	(1)
Payments	(3)	(4)
Restructuring reserve, ending	$ 6	$ 0

Commitments and Contingent Liabilities - Summary of Asset Retirement Obligations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Balance at January 1,	$ 76	$ 76	$ 76
Obligations incurred or acquired			12
Increase (decrease) in estimated cash outflows	2	1	(14)
Accretion expense	10	2	4
Settlements and payments	(5)	(3)	(2)
Balance at December 31,	83	76	76
Current portion	10	14	13
Non-current portion	$ 73	$ 62	$ 63

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 31, 2022	Feb. 06, 2023	Jun. 30, 2022
Cover [Abstract]
Entity Registrant Name	The Chemours Company
Entity Central Index Key	0001627223
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Document Type	10-K
Trading Symbol	CC
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		148,335,834
Entity Shell Company	false
Entity File Number	001-36794
Entity Tax Identification Number	46-4845564
Entity Address, Address Line One	1007 Market Street
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19801
City Area Code	302
Local Phone Number	773-1000
Title of 12(b) Security	Common Stock ($0.01 par value)
Security Exchange Name	NYSE
Entity Incorporation, State or Country Code	DE
Document Annual Report	true
Document Transition Report	false
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Public Float			$ 5.0
ICFR Auditor Attestation Flag	true
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	New York, New York
Auditor Firm ID	238
Documents Incorporated by Reference	Documents Incorporated by Reference Portions of the registrant’s definitive proxy statement relating to its 2023 annual meeting of shareholders (the “2023 Proxy Statement”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2023 Proxy Statement will be filed with the U. S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.

Long-term Employee Benefits (Schedule of Net Periodic Pension (Cost) Income and Amounts Recognized in Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Total net periodic pension cost	$ (9)	$ (6)	$ (14)
Net (loss) gain	(2)	(22)	4
Prior service benefit (cost), pre-tax	2		(1)
Amortization of actuarial loss, pre-tax	8	7	9
Amortization of prior service gain	(2)	(2)	(3)
Curtailment gain			4
Effect of foreign exchange rates	7	6	(9)
(Cost) benefit recognized in other comprehensive income	13	(10)	9
Pension Plan [Member] \| Foreign [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	(14)	(15)	(15)
Interest cost	(7)	(5)	(6)
Expected return on plan assets	18	20	17
Amortization of actuarial loss	(8)	(7)	(9)
Amortization of prior service gain	2	2	3
Settlement loss		(1)	(5)
Curtailment gain			1
Total net periodic pension cost	(9)	(6)	(14)
Net (loss) gain	(2)	(22)	4
Prior service benefit (cost), pre-tax	2		(1)
Amortization of actuarial loss, pre-tax	8	7	9
Amortization of prior service gain	(2)	(2)	(3)
Settlement loss		1	5
Curtailment gain			4
Effect of foreign exchange rates	7	6	(9)
(Cost) benefit recognized in other comprehensive income	13	(10)	9
Total changes in plan assets and benefit obligations recognized in other comprehensive income	$ 4	$ (16)	$ (5)

Other Income (Expense), Net

12 Months Ended

Dec. 31, 2022

Other Income and Expenses [Abstract]

Other Income (Expense), Net

Note 8. Other Income (Expense), Net

The following table sets forth the components of the Company’s other income (expense), net for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021		2020
Leasing, contract services, and miscellaneous income (1)	$	53		$	14	$	20
Royalty income (2)		6			22		18
Gain on sales of assets and businesses, net (3)		21			115		8
Exchange (losses) gains, net (4)		(15	)		3		(26	)
Non-operating pension and other post-retirement employee benefit income (5)		5			9		1
Total other income, net	$	70		$	163	$	21

(1)

For the year ended December 31, 2022, miscellaneous income includes proceeds from a settlement of a patent infringement matter relating to certain copolymer patents associated with the Company’s Advanced Performance Materials segment.

(2)

Royalty income is primarily from technology licensing.

(3)

For the year ended December 31, 2022, gain on sale of assets and businesses, net includes pre-tax gain on sale of $5 related to the Beaumont Transaction and $18 related to the Pascagoula Transaction (see “Note 4 – Acquisitions and Divestitures”). For the year ended December 31, 2021, gain on sale of assets and businesses, net includes pre-tax gain on sale of $112 associated with the sale of the Company’s Mining Solutions business (see “Note 4 – Acquisitions and Divestitures”). For the year ended December 31, 2020, gain on sale includes a $6 gain associated with the sale of the Company’s Oakley, California site, which was contingent upon the completion of certain environmental remediation activities at the site.

(4)

Exchange gains (losses), net includes gains and losses on the Company’s foreign currency forward contracts that have not been designated as a cash flow hedge.

(5)

Non-operating pension and other post-retirement employee benefit income represents the non-service cost component of net periodic pension income (cost).

Earnings Per Share of Common Stock - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income attributable to Chemours	$ 578	$ 608	$ 219
Denominator:
Weighted-average number of common shares outstanding - basic	155,359,361	164,943,575	164,681,827
Dilutive effect of the Company's employee compensation plans	2,943,646	3,754,864	1,664,702
Weighted-average number of common shares outstanding - diluted	158,303,007	168,698,439	166,346,529
Basic earnings per share of common stock	$ 3.72	$ 3.69	$ 1.33
Diluted earnings per share of common stock	$ 3.65	$ 3.60	$ 1.32

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets

12 Months Ended

Dec. 31, 2022

Other Assets

17. Other Assets

The following table sets forth the components of the Company’s other assets at December 31, 2022 and 2021.


	December 31,
	2022		2021
Capitalized repair and maintenance costs	$	240	$	195
Pension assets (1)		50		55
Deferred income taxes		152		171
Miscellaneous (2)		81		26
Total other assets	$	523	$	447

Pension assets represents the funded status of certain of the Company’s long-term employee benefit plans.

Commitments and Contingent Liabilities - Schedule of Environmental Remediation Liabilities (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
On-site Surface Water and Groundwater Remediation [Member]
Environmental Remediation [Line Items]
Additional accrued environmental remediation		$ 64
Fayetteville Works, Fayetteville, North Carolina [Member]
Environmental Remediation [Line Items]
Additional accrued environmental remediation	$ 174	$ 181

Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Capitalized repair and maintenance costs	$ 240	$ 195
Pension assets	50	55
Deferred income taxes	152	171
Miscellaneous	81	26
Total other assets	$ 523	$ 447

Equity (Tables)

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Schedule of Share Repurchase Activity

The following table sets forth the Company’s share repurchase activity under the 2018 Share Repurchase Program for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Total number of shares purchased		7,824,039		5,533,746		-
Total paid for shares purchased	$	251	$	177	$	-
Average price paid per share	$	32.06	$	31.99	$	-

The following table sets forth the Company’s share repurchase activity under the 2022 Share Repurchase Program for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
Total number of shares purchased		8,234,314		-		-
Total paid for shares purchased	$	241	$	-	$	-
Average price paid per share	$	29.24	$	-	$	-

Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	$ 1,081
Other comprehensive income (loss)	21	$ (54)	$ 39
Ending Balance	1,107	1,081
Net Investment Hedge [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(21)	(76)	(10)
Other comprehensive income (loss)	40	55	(66)
Ending Balance	19	(21)	(76)
Cash Flow Hedge [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	5	(8)	2
Other comprehensive income (loss)	1	13	(10)
Ending Balance	6	5	(8)
Currency Translation Adjustment [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(236)	(120)	(231)
Other comprehensive income (loss)	(32)	(116)	111
Ending Balance	(268)	(236)	(120)
Defined Benefit Plans [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(112)	(106)	(110)
Other comprehensive income (loss)	12	(6)	4
Ending Balance	(100)	(112)	(106)
Accumulated Other Comprehensive (Loss) Income [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(364)	(310)	(349)
Other comprehensive income (loss)	21	(54)	39
Ending Balance	$ (343)	$ (364)	$ (310)

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Share-Based Payment Arrangement [Abstract]

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Tax Credit Carryforward [Line Items]
Earnings and Profits (E&P) of foreign subsidiaries	$ 531
Change in valuation allowance	4	$ (16)	$ 13
Net income tax expense related to transfer pricing uncertain tax positions	36
Deferred tax assets valuation allowance reversed		16
R&D tax credits	7	6	7
Unrecognized tax benefits.	65	5	7	$ 9
Penalties and interest	4	(1)	1
Effects of potential transfer pricing adjustments included in other assets	26
Income Tax Expense (Benefit)	163	68	(40)
Other Liabilities [Member]
Tax Credit Carryforward [Line Items]
Unrecognized tax benefits.	54
Deferred Tax Assets [Member]
Tax Credit Carryforward [Line Items]
Unrecognized tax benefits.	11
U.S State [Member] \| Expiration Between Years 2036 To 2040 [Member]
Tax Credit Carryforward [Line Items]
Tax loss carryforwards	4
Foreign [Member] \| Expiration Between Years 2026 to 2031 [Member]
Tax Credit Carryforward [Line Items]
Tax loss carryforwards	6
Foreign [Member] \| Expiration Between Years 2025 to 2031 [Member]
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	11
Foreign Subsidiary [Member]
Tax Credit Carryforward [Line Items]
Change in valuation allowance			12
Deferred tax assets valuation allowance reversed		12
Foreign Tax Credits [Member]
Tax Credit Carryforward [Line Items]
Change in valuation allowance	3	$ 1	$ 2
State Net Operating Losses [Member]
Tax Credit Carryforward [Line Items]
Change in valuation allowance	$ 1

Stock-based Compensation

12 Months Ended

Dec. 31, 2022

Stock-based Compensation

24. Stock-based Compensation

The Company’s total stock-based compensation expense amounted to $27, $34, and $16 for the years ended December 31, 2022, 2021 and 2020, respectively.

In 2017, Chemours’ stockholders approved Chemours’ Equity and Incentive Plan (the “Equity Plan”), which provides for grants to certain employees, independent contractors, or non-employee directors of the Company of different forms of awards, including stock options, RSUs, and PSUs, with 19,000,000 shares reserved for issuance. The Equity Plan replaced the Company’s prior plan adopted at Separation (the “Prior Plan”). As a result, no further grants will be made under the Prior Plan.

On April 28, 2021, Chemours’ stockholders approved an amendment and restatement of the Equity Plan to increase the number of shares of the Company’s common stock reserved for issuance by 3,050,000 shares.

Following the amendment and restatement of the Equity Plan, a total of 22,050,000 shares of the Company’s common stock may be subject to awards granted under the Equity Plan, less one share for every one share that was subject to an option or stock appreciation right granted after December 31, 2016 under the Prior Plan, and one-and-a-half shares for every one share that was subject to an award other than an option or stock appreciation right granted after December 31, 2016 under the Prior Plan. Any shares that are subject to options or stock appreciation rights will be counted against this limit as one share for every one share granted, and any shares that are subject to awards other than options or stock appreciation rights will be counted against this limit as one-and-a-half shares for every one share granted. Awards that were outstanding under the Prior Plan remain outstanding under the Prior Plan in accordance with their terms. The underlying share awards granted under the Prior Plan after December 31, 2016 that are forfeited, cancelled, or that otherwise do not result in the issuance of shares, will be available for issuance under the Equity Plan. At December 31, 2022, approximately 10,000,000 shares of the Equity Plan reserve are available for grants.

The Chemours Compensation and Leadership Development Committee determines the long-term incentive mix, including stock options, RSUs, and PSUs, and may authorize new grants annually.

Stock Options

During the years ended December 31, 2022, 2021 and 2020, Chemours granted non-qualified stock options to certain of its employees, which will vest over a three-year period and expire 10 years from the date of grant. The fair values of the Company’s stock options are based on the Black-Scholes valuation model.


	Year Ended December 31,
	2022			2021			2020
Risk-free interest rate		1.61	%		0.91	%		0.94	%
Expected term (years)		6.00			6.00			6.00
Volatility		56.71	%		63.85	%		53.18	%
Dividend yield		3.85	%		4.16	%		6.93	%
Fair value per stock option	$	9.89		$	9.78		$	3.74

The Company determined the dividend yield by dividing the expected annual dividend on the Company's stock by the option exercise price. A historical daily measurement of volatility is determined based on the blended volatilities of Chemours and the average of its peer companies, adjusted for Chemours’ debt leverage. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected term of the option granted. The expected term is determined using a simplified approach, calculated as the mid-point between the graded vesting period and the contractual life of the award.

The following table sets forth Chemours’ stock option activity for the years ended December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Exercise Price (per Share)		Weighted-average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value (in Thousands)
Outstanding, December 31, 2019		6,056		$	20.92		4.71	$	19,087
Granted		2,778			14.42
Exercised		(1,124	)		14.23
Forfeited		(186	)		23.84
Expired		(165	)		29.99
Outstanding, December 31, 2020		7,359		$	19.21		6.21	$	63,894
Granted		1,153			24.35
Exercised		(1,376	)		17.01
Forfeited		(107	)		20.62
Expired		(62	)		36.71
Outstanding, December 31, 2021		6,967		$	20.32		6.60	$	101,261
Granted		1,031			25.98
Exercised		(3,041	)		16.76
Forfeited		(202	)		21.29
Expired		(87	)		32.78
Outstanding, December 31, 2022		4,668		$	23.61		7.08	$	42,668
Exercisable, December 31, 2022		2,189		$	25.71		5.78	$	20,561

The aggregate intrinsic values in the preceding table represent the total pre-tax intrinsic value (the difference between the Company's closing stock price on the last trading day at the end of the year and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at year-end. The amount changes based on the fair market value of the Company’s stock. The total intrinsic value of all options exercised for the years ended December 31, 2022, 2021 and 2020 amounted to $45, $23, and $12, respectively.

For the years ended December 31, 2022, 2021 and 2020, the Company recorded $8, $10, and $9 in stock-based compensation expense specific to its stock options, respectively. At December 31, 2022, there was $9 of unrecognized stock-based compensation expense related to stock options, which is expected to be recognized over a weighted-average period of 1.83 years.

Restricted Stock Units

Chemours grants RSUs to key management employees that generally vest over a three-year period and, upon vesting, convert one-for-one to Chemours’ common stock. The fair value of all stock-settled RSUs is based on the market price of the underlying common stock at the grant date. RSUs vest contingent upon a time-based vesting condition and do not have explicit performance conditions.

The following table sets forth non-vested RSUs at December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2019		546		$	29.95
Granted		585			17.01
Vested		(161	)		38.68
Forfeited		(60	)		25.78
Non-vested, December 31, 2020		910		$	20.51
Granted		461			26.30
Vested		(188	)		24.33
Forfeited		(24	)		19.96
Non-vested, December 31, 2021		1,159		$	22.20
Granted		388			28.08
Vested		(473	)		20.97
Forfeited		(77	)		21.75
Non-vested, December 31, 2022		997		$	25.10

For the years ended December 31, 2022, 2021 and 2020, the Company recorded $11, $12, and $7 in stock-based compensation expense specific to its RSUs, respectively. At December 31, 2022, there was $12 of unrecognized stock-based compensation expense related to RSUs, which is expected to be recognized over a weighted-average period of 0.71 years.

Performance Share Units

Chemours grants PSUs to key senior management employees which, upon vesting, convert one-for-one to Chemours’ common stock if specified performance goals, including certain market-based conditions, are met over the three-year performance period specified in the grant, subject to exceptions through the respective vesting period of three years. Each grantee is granted a target award of PSUs, and may earn between 0% and 250% of the target amount depending on the Company’s performance against stated performance goals.

The following table sets forth non-vested PSUs at 100% of target amounts at December 31, 2022, 2021 and 2020.


	Number of Shares (in Thousands)			Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2019		529		$	39.53
Granted		542			17.14
Vested		(176	)		35.84
Forfeited		(51	)		27.79
Non-vested, December 31, 2020		844		$	29.05
Granted		309			27.42
Vested		(122	)		52.34
Forfeited		(276	)		23.26
Non-vested, December 31, 2021		755		$	26.72
Granted		316			28.77
Vested		(213	)		43.83
Forfeited		—			—
Non-vested, December 31, 2022		858		$	22.48

A portion of the fair value of PSUs was estimated at the grant date based on the probability of satisfying the market-based conditions associated with the PSUs using the Monte Carlo valuation method, which assesses probabilities of various outcomes of market conditions. The other portion of the fair value of the PSUs is based on the fair market value of the Company’s stock at the grant date, regardless of whether the market-based conditions are satisfied. The per unit weighted-average fair value at the date of grant for PSUs granted during the year ended December 31, 2022 was $28.77. The fair value of each PSU grant is amortized monthly into compensation expense based on its respective vesting conditions over a three-year period. Compensation cost is incurred based on the Company’s estimate of the final expected value of the award, which is adjusted as required for the portion based on the performance-based condition. The Company assumes that forfeitures will be minimal and recognizes forfeitures as they occur, which results in a reduction in compensation expense. As the payout of PSUs includes dividend equivalents, no separate dividend yield assumption is required in calculating the fair value of the PSUs.

For the years ended December 31, 2022, 2021, and 2020 the Company recorded stock-based compensation expense of $8, $12, and a reduction of stock-based compensation expense of less than $1 specific to its PSUs, respectively. At December 31, 2022, based on the Company’s assessment of its performance goals, approximately 1,120,000 additional shares may be awarded under the Equity Plan.

Employee Stock Purchase Plan

Since 2017, the Company has provided employees the opportunity to participate in Chemours’ Employee Stock Purchase Plan (“ESPP”). Under the ESPP, a total of 7,000,000 shares of Chemours’ common stock is reserved and authorized for issuance to participating employees, as defined by the ESPP, which excludes executive officers of the Company. The ESPP provides for consecutive 12-month offering periods, each with two purchase periods in March and September within those offering periods. Participating employees are eligible to purchase the Company’s common stock at a discounted rate equal to 95% of its fair value on the last trading day of each purchase period. To date, the Company has executed open market transactions to purchase the Company’s common stock on behalf of its ESPP participants, which amounted to 292,000 shares. The total amount of Chemours’ common stock received by employees in connection with the ESPP amounted to $7 at December 31, 2022.

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]
Dividends per share declared during period	$ 1.00	$ 1.00	$ 1.00

Other Liabilities - Schedule of Other Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Liabilities, Noncurrent [Abstract]
Employee-related costs	$ 82	$ 94
Accrued litigation	55	50
Asset retirement obligations	73	62	$ 63
Miscellaneous	109	63
Total other liabilities	$ 319	$ 269

Accounts and Notes Receivable, Net

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Accounts and Notes Receivable, Net

11. Accounts and Notes Receivable, Net

The following table sets forth the components of the Company’s accounts and notes receivable, net at December 31, 2022 and 2021.


	December 31,
	2022		2021
Accounts receivable - trade, net (1)	$	509	$	644
VAT, GST, and other taxes (2)		88		41
Other receivables (3)		29		35
Total accounts and notes receivable, net	$	626	$	720

(1)

(2)

Value added tax (“VAT”) and goods and services tax (“GST”) for various jurisdictions.

(3)

Accounts and notes receivable are carried at amounts that approximate fair value. Bad debt expense amounted to $9, $2 and $3 for the years ended December 31, 2022, 2021 and 2020, respectively.

The following table sets forth the change in the Company's allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Balance at January 1,	$	5		$	7		$	5
Additions charged to expenses		9			2			3
Deductions from reserves (1)		(4	)		(4	)		(1	)
Balance at December 31,	$	10		$	5		$	7

(1)

Bad debt write-offs were less than $1, $1, and $1 for the years ended December 31, 2022, 2021 and 2020, respectively.

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Components of Provision for (Benefit from) Income Taxes

The following table sets forth the components of the Company’s provision for (benefit from) income taxes for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Current tax expense (benefit):
U.S. federal	$	83		$	60		$	4
U.S. state and local		13			12			1
International		47			72			75
Total current tax expense		143			144			80
Deferred tax expense (benefit):
U.S. federal		8			(69	)		(86	)
U.S. state and local		(2	)		(6	)		(12	)
International		14			(1	)		(22	)
Total deferred tax expense (benefit)		20			(76	)		(120	)
Total provision for (benefit from) income taxes	$	163		$	68		$	(40	)

Schedule of Deferred Tax Assets and Liabilities Components

The following table sets forth the components of the Company’s deferred tax assets and liabilities at December 31, 2022 and 2021.


	December 31,
	2022			2021
Deferred tax assets:
Environmental and other liabilities	$	188		$	162
Employee related and benefit items		49			64
Other assets and accrual liabilities		133			111
Tax attribute carryforwards		73			91
Operating lease liability		57			56
Total deferred tax assets		500			484
Less: Valuation allowance		(12	)		(8	)
Total deferred tax assets, net		488			476
Deferred tax liabilities:
Property, plant, and equipment and intangible assets		(257	)		(244	)
LIFO inventories		(30	)		(18	)
Operating lease asset		(55	)		(53	)
Other liabilities		(55	)		(40	)
Total deferred tax liabilities		(397	)		(355	)
Deferred tax assets, net	$	91		$	121

Schedule of Effective Income Tax Rate


	Year Ended December 31,
	2022						2021						2020
	$			%			$			%			$			%
Statutory U.S. federal income tax rate	$	156			21.0	%	$	142			21.0	%	$	38			21.0	%
State income taxes, net of federal benefit		7			1.0	%		3			0.4	%		(11	)		(6.1	)%
Lower effective tax rate on international operations, net		(16	)		(2.2	)%		(19	)		(2.8	)%		(34	)		(19.0	)%
Foreign-derived intangible income deduction		—			—	%		(12	)		(1.8	)%		—			—	%
Goodwill		—			—	%		10			1.5	%		—			—	%
Depletion		(6	)		(0.8	)%		(7	)		(1.0	)%		(6	)		(3.4	)%
Exchange gains		(8	)		(1.1	)%		(13	)		(1.9	)%		—			—	%
Provision to return and other adjustments		(2	)		(0.3	)%		(11	)		(1.6	)%		(37	)		(20.6	)%
Valuation allowance		4			0.5	%		(16	)		(2.4	)%		13			7.3	%
Stock-based compensation		(9	)		(1.2	)%		(4	)		(0.6	)%		—			—	%
R&D credit		(7	)		(0.9	)%		(6	)		(0.9	)%		(7	)		(3.8	)%
Uncertain tax positions		36			4.9	%		(3	)		(0.4	)%		(1	)		(0.5	)%
Other, net		8			1.1	%		4			0.6	%		5			2.8	%
Total effective tax rate	$	163			22.0	%	$	68			10.1	%	$	(40	)		(22.3	)%

Schedule of Income (Loss) before Income Taxes

The following table sets forth the Company’s income (loss) before income taxes for its U.S. and international operations for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
U.S. operations (including exports)	$	217	$	44	$	(136	)
International operations		524		632		315
Income before income taxes	$	741	$	676	$	179

Schedule of open tax years by significant jurisdiction

The following table sets forth the Company’s significant jurisdictions’ tax returns that are subject to examination by their respective taxing authorities for the open years listed.


Jurisdiction		Open Years
China		2015 through 2022
India		2015 through 2022
Mexico		2016 through 2022
Netherlands		2020 through 2022
Singapore		2019 through 2022
Switzerland		2019 through 2022
Taiwan		2015 through 2022
U.S.		2017 through 2022

Schedule of Unrecognized Tax Benefits

The following table sets forth the change in the Company’s unrecognized tax benefits for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Balance at January 1,	$	5	$	7		$	9
Gross amounts of increases and decreases in unrecognized tax benefits as a result of adjustments to tax provisions taken during the prior period		54		(1	)		(2	)
Gross amounts of increases and decreases in unrecognized tax benefits as a result of tax positions taken during the current period		6		—			1
Reduction to unrecognized tax benefits as a result of a lapse of the applicable statute of limitations		—		(1	)		(1	)
Balance at December 31,	$	65	$	5		$	7

Total unrecognized tax benefits, if recognized, that would impact the effective tax rate	$	42	$	4		$	8
Total amount of interest and penalties recognized in the consolidated statements of operations		4		(1	)		1
Total amount of interest and penalties recognized in the consolidated balance sheets		4		1			1

Summary of Deferred Tax Asset Valuation Allowance

The following table sets forth a rollforward of the Company’s deferred tax asset valuation allowance for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Balance at January 1,	$	8	$	24		$	10
Charges to income tax expense		4		—			14
Release of valuation allowance		—		(16	)		—
Balance at December 31,	$	12	$	8		$	24

In connection with the classification of assets held for sale during the third quarter of 2021 related to the sale of the Mining Solutions Business on December 1, 2021, the Company recorded an income tax benefit of $16 related to the release of a valuation allowance on the deferred tax assets of one of its Mexican subsidiaries. The Company has evaluated all available positive and negative evidence, including the impact of the sale of the Mining Solutions business, as well as the future projections of profitability for the entity post sale. As a result, the Company determined that all of its deferred tax assets related to the Mexican subsidiary are more likely than not to be realized and accordingly reversed the valuation allowance against those deferred tax assets.

Income Taxes

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Note 9. Income Taxes

The following table sets forth the components of the Company’s provision for (benefit from) income taxes for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022			2021			2020
Current tax expense (benefit):
U.S. federal	$	83		$	60		$	4
U.S. state and local		13			12			1
International		47			72			75
Total current tax expense		143			144			80
Deferred tax expense (benefit):
U.S. federal		8			(69	)		(86	)
U.S. state and local		(2	)		(6	)		(12	)
International		14			(1	)		(22	)
Total deferred tax expense (benefit)		20			(76	)		(120	)
Total provision for (benefit from) income taxes	$	163		$	68		$	(40	)

The following table sets forth the components of the Company’s deferred tax assets and liabilities at December 31, 2022 and 2021.


	December 31,
	2022			2021
Deferred tax assets:
Environmental and other liabilities	$	188		$	162
Employee related and benefit items		49			64
Other assets and accrual liabilities		133			111
Tax attribute carryforwards		73			91
Operating lease liability		57			56
Total deferred tax assets		500			484
Less: Valuation allowance		(12	)		(8	)
Total deferred tax assets, net		488			476
Deferred tax liabilities:
Property, plant, and equipment and intangible assets		(257	)		(244	)
LIFO inventories		(30	)		(18	)
Operating lease asset		(55	)		(53	)
Other liabilities		(55	)		(40	)
Total deferred tax liabilities		(397	)		(355	)
Deferred tax assets, net	$	91		$	121

The following table sets forth an analysis of the Company’s effective tax rates for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022						2021						2020
	$			%			$			%			$			%
Statutory U.S. federal income tax rate	$	156			21.0	%	$	142			21.0	%	$	38			21.0	%
State income taxes, net of federal benefit		7			1.0	%		3			0.4	%		(11	)		(6.1	)%
Lower effective tax rate on international operations, net		(16	)		(2.2	)%		(19	)		(2.8	)%		(34	)		(19.0	)%
Foreign-derived intangible income deduction		—			—	%		(12	)		(1.8	)%		—			—	%
Goodwill		—			—	%		10			1.5	%		—			—	%
Depletion		(6	)		(0.8	)%		(7	)		(1.0	)%		(6	)		(3.4	)%
Exchange gains		(8	)		(1.1	)%		(13	)		(1.9	)%		—			—	%
Provision to return and other adjustments		(2	)		(0.3	)%		(11	)		(1.6	)%		(37	)		(20.6	)%
Valuation allowance		4			0.5	%		(16	)		(2.4	)%		13			7.3	%
Stock-based compensation		(9	)		(1.2	)%		(4	)		(0.6	)%		—			—	%
R&D credit		(7	)		(0.9	)%		(6	)		(0.9	)%		(7	)		(3.8	)%
Uncertain tax positions		36			4.9	%		(3	)		(0.4	)%		(1	)		(0.5	)%
Other, net		8			1.1	%		4			0.6	%		5			2.8	%
Total effective tax rate	$	163			22.0	%	$	68			10.1	%	$	(40	)		(22.3	)%

The following table sets forth the Company’s income (loss) before income taxes for its U.S. and international operations for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021		2020
U.S. operations (including exports)	$	217	$	44	$	(136	)
International operations		524		632		315
Income before income taxes	$	741	$	676	$	179

Management asserts that it is indefinitely reinvested with respect to all undistributed earnings prior to 2018 and, therefore, has not recorded deferred tax liabilities with respect to those earnings. Beginning in 2018, management determined that the Company’s earnings from certain foreign subsidiaries are not indefinitely reinvested and presumed such earnings will be distributed to the U.S. At December 31, 2022 and 2021, deferred tax liabilities for the foreign subsidiaries that are not indefinitely reinvested were not material to the Company’s consolidated financial statements. At December 31, 2022, the amount of indefinitely reinvested unremitted earnings was approximately $531. The potential tax implications of the repatriation of unremitted earnings are driven by the facts at the time of distribution; however, due to U.S. tax reform and the U.S. Transition Tax, the incremental cost to repatriate earnings is expected to be primarily related to withholding taxes and is not expected to be material.

For the years ended December 31, 2022 and 2021, the Company recorded $3 and $1 of valuation allowance on certain foreign tax credits, respectively. Additionally, the Company recorded $1 of valuation allowance on state net operating losses for the year ended December 31, 2022. For the year ended December 31, 2020, the Company recorded $12 of valuation allowance on certain foreign subsidiary net deferred tax assets, which was subsequently reversed during the year ended December 31, 2021, and $2 of valuation allowance on certain foreign tax credits.

The Company reviews its tax return positions, taking into account the progress of audits by various taxing jurisdictions and other changes in relevant facts and circumstances evident at each balance sheet date. At December 31, 2022, the Company recognized net tax expense of $36 related to transfer pricing uncertain tax positions. The Company maintains its as filed tax positions are appropriate and supportable.

Under the tax laws of various jurisdictions in which the Company operates, deductions or credits that cannot be fully utilized for tax purposes during the current year may be carried forward or back, subject to statutory limitations, to reduce taxable income or taxes payable in future or prior years. At December 31, 2022, the Company’s U.S state tax losses amounted to $4, which substantially expire between 2036 and 2040. The Company has foreign net operating losses of $6, which expire between 2026 and 2031, and $11 of certain foreign tax credits, which expire between 2025 and 2032.

Each year, Chemours and/or its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and non-U.S. jurisdictions.

The following table sets forth the Company’s significant jurisdictions’ tax returns that are subject to examination by their respective taxing authorities for the open years listed.


Jurisdiction		Open Years
China		2015 through 2022
India		2015 through 2022
Mexico		2016 through 2022
Netherlands		2020 through 2022
Singapore		2019 through 2022
Switzerland		2019 through 2022
Taiwan		2015 through 2022
U.S.		2017 through 2022

Positions challenged by the taxing authorities may be settled or appealed by Chemours and/or EID in accordance with the tax matters agreement. As a result, income tax uncertainties are recognized in the Company’s consolidated financial statements in accordance with accounting for income taxes, when applicable.

The following table sets forth the change in the Company’s unrecognized tax benefits for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Balance at January 1,	$	5	$	7		$	9
Gross amounts of increases and decreases in unrecognized tax benefits as a result of adjustments to tax provisions taken during the prior period		54		(1	)		(2	)
Gross amounts of increases and decreases in unrecognized tax benefits as a result of tax positions taken during the current period		6		—			1
Reduction to unrecognized tax benefits as a result of a lapse of the applicable statute of limitations		—		(1	)		(1	)
Balance at December 31,	$	65	$	5		$	7

Total unrecognized tax benefits, if recognized, that would impact the effective tax rate	$	42	$	4		$	8
Total amount of interest and penalties recognized in the consolidated statements of operations		4		(1	)		1
Total amount of interest and penalties recognized in the consolidated balance sheets		4		1			1

As of December 31, 2022, the total amount of unrecognized tax benefits was $65, of which $54 was recorded in other liabilities and $11 was recorded as an offset to deferred tax assets. In addition, accruals of $4 have been recorded for penalties and interest, as of December 31, 2022, in other liabilities. These liabilities at December 31, 2022 were reduced by $26 for offsetting benefits from the corresponding effects of potential transfer pricing adjustments included in other assets.

The following table sets forth a rollforward of the Company’s deferred tax asset valuation allowance for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
	2022		2021			2020
Balance at January 1,	$	8	$	24		$	10
Charges to income tax expense		4		—			14
Release of valuation allowance		—		(16	)		—
Balance at December 31,	$	12	$	8		$	24

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690